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Methods/Measurements:  A cross-sectional correlational design explored the 
relationships between symptoms, functional status, health perceptions and QoL in women with 
CVD.  The aims of the study were: 1) to determine the relationship of symptoms 
(depression/anxiety) to functional status (health-promoting behaviors), health perceptions (illness 
perception), and QoL; and 2) to determine whether age is a factor contributing to negative mood 
symptoms, functional status, health perceptions, and QoL after controlling for social support.  
Measurements were collected at one time-point to address these aims that included the 
following:  biological function (Framingham Recurrent Risk Model and Functional Comorbidity 
Index), symptoms (Patient Health Questionnaire-8 and Generalized Anxiety Disorder-7), 
functional status (Health-Promoting Lifestyle Profile-II), general health perceptions (Illness 
Perception Questionnaire-Revised-Cardiac version), QoL (Quality of Life Index-Cardiac 
version) and social support (Medical Outcomes Study-Social Support Survey).  A convenience 
sample of 81 women aged 35-78 years with CVD were recruited from two cardiology clinic sites 
within a single health care system in the Chicago west suburbs.  The study was approved by the 
institutional review boards from Advocate Health Care and Loyola University Chicago. 
Data Analysis:  The primary study hypothesis was that negative mood symptoms 
(depression/anxiety) will be associated with fewer health-promoting behaviors, less perception of 
risk (illness), and poorer QoL.  SPSS Statistics version 25 was used to perform all the analyses. 





correlations, and multiple regression. 
   Correlational analyses demonstrated the following: (1) more depressive symptoms were 
associated with greater anxiety symptoms (r = .689, p < .01), less health promoting behaviors (r 
= -.366, p < .01), poorer QoL (r = -.673, p < .01), less social support (r = -.380, p < .01), and 
greater functional comorbidities (r = .431, p < .01), (2) symptoms of higher anxiety were 
associated with less health promoting behaviors (r = -.328, p < .01), poorer QoL (r = -.687, p < 
.01), less social support (r = -.431, p < .01) and greater functional comorbidities (r = .345, p < 
.01), (3) better QoL was significantly associated with more health promoting behaviors (r = .535, 
p < .01).  When examining illness perception, correlations indicated that greater depressive and 
anxiety symptoms were associated with: (1) greater number of CVD symptoms (r = .274, p < 
.05; r = .246, p < .05), (2) less understanding of CVD (r = -.340, p < .01; r = -.322, p < .01), and 
that (3) CVD caused distress (r = .431, p < .01; r = .522, p < .01).   
Stepwise multiple regression method was used to determine the variables that predict 
QoL.  Anxiety symptoms ( = -.324 (SE = .120, t = -3.69, p < .001), health promoting behaviors 
( = .292 (SE = .014, t = 4.08, p < .001), functional comorbidities ( = -.257 (SE = .119, t = - 
3.68, p < .001), illness perception CVD caused distress ( = -.215 (SE = .067, t = -2.80, p < .01), 
and social support ( = .152 (SE = .026, t = 2.03, p < .05), were significant predictors of QoL.  
Greater anxiety symptoms, greater functional comorbidities, and the belief that CVD caused 
distress predicted poorer QoL.  Greater health promoting behaviors and greater social support 
predicted greater QoL.  Although depressive symptoms were not a predictor of QoL, there was a 
trend ( = -.178 (t = -1.85, p = .069) toward poorer QoL. An important finding is that anxiety 
symptoms ( = -.324) were a greater predictor of poorer QoL than depressive symptoms ( = -





The secondary hypothesis was that women who are younger will have more negative 
symptoms, fewer health-promoting behaviors, less perception of illness, and lower QoL than 
women who are older.  In order to test this hypothesis, Analysis of covariance (ANCOVA) for 
social support was used to examine differences between age groups (less than 65 or 65 and older) 
among the key study variables.  The analysis results found that younger women had lower QoL 
compared to the older women (F(1,78) = 5.81, p < .05).  In addition, there was a trend for 
younger women to have more anxiety symptoms (F(1,78) = 3.41, p = .068) and perceive more 
emotional distress related to CVD (F(1,78) = 3.86, p = .053). 
In summary, younger women with CVD reported worse outcomes than older women. 
These findings support the importance to target the younger women to treatments, such as 
antidepressant/anti-anxiety medications, education on CVD illness, and health promoting 
behaviors to increase their overall QoL.   
Nursing and Healthcare Implications:  Overall, findings from this study support the 
need to identify early detection of negative mood symptoms and implement interventions to 
promote healthy behaviors, address illness perceptions to improve QoL.  Collaborative care 
models, managed by advanced practice nurses, have been shown to be more effective in 
improving negative mood, healthy behaviors, and QoL in patients with CVD.  Ultimately, 
advanced practice nurses have the opportunity to develop evidence-based practice guidelines to 
develop and implement a collaborative care approach to improve women’s CVD health and QoL.  
The overall benefit could potentially reduce CVD secondary events that translate to cost savings 







Magnitude and Importance of the Problem 
Cardiovascular disease (CVD) is a widespread chronic illness that is a major cause of 
morbidity and mortality in the United States.  CVD is the leading cause of death for females in 
the United States accounting for 289,758 deaths in 2013 (American Heart Association, 2015; 
Kochanek, Xu, Murphy, Minino, & Kung, 2011; Mozaffarin et al., 2015; Roger et al., 2012; Xu, 
Murphy, Kochanek, & Bastian, 2016). One out of every three female deaths is due to CVD and 
the mortality rate continues to grow (American Heart Association, 2015). Statistics support the 
claim that heart disease has a significant impact on health care costs across the nation (Centers 
for Disease Control (CDC), 2014; Mozaffarin et al., 2015). In 2011, the estimated direct and 
indirect costs for CVD were approximately 320 billion dollars (National Heart Lung Blood 
Institute, 2012).  Over the past decade there has been an increased awareness of women and heart 
disease through campaigns such as “Go Red for Women”, although there remains an under-
representation of women in clinical trials examining CVD prevention (Low, Thurston, & 
Matthews, 2010).  There is a need to continue to study women with heart disease due to the 
increase in mortality rate in women as compared to men and the significant cost to health care.  
Depression 
 Depression is common and often unrecognized in CVD patients (Huffman, Celano, 




prevalent in individuals with CVD and has a significant association with increased morbidity and 
mortality rates, independent of traditional CVD risk factors (Lichtman et al., 2014; Meijer et al. 
2011; Rutledge et al., 2006.) Studies have found that depressed CVD patients have an increased 
risk for cardiac events (Gan et al., 2014; Huffman et al., 2013). These cardiac events have been 
attributed to poor adherence to healthy behaviors including exercise, diet modification, and 
smoking cessation (Kronish et al., 2006; Lichtman et al., 2014). Depression is present in 7.6% of 
the general population (Pratt & Brody, 2014) and may be as high as 20-40% in patients with 
CVD (Celano & Huffman, 2011).  Furthermore, 15-20% of patients with CVD meet the criteria 
for major depressive disorder (MDD) (Carney & Freedland, 2008; Lesperance, Frasure-Smith, 
Juneau, & Theroux, 2000; Thombs, Bass et al., 2006; Thombs, de Jonge et al., 2008). In 
conjunction with CVD demonstrating inflated levels of depression, reports suggest females are 
generally more susceptible to depression (Pratt & Brody, 2014; Vaccarino, 2010).   
Research data has shown that depression is often chronic and recurrent in individuals 
with stable CVD (Rudledge, Reis, Linke, Greenberg, & Mills, 2006).  Depression is a comorbid 
disorder that is significantly associated with worse illness perception and increased perceived 
symptoms in individuals with CVD (Mommersteeg, Pot, Aarnoudse, Denollet, & Widdershoven, 
2013; Rogerson, Murphy, Bird, & Morris, 2012).  Depression can worsen adherence to healthy 
behaviors making medication compliance, exercise, diet modification, and smoking cessation 
challenging for the patient (Bigger & Glassman, 2010; Pozuelo et al., 2009; Tsu, 2012).  
Anxiety 
Concomitant with depression are also increased levels of anxiety. Anxiety is a negative 




approximately 19 million adults in the US annually and have been associated with impaired 
QoL, increased adverse health behaviors, and poor outcomes related to chronic illness (Strine, 
Chapman, Kobau, & Balluz, 2005).  This suggests an individual’s emotional response may have 
an effect on behavioral changes. A meta-analysis of twenty studies found anxiety to be an 
independent risk factor for CVD and cardiac mortality (Roest, Martin, de Jonge, & Denollet, 
2010).  Anxious individuals had a 26 % increased risk of CVD and a 48 % increased risk for 
mortality (Roest et al., 2010). Anxiety has been associated with progressive atherosclerosis, 
ventricular arrhythmias, and decreased heart rate variability (Martens, Nyklíček, Szsabó, & 
Kupper, 2008; Paterniti et al., 2001; Van den Broek et al., 2009).  Anxiety has also been 
associated with an increase in mortality risk for middle aged women (Denollet, Maas, 
Knottnerus, Keyzer, & Pop, 2009).  Brezinka and Kittel (1996) reviewed nine studies examining 
emotional responses in men and women post myocardial infarction (MI).  Eight of the nine 
studies found anxiety and depression to be greater in women compared to men.  Unhealthy 
lifestyle behaviors, including decreased physical activity, smoking, and increased weight, were 
found in individuals with anxiety.   
Anxiety can alter an individual’s perception by creating an overwhelming feeling 
accompanied by a health threat message.  The health threat message alters the individual’s 
internal emotional response and creates a negative mood that becomes a barrier to healthy 
behavior. The individual adopts unhealthy behaviors in attempt to reduce the negative mood and 
reduce the anxiety (Rozanski, 2005).  The unhealthy behaviors used to reduce anxiety may 
include smoking, physical inactivity, or stress-related eating.  These harmful behaviors increase 




symptoms that adversely affect the health of individuals with CVD.  However, the link between 
mood and the illness perception in individuals with chronic CVD has yet to be clearly 
understood.  
Health-Promoting Behaviors 
Healthy behaviors are self-care behaviors that contribute to a significant reduction in 
CVD risk through prevention and management of the disease.  Healthy behaviors include diet, 
physical exercise, weight reduction, medication adherence, and smoking cessation.  Unhealthy 
lifestyle behaviors contribute to increased cardiovascular risk in women. Although risk factors 
for heart disease are similar for women and men, women with known CVD have worse outcomes 
than men (Pearson, 2010).  There is evidence to suggest that women are knowledgeable about 
cardiovascular risk reduction behaviors; however, many do not change their health behaviors or 
their change in behavior is not sustained (Mosca et al., 2006).  Data indicate that women who 
acknowledge risk factors for CVD, lack understanding of preventive strategies (Webster & 
Heeley, 2010).  This may suggest that factors, such as emotional responses, can alter a woman’s 
perception of illness, which may influence healthy behaviors for risk reduction. Women who do 
not make changes in their health behaviors are at significantly greater risk for MI, stroke, and 
death (Hammond et al., 2007; Mosca et al., 2006; Murphy et al., 2005).    
There is sufficient evidence to suggest why women are not successful in making 
alterations to their health behaviors (Hart, 2005; Thanavaro, 2005).  Such behaviors, known as 
barriers to change, include family/care-giving responsibilities, multiple role functions, confusion 
in the media of preventive strategies, lack of money for health insurance or medications, and 




of knowledge regarding relationship between cardiovascular risk factors and CVD, religious 
beliefs, stress, and depression (Mochari-Greenberger, Mills, Simpson, & Mosca, 2010). There is 
evidence indicating the significant role of negative mood symptoms (depression, anxiety) in 
illness perception, which in turn will influence CVD risk perception and self-care behaviors in 
individuals with chronic heart disease (McKenzie & Skelly, 2010; Mommersteeg et al., 2013; 
Strine et al., 2005).  
Unhealthy lifestyle behaviors have placed women at an increased risk for both primary 
and secondary CVD events.  Unhealthy lifestyle behaviors for CVD include eating patterns (high 
saturated and trans fat diets), sedentary lifestyle, overweight/obesity, tobacco use, and 
medication non-adherence.  Although there is an increase in awareness of healthy lifestyles to 
prevent CVD, some women continue to engage in unhealthy behaviors, where others do not.  
Barriers to healthy behavior change are plentiful and factual in women’s everyday life. Negative 
mood symptoms have been identified as a barrier to healthy behavior change in some 
individuals. Illness perception may predict an individual’s ability to adopt healthy behaviors. 
However, little research has been conducted regarding whether negative mood symptoms affect 
illness perception.  Although negative emotions are risk factors for developing CVD and a 
barrier to healthy behaviors, these emotions are not routinely screened for nor are they integrated 
into cardiology practice guidelines. Learning more about what prevents women from adopting 
healthy behaviors for secondary risk reduction for CVD events may have a positive impact on 
women’s health in the United States of America. 
Illness Perception 




but still only 54% of women recognize heart disease as the major cause of death for the female 
gender (Mosca, Mochari-Greenberger, Dolor, Newby, & Robb, 2010). Psychological factors that 
influence the prognosis for individuals with CVD is an important area for research (Fennessy, 
DeVon, Ryan, Lopez, & Zerwic, 2013; Smith, Pedersen, Van Domburg, & Denollet, 2008). 
Illness representation is the individual’s perception of the significance and meaning of a health 
threat or disease (Cherrington, Moser, Lennie, & Kennedy, 2004).  Illness perception is defined 
as an individual acknowledging they have disease, such as CVD, hypertension, heart failure, 
hyperlipidemia, arrhythmias, or obesity and/or diabetes.  Studies have demonstrated that illness 
perception affected patients’ health behaviors and the confidence to maintain long-term 
behavioral changes in patients with an acute MI (Steca et al., 2013).  There is limited information 
on whether negative mood symptoms (depression/anxiety) influence illness perception in 
individuals with chronic CVD. 
Risk Perception 
Risk perception is the degree of understanding one’s risk for illness/disease.  Higher 
levels of risk perception should increase one’s motivation to adopt healthy behaviors that will 
reduce the illness threat.  Studies have shown that women with increased risk perception for 
CVD do not engage in promoting changes in their healthy behaviors (Galbraith, Mehta, Veledar, 
Vaccarino, & Wenger, 2011).  Additionally, women with CVD underestimate their risk for 
future CVD events (Hart, 2005; Webster, 2010). One factor contributing to an individual’s 
decreased perception of risk is optimistic bias (Weinstein, 1982). Optimistic bias is when an 
individual overestimates the positivity of a situation.  In other words, the individual 




stroke.  An individual’s perception of risk for CVD is a major consideration in preventing further 
development of CVD (Mosca, Ferris, Fabunmi, & Robertson, 2004).  There are cognitive, 
perceptual, and environmental factors affecting risk perception of CVD in women (Ammouri & 
Neuberger, 2008; Dearborn & McCullough, 2008).  Cognitive factors include the individual’s 
knowledge and understanding of CVD risk factors, the number of current risk factors, and 
educational level.  Perceptual factors include symptoms, socio-economic variables, belief in a 
higher being in charge (God), and unrealistic optimism.  Environmental factors affecting risk 
perception are communication with healthcare providers, access to health care, media, and 
family/friends.  The focus on risk reduction for individuals with CVD should remain dynamic to 
prevent disease progression and the occurrence of cardiac events (Moore, Kimble, & Minick, 
2010). Individual perceptions of risk have been linked to risk reduction behavior, known as 
healthy behaviors. Psychological factors, such as depression/anxiety symptoms, may explain 
some of the resistance to behavior change seen in individuals with chronic heart disease.  There 
is limited data about psychological factors and risk perception for heart disease, especially in 
women with known CVD.   
Quality of Life (QoL) in Women with CVD 
QoL has been defined in terms of an individual’s overall satisfaction with life.  Health-
related quality of life (HRQoL) is a subcategory of QoL that conceptualizes and measures QoL 
with symptoms of a specific disease (Wilson and Cleary, 1985).  HRQoL was developed as a 
means of relating health status to satisfaction with life.  HRQoL contains three major 
characteristics:  multidimensional (physiological, psychological, sociological, spiritual), 




individual’s own thought or perception) (Ferrans & Powers, 1985; Padilla & Grant, 1985).  
HRQoL measures QoL and the way a disease expresses itself in an individual’s daily life. These 
include symptoms, functional ability, psychological states, social states, and physical wellness 
(Broddadottir, Jensen, Norris, & Graham, 2009).   There is no consensus in the healthcare 
disciplines on defining QoL and how to measure the concept, other than the general view that 
QoL is an important outcome of health care intervention (Anderson & Burckhardt, 1999).  This 
study used the term QoL to refer to an overall satisfaction with life maintained by the individual 
with CVD. 
QoL is lower in individuals with CVD compared to individuals without CVD, and 
women with CVD have worse QoL when compared to men with CVD (Ford et al., 2004).  When 
comparing QoL between men and women it has been found that women are worse off in the 
following categories: general health, physical functioning, social functioning, well-being, self-
esteem, depression levels, anxiety, and social supports (Broddadottir et al., 2009).  The effect 
that depressive/anxiety symptoms and age may have on QoL in gender comparison studies 
remains unclear.  Although women with CVD consistently report worse QoL compared to men 
with CVD, there is limited and inconsistent understanding of the effect of mood and age on QoL 
(Broddadottir et al., 2009).  
Social Support 
Social support is defined as support provided by tangible tasks, financial support, and 
support that is informational, emotional, and structural (Lett, Blumenthal, Babyak, & Strauman, 
2005; Sherbourne & Stewart, 1991).  Social support consists of two domains: functional support 




network that includes providing information, a sense of being loved, and help with tasks.  
Structural support describes the characteristics of the social network that includes group 
membership, number/frequency of contacts, and marital status (Barth, Schneider, & von Kanel, 
2010). This support provides a positive influence for individuals to better cope with stressful 
encounters.  Social support is a known predictor of CVD etiology and prognosis. Impaired social 
support is a known predictor for greater CVD mortality.  In addition, social support has been 
found to have a positive influence on healthy behaviors and QoL (Lett et al., 2005; Stanuite, 
Brozaitiene, & Bunevicius, 2013).  
Older Population 
The past several decades have shown a significant growth in the number of older adults 
in the United States.  The first Baby Boomers came to age 65 years in 2011, predicting an 
increase in the older population for the next twenty years (West, Cole, Goodkind, & He, 2014). 
The older population (> 65 years) is estimated to increase from 12.4% to 20.3% between 2000 
and 2030 (West et al., 2014).  The subgroup of individuals 85 years and older is expected to 
triple by 2050.  There is a significant disproportion of older women compared with older men, 
with women outnumbering men by 3.6 million among those aged 65 years and over (West et al., 
2014). Studies have found that women develop CVD disease approximately ten years later than 
men.  Women have a longer life expectancy and develop CVD at an older age resulting in a 
higher prevalence of heart disease in women over the age of sixty five years of age.  Studies have 
indicated 10% to 15% of older patients (age ≥ 65 years) with CVD are depressed and 20% show 
symptoms of anxiety (Berkman et al., 2000; Williams et al., 2002).  Few studies have evaluated 




known heart disease.  There may be a difference in negative mood symptoms and illness 
perception in women of older age (≥ 65 years) compared with middle-aged populations. Older 
aged women with and without CVD have been found to have less depressive symptoms 
compared with middle-aged women (Broddadottir et al., 2009;  Rutledge et at., 2012;  Shah et 
al., 2014).  Broddadottir et al. (2009) found depressive symptoms were greater in younger 
women (32-59 years) compared to middle age (age 60-75 years) or older (age 76–88 years) 
women with CVD.  Rutledge et al. (2012) studied women (n = 620) with suspected ischemic 
heart disease and found depressive symptoms were greater in middle-aged women (mean age 56 
years) compared to older (mean age 59 years) women.  Shah et al. (2014) studied women with 
CVD (n = 1071) and found depressive symptoms were greater in younger women (< 55 years) 
compared to middle-aged (56 – 64 years) or older aged (≥ 65 years) women.  Mirowsky and 
Ross (1992) found depressive symptoms to be most prevalent among younger adults (age 18-39 
years) followed by older adults (≥ 65 years) and least prevalent in middle-aged adults (40 - 64 
years).  Keyes (2004) found depressive symptoms were most prevalent in women with CVD 
between the ages of 45 and 74 years.  Beckie, Fletcher, Groer, Kip & Ji (2015) examined women 
with CAD (n = 252) after acute coronary syndrome (ACS) or MI and found anxiety and 
depressive symptoms to be greater in younger women (< 55 years) compared to older women.  
Fang et al. (2018) studied anxiety symptoms in men and women post MI and found anxiety 
symptoms were greater in younger women and men (age < 65 years) compared to older 
individuals. There are limited and inconsistent findings in the literature on individuals with CVD 






The theoretical framework that guided this study was proposed by Wilson and Cleary 
(1995) who integrate biological, psychological, and social facets of health outcomes to examine 
HRQoL.  Their model was developed to conceptualize the relationships of pertinent clinical 
variables to measures of HRQoL.  The theory examines causal relationships between multiple 
health concepts that affect an individual’s QoL.  The model is comprised of individual and 
environmental characteristics that influence an individual’s symptoms, functional status, general 
health perceptions and overall QoL (Wilson & Cleary, 1995).  Individual characteristics include 
one’s own preferences or values and environmental characteristics include social, economic, and 
psychological support.  Wilson-Cleary’s model examines the relationships among five different 
levels of patient outcomes: biological and physiological variables, symptoms status, functional 
status, health perceptions, and overall QoL.  The biological and physiological variables are 
medical diagnoses, laboratory values, and physical examination findings that affect an 
individual’s health status.  The symptom status concept includes physical, emotional, and 
cognitive symptoms perceived by the individual.  Functional status measures the physical and 
social roles and the psychological function of the individual.  General health perception is a 
subjective rating of all the preceding health concepts, including mental health.  Overall QoL is 
the individual’s subjective well-being that is assessed by how happy and/or satisfied the 
individual is with life as a whole.  Wilson-Cleary’s model has provided a framework that was 
best suited to guide the proposed study because it identifies the multiple key concepts that affect 




revision of the Wilson-Cleary model, which indicates that biological function is influenced by 
individual and environmental characteristics.   
For the proposed study, the revised Wilson-Cleary’s Model for HRQoL (Figure 1) was 
used to examine mood symptoms, general health perception, functional status and QoL.  The 
characteristics of the individual included age, race/ethnicity, marital status, education, 
socioeconomic status, and employment.  The biological variables for the proposed study were 
cardiovascular risk factors and comorbidities measured by the Framingham Recurrent Risk 
Model and the Functional Comorbidity Index tool.  Evidence shows that cardiovascular risk 
factors and the number of comorbidities influence one’s risk for a secondary CVD event, as well 
as mortality (Mozaffarian et al., 2015).  Symptom status assessed depressive symptoms (Patient 
Health Questionnaire-8, PHQ-8) and anxiety symptoms (Generalized Anxiety Disorder-7, GAD-
7).  Functional status was assessed by health promotion behaviors (Health-Promoting Lifestyle 
Profile-II scale, HPLP-II).  General health perceptions was assessed by asking women with CVD 
their perception of cardiac illness (Illness Perception Questionnaire-Revised Cardiac version, 
IPQ-R Cardiac).  There is evidence that functional status has an effect on health perceptions, as 
health perceptions influence functional status. Consequently, a reciprocal relationship is 
indicated on this model with permission of Dr. Carol Ferrans (Personal Communication, June 1, 
2016).  QoL measured overall satisfaction with life that included the following subscales: health 
and functioning, social and economic, psychological and spiritual, and family (Quality of Life 
Index-Cardiac version, QLI-Cardiac).  Lastly, environmental characteristics included social 





Figure 1. Study conceptualization using the revised Wilson and Clearly Health-Related Quality 












Purpose of the Study 
 
Purpose of the Study 
The purpose of this study was to better understand whether negative mood symptoms 
(depression, anxiety) contributed to the lack of successful change in healthy behaviors in women 
with known CVD.  Negative mood symptoms may impact illness perception which may be 
related to a decrease in health-promoting behaviors, which negatively impacts QoL. Therefore, 
this study examined the effect of negative mood symptoms on functional status, general health 
perceptions, and QoL.  For this study, the concept of mood was assessed by examining the 
symptoms of depression and anxiety using the PHQ-8 and the GAD-7 instruments.      
Characteristics of the Individual 
 Age, Race, Ethnicity, Marital, Education, 
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Study Aims and Hypotheses 
The primary aims and hypotheses were:  
Aim 1:  To determine the relationship of symptoms (depression, anxiety) to functional 
status (health-promoting behaviors), health perceptions (illness perception), and QoL.   
Hypothesis:  Negative mood symptoms (depression or anxiety) will be associated with 
fewer health-promoting behaviors, less perception of risk (illness), and poorer QoL. 
Aim 2: To determine whether age is a factor contributing to negative mood symptoms, 
functional status, health perceptions, and QoL after controlling for social support.  
Hypothesis:  Women who are younger will have more negative symptoms, fewer health-
promoting behaviors, less perception of risk, and lower QoL than women who are older (≥ 65 
years) after controlling for social support. 
The study identified the effect mood had on functional status, health perceptions, and QoL, 
and whether age was a contributing factor.  This knowledge will benefit nursing practice by 
enabling advanced practice nurses (APNs) to target the factors that affect functional status and 
QoL.  These findings may support the benefits of regular screening for depression and anxiety 
symptoms in cardiology clinics. Identifying and treating depression and anxiety symptoms may 
promote positive illness perception, which may help improve treatment and disease outcomes in 







 The theoretical framework that guided this study was the revised Wilson and Cleary’s 
HRQoL model.  As described in the previous chapter, the key components included the 
following:  individual characteristics, biological function, symptom status, functional status, 
general health perception, and environmental factors.  Each theoretical component of the HRQoL 
model will be presented with its supporting literature to justify its inclusion in this study.   
Characteristics of the Individual 
Women and Heart Disease 
CVD is the leading cause of death for females in the United States, accounting for 
289,758 deaths in 2013 (American Heart Association, 2015; Kochanek, Xu, Murphy, Minino, & 
Kung, 2011; Mozaffarin et al., 2015; Roger et al., 2012; Xu, Murphy, Kochanek, & Bastian, 
2016). One out of every three female deaths is due to CVD and the mortality rate continues to 
grow (American Heart Association, 2015). The risk for CVD increases as women become older.  
Studies have found women develop CVD approximately ten years later than men. CVD is 
present in 69.1% of men and 67.9% of women between the ages of 60-79. Of said percentages, 
11.3% of men and 4.2% of women had an MI.  There is a higher proportion of CVD in men than 
women before the age of 75 years, but after this age the paradigm shifts with women accounting 
for the higher proportion of CVD.  In the age group exceeding 80 years, CVD is comparable 




and 8.9% of women experienced an MI.  Women have a longer life expectancy and develop 
CVD at an older age, resulting in a higher prevalence of heart disease over 65 years of age.   
Similarly, the mortality rate from an MI increases with age, especially over the age of 80 
years. One year after an acute MI, women over the age of 45 years who have had an MI have a 
26% mortality rate compared to 19% in men (Mozaffarin et al., 2015). The mortality rate five 
years after a first MI is 47% in women and 36% in men (McSweeney et al., 2016). The disparity 
in deaths between men and women may be due to the fact that women have MIs at an older age 
than do men, and as one ages there is a greater incidence of comorbidities.  Diabetes, 
hypertension, hypercholesterolemia, and genetic history of heart disease are more prevalent in 
women with CVD than men with CVD (Shirato & Swan, 2010).  The greater number of 
cardiovascular risk factors increases the likelihood for a cardiac event. 
There are racial/ethnic variations in CVD in the United States with a higher occurrence in 
black women (7%) compared to Hispanic (5.9%) and white (4.6%) women.  The same trend is 
found with MI (2.2%, 1.7%, and 1.8% respectively) and angina (5.0%, 3.8%, and 2.9%) (Go et 
al., 2014).  Low income, low educational level and crime-ridden neighborhoods are found to 
influence CVD risk reduction behaviors in women without CVD (Finkelstein, Khavjou, Mobley, 
Haney, & Will, 2004; Mosca et al., 2006).  Low income may influence an unhealthy diet and an 
unsafe neighborhood may limit physical activity. 
The delay in diagnosis and treatment of MI contributes to an increase in mortality.  The 
difference in cardiac symptoms between men and women may account for the delay in diagnosis 
and treatment for women.  Although the most frequent cardiac symptoms prior to an ACS in men 




indigestion, palpitations, nausea, numbness of the hands, and weakness (Devon, Ryan, Ochs, & 
Shapiro, 2008; Eastwood, Johnson, Rutledge, Bittner, Whittaker et al., 2013).  The latter 
symptoms reported by women are not the typical symptoms associated with ACS and may 
contribute to a delay in diagnosis.  The World Health Organization (WHO), Northern Sweden 
Multinational MONItoring of Trends and Determinants of CArdiovascular Disease (MONICA) 
study examined symptoms and time delay to medical presence in men (n = 5072) and women (n 
= 1470) with MI over a 15-year period (Isaksson, Holmgren, Lundblad, Brulin, & Eliasson, 
2008). There was no gender difference in prehospital delay until after the age of 65.  The 
individuals 65 and older had a longer time preceding hospitalization and fewer typical MI 
symptoms, compared to those under the age of 65.  In addition, overall women had longer 
prehospital delay compared to men (Isaksson et al., 2008).  There are many studies that provide 
insight into the delay in seeking care for women.  One of the largest contributors to delay in 
treatment is women’s inability to identify MI symptoms and promptly seek medical care 
(Isaksson, Brulin, Eliasson, Naslung, & Zingmark, 2013).  Another contributing factor to delay 
care is the healthcare provider’s uncertainty in diagnosing CVD and less aggressive treatment 
when women disclose chest symptoms.   
Secondary prevention of heart disease involves the long-term management of cardiac risk 
factors in women with known CVD.  Individuals with CVD are considered to be at high risk for 
a secondary event.  Individuals  ≥ 65 years of age with a first MI will have a recurrent MI or fatal 
coronary heart disease (CHD) event within five years. The breakdown of statistics shows 21% 
Caucasian men and women, 33% black men, and 26% of black women will experience such 




men, 23% of white women, and 24% of black women within this five year time period (Rogers 
et al., 2012).  There is a high rate of adverse outcomes in older patients, especially minorities, 
with CVD supporting the need for secondary prevention of cardiac events.   
Biological Function 
Patients with a history of coronary artery disease (CAD) have an increased risk of 
subsequent cardiac events, including MI, stroke, or death.  Women with CAD are considered to 
be at high risk for a secondary cardiac event (Mosca et al., 2010).  The American Heart 
Association (AHA) and the American College of Cardiology Foundation (ACCF) guidelines for 
secondary prevention include healthy lifestyle changes and medication adherence, as well as 
blood pressure < 140/90 mmHg, low density lipoprotein (LDL) < 100mg/dL and cardiac 
rehabilitation (Smith et al., 2011).  The number of cardiac risk factors correlates to the percent of 
risk for a secondary cardiac event (D’Agostino et al., 2000).  The greater the number of risk 
factors, the greater the risk for a secondary event.  The traditional risk factors for CVD in women 
are comparable to those in men and include tobacco use, inactivity, obesity, dyslipidemia, 
hypertension, diabetes mellitus, older age, and family history (Yusuf et al., 2004).   
There are specific risk factors for women that increase their risk for a cardiac event.  The 
female specific risk factors are menopause and depression.  Menopause causes the loss of 
estrogen and low estrogen levels contributes to endothelial dysfunction (McSweeney et al., 
2016).  Although it continues to remain controversial, lack of estrogen may contribute to CAD in 
postmenopausal women.  There is also a greater occurrence of depression in women compared to 
men.  Depression contributes to adverse physiological and psychosocial function, increasing the 




and recommends screening and treating depression in cardiac patients to decrease the risk for 
secondary events (Lichtman et al., 2008; Smith et al., 2011). 
Individuals with CAD typically have other comorbid conditions, such as diabetes, 
hypertension, hypercholesterolemia, and tobacco use.  This may be partly due to the fact that 
CAD usually occurs in an individual at an older age, 60 years or greater.  For decades, research 
studies have identified that comorbid conditions have been found to have a negative effect on 
QoL in individuals with heart disease (Jamieson et al., 2002; Stewart et al., 1989).  Patients may 
differ significantly in their general health perception due to their comorbid illnesses (Groll et al., 
2005).  Some comorbid illnesses, for example arthritis or chronic obstructive pulmonary disease, 
may impact physical function, contributing to less engagement in health-promoting behaviors 
that require physical exercise.  It is essential to adjust for comorbid illnesses when examining the 
relationship between negative mood symptoms, illness perception, health-promoting behaviors, 
and overall QoL.  This is of particular importance in the older populations where more chronic 
illnesses are present in the same individual (Groll et al., 2005).    
Symptom Status 
Depression 
 Depression is a known risk factor for the development of CVD in healthy individuals and 
for recurrent CVD events in patients with known CVD disease (Lichtman et al., 2008; Lichtman 
et al., 2014; Low et al., 2010).  Gan et al. (2014) conducted a meta-analysis based on thirty 
prospective cohort studies to examine the association between depression and the risk of CHD.  
The studies included a total of 893,850 participants from both genders during a follow-up 




from the thirty studies, with twenty-seven reports measuring the outcome CHD and thirteen 
reports measuring the outcome MI.  The pooled relative risks for depression were 1.30, 95% CI 
[1.22-1.40] for CHD and 1.30, 95% CI [1.18-1.44] for MI (Gan et al., 2014). The data shows a 
positive association between depression and risk for CHD.  There was moderate heterogeneity 
among the studies. 
Most subgroup analyses, which were stratified by sex, mean age at baseline, publication 
year, duration of follow-up, study location, and type of depression measure—whether smoking, 
body mass index (BMI), diabetes, hypertension, physical activity, cholesterol or socioeconomic 
status were controlled or not—found similar associations between depression, CHD, and MI 
(Gan et al., 2014).  Two major findings from the subgroup analysis were that 1) depression was 
an independent risk factor for CHD, and 2) depression increased the risk for CHD in the group 
with less than a 15-year follow-up.  There was a positive association between depression and 
CHD after the subgroup analysis was adjusted for smoking, BMI, hypertension, diabetes, 
physical activity, and socioeconomic status.  It was found that depression significantly increased 
the risk for CHD in the group of less than a 15-year follow-up although not for the group equal 
or greater than the 15-year follow-up.  It is possible that over time, treated depressive individuals 
may weaken the association between depression and CHD risk. Nonetheless, data confirm that 
depression is associated with CHD (Gan et al., 2014). 
This report also noted that depression, assessed using self-reported measurement scales 
rather than structured clinical diagnosis, had a stronger association with CHD.  Within the meta-
analysis, twenty-two studies administered a validated self-report depressive symptom 




(BDI), Center of Epidemiology Studies Depression Scale (CES-D), Geriatric Depression Scale 
(GDS), General Health Questionnaire (GHQ), General Well-Being Schedule-Depressed Mood 
(GWB), Hospital Anxiety Depression Scale-D (HADS-D), Mental Health Index-5 (MHI-5), 
Minnesota Multiphasic Personality Inventory-Depression-Obvious Depression Subscale (MMPI-
OBD), and the Zung Self Rating Depression Scale (ZSDS) (Gan et al., 2014). Self-reported 
depression scales will allow the inclusion of individuals with significant depressive symptoms 
who fail to meet formal criteria for a diagnostic disorder, which may have been the reason for 
this positive association.  However, individuals with depressive symptoms are important to 
include since there is a large body of evidence that associates depressive symptoms to adverse 
functional outcomes, disability, morbidity, and mortality (Lichtman et al., 2008).   
Anxiety  
 There is evidence that anxiety has an adverse effect on prognosis in CVD patients 
independent of depression (Grace, Abbey, Irvine, Shnek, & Stewart, 2004; Roest, Zuidersma, & 
de Jonge, 2012; Rothenbacher, Hahmann, Wust, Koenig, & Brenner, 2007; Shibeshi, Yound-Xu, 
& Blatt, 2007; Strik, Denollet, Lousberg, & Honig, 2003).   Although there are several studies 
that suggest anxiety is associated with the development of CVD and MI, there are other studies 
that found no association. Roest et al. (2010) conducted a meta-analysis using prospective 
studies examining the association between anxiety and heart disease in healthy individuals.  The 
aim of the analysis was to assess the association between common anxiety constructs (anxiety, 
panic, phobia, post-traumatic stress, and worry) and the incident of CHD (Roest et al., 2010).  
Twenty one studies were included in the meta-analysis.  Of these twenty-one studies, twenty 




249,846 participants with follow-up periods ranging from 2.0-20.9 years.  The mean age at 
baseline assessment ranged from 38-72 years.  The analysis included studies of males (n = 9), 
females (n = 5), and both (n = 6).  Findings indicated a positive association between anxiety and 
CHD after adjusting for the covariates of demographic variables, biological risk factors, and 
health behaviors (Roest et al., 2010).  Overall, there was a 26% increase in incident CHD (HR 
1.26, 95% CI [1.15-1.38]) and a 48% increase in cardiac mortality (HR 1.48, 95% CI [1.14-1.92] 
for cardiac mortality and HR 1.43, 95% CI [0.85-2.40] for nonfatal MI).  However, it should be 
noted that these results were based on subgroup analysis of only five studies.   
Batelaan, Seldenrijk, Bot, van Balkom, and Penninx (2016) conducted a meta-analysis 
comprised of thirty seven studies of men and women (n = 1,565,699) to determine the 
independent association and causality between anxiety and incident CVD.  The follow-up ranged 
from 1-24 years.  The results found anxiety was associated with a 52% risk for increased 
incidence of CVD (HR 1.52, 95% CI [1.36-1.71]).  The CVD risk seemed independent of 
depression and the traditional CVD risk factors.  
Tully, Cosh, and Baune (2013) provided a narrative review of experimental and 
observational studies to present psychophysiological and behavioral pathways upon 
cardiovascular function. These pathways illustrated the involvement of worry and generalized 
anxiety disorder (GAD).  The review included studies from 1975-2011 that examined GAD and 
worry on cardiac function in individuals with and without CVD.  Excessive and uncontrollable 
worry is the hallmark clinical symptom of GAD (Andrews et al., 2010).  The review identified 
that worry had physiological effects of diminished heart rate variability and elevated heart rate 




al., 2011).  GAD and worry were found to be associated with hypertension and use of 
hypertension medications, but independent of depression. Individuals with established CAD and 
GAD showed an increased risk for major cardiac events independent of depression (Frasure-
Smith & Lesperance, 2008; Martens et al., 2010; Tully et al., 2011).   
Frasure-Smith and Lesperance (2008) examined the effect that major depression and 
GAD had on major adverse cardiac events in stable CAD patients (n = 804) two years after the 
initial CAD event.  MDD (OR 2.55, 95% CI [1.38-4.73]), GAD (OR 2.47, 95% CI [1.23-4.97]), 
the elevated Beck Depression Inventory-II (BDI-II) (OR 1.66, 95% CI [1.20-2.73]), and the 
elevated Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scale (OR 1.66, 95% CI 
[1.12-2.47]) all predicted major adverse cardiac events.  The results of the study suggest that 
GAD is associated with adverse cardiac outcomes independent of MDD. Martens et al. (2010) 
examined the effect of GAD on subsequent cardiovascular events (n = 1015) in stable outpatient 
CHD patients.  GAD was associated with a 62% higher rate of cardiovascular events (HR 1.62, 
95% CI [1.11 – 2.37]) after adjusting for demographics, comorbid conditions (including major 
depression), cardiac disease severity, and medication use.  Patients with CHD and GAD were 
frequent smokers, practiced less adherence to medications, and performed less physical activity.  
Tully et al. (2011) examined depression and anxiety in relation to cardiac surgery 
morbidity (n = 158).  Cardiac morbidity included stroke, renal failure, ventilation > 24 hours, 
deep sternal wound infection, reoperation, arrhythmia, and 30-day mortality.  GAD was 
associated with increased cardiac morbidity (OR = 3.26, 95% CI [1.10-9.67], p = 0.03).  
One study found individuals with CAD and GAD (n = 436) had a lower risk for major 




conducted a longitudinal study that examined the effect GAD had on cardiac outcome five years 
after the initial CAD event.  Cardiac outcome was a composite measure of cardiac admission, 
cardiac death, and/or a cardiac event between the one month and five year review. GAD was 
associated with a reduced risk for cardiac outcome (OR = .35, 95% CI [.17-.75]). GAD was 
believed to be associated with constructive worry that may influence seeking out medical care 
for symptoms and participating in cardiac rehabilitation programs (Parker et al., 2011).  Worry 
was not shown to be beneficial for promoting healthy behaviors in individuals with CVD.   
Low et al. (2010) conducted a literature review (1995-2009) examining the relationship 
between psychosocial risk factors and CHD in women.  The psychosocial risk factors included 
negative mood (depression, anxiety, hostility, and anger suppression), stress, social relationships, 
and positive psychological factors (optimism, positive well-being, sense of vitality, and 
emotional control). The two negative moods, depression and anxiety, will be reported because 
these two moods will be examined in the research proposal.  Depression was twice as common 
among women compared to men and was a consistent predictor of both initial and recurrent 
CHD among women.  Fifteen studies examined depression and incident CHD and 75% of the 
studies found depression was related to incident CHD in women (RR 1.03-3.00, with most less 
than 2.0).  Seven studies examined the association between depression and recurrent CHD and 
found that depression was associated with recurrent cardiac events.  Seven studies found anxiety 
was associated with increased risk for CHD in healthy men and women (RR 1.30-4.20).  Two 
studies examined the association between anxiety and recurrent cardiac events.  One study found 
that anxiety in patients with CHD predicted cardiac mortality one year post-MI for men but not 




Bourassa, 1999).   Another study found anxiety and depression to predict greater major adverse 
cardiac events (cardiac death, MI, cardiac arrest, or non-elective revascularization) in men and 
women within two years after hospital discharge for ACS (Frasure-Smith & Lesperance, 2008).  
Overall, evidence indicates that depression and anxiety are independently associated with 
increased CHD and recurrent cardiac events. 
Functional Status 
 For this study, the variable of functional status will be examined relative to health-
promoting behaviors. Several studies have identified that women are less likely to engage in 
healthy behaviors to reduce the risk for CVD even though they are knowledgeable about CVD 
(Hart, 2005; Mochari-Greenberger et al., 2010; Mosca et al., 2006; Tanavaro, 2005).  There are 
several studies examining the lack of CVD risk-reduction behaviors in women who are 
knowledgeable on heart disease. The findings from these studies support examining whether 
negative mood symptoms contribute to decreased healthy behaviors.  
There is a strong link between depression and CVD with depression contributing to 
adverse physiological and behavioral factors, such as lower adherence to health-promoting 
behaviors.  Huffman et al. (2013) summarized findings from a literature review on depression 
and cardiac disease.  The summary included associations between depression and cardiac 
outcomes and whether healthy behaviors mediated the link. Studies have found that individuals 
with depression are less likely to engage in healthy behaviors.  Depressed patients are less likely 
to eat a low-salt low-fat diet, exercise regularly, adhere to medications, reduce stress, and 




Waechter, Josephson, & Rosneck, 2008; May et al., 2010; McGrady, McGinnis, Badenhop, 
Bentle, & Rajput, 2009; Whooley et al., 2008; Ziegelstein et al., 2000).   
Bauer et al. (2012) examined the association between improvements in depression and 
anxiety and adherence to healthy behaviors in depressed patients with heart disease (acute 
coronary syndrome, heart failure, or arrhythmia).  The Medical Outcomes Study Specific 
Adherence Scale (MOS-SAS) questionnaire was used to measure adherence to healthy behaviors 
using a 5-point Likert scale with 0 = never and 5 = always.  Four items were used to measure 
adherence to healthy behaviors.  Total scores range from 0-20, with higher scores indicating 
better adherence.  The healthy behaviors assessed were adherence to a low-salt low-fat diet, 
exercise, stress reduction, and medications.  The study consisted of 134 participants, men (n = 
65) and women (n = 69), with a mean age of 61.49, who were enrolled in a randomized trial of 
collaborative depression management care. The depression collaborative care was a twelve-week 
intervention that was guided by a psychiatrist’s recommendation of depression care and a case 
manager who provided serial assessments of depression.  Adherence to healthy behaviors was 
measured at six weeks, twelve weeks, and six months in both groups.  The depressed individuals 
had significantly less healthy behavior adherence compared to the non-depressed with significant 
(p < 0.001) between-group differences at all three time points. Patients receiving the 
collaborative care intervention had significantly greater decreases in depression and anxiety at 
six and twelve weeks compared to those in usual care.  Adherence scores at six weeks in the 
depressed patients versus the non-depressed patients were 14.4 versus 16.5 (t = 4.19, p < 0.001).  
Scores at twelve weeks were depressed 14.2 and non-depressed 16.7 (t = 4.08, p < 0.001) and six 




strong and significant relation between change in depression score and adherence at six months 
(β 0.263, p < 0.001). Anxiety score changes at six months were not associated with adherence. 
Results of the study concluded that an improvement in depression was associated with an 
improvement in healthy behavior adherence.  Anxiety patients with an improvement in their 
anxiety symptoms had an improvement in healthy behaviors at six weeks, but no improvement at 
twelve weeks or six months.  Less improvement in anxiety compared to depression may be due 
to the intervention which focused on depression and not anxiety.  Adequate adherence to healthy 
behaviors has been shown to improve cardiac risk factors and decrease cardiac events in ACS 
patients (Chow et al., 2010; Gehi, Ali, Na, & Whooley, 2007). Symptoms of anxiety may have a 
lesser impact on adherence to healthy behaviors.  Some patients with anxiety may be more 
focused on health concerns that may lead to greater adherence to healthy behaviors. However, 
other patients with anxiety may be restrained by the anxious symptoms and unable to adhere to 
healthy behaviors. 
Ziegelstein et al. (2000) studied men (n = 116) and women (n = 88) post-MI to determine 
whether depression affects adherence to healthy behaviors for CVD risk reduction.  Depression 
was measured by interview and the BDI scale three to four days following their MI.  The 
Medical Outcomes Study Specific Adherence Scale (MOS-SAS) questionnaire was used to 
measure healthy adherence behaviors four months after admission to the hospital. The behaviors 
are diets consisting of low sodium, fat, and cholesterol; medication adherence; exercise; stress 
reduction; carrying medical supplies (e.g., nitroglycerine); diabetic diet for diabetic patients; 
smoking cessation; and social support. Patients with mild to moderate depression or major 




low-fat diet (F1,197 = 3.82, p = .046), regular exercise (F1,197 = 6.88, p < .01), reducing stress 
(F1,158 = 8.42, p < .004), and increasing social support at four months (F1,158 = 4.11, p < .04).  
Patients with major depression and/or dysthymia also reported poor medication adherence (F1,197 
= 4.82, p <.03).  Overall, the results of the study found that depressed patients post-MI had poor 
adherence to recommended healthy cardiac behaviors.  
The Heart and Soul Study found that behaviors, particularly physical inactivity, explained 
the association between depression and adverse CVD events (Whooley et al., 2008).  The 
purpose of the Heart and Soul Study was to examine why depressive symptoms are associated 
with a greater risk for CVD events.  The participants were men and women (n = 1017) with 
established CAD (MI, 50% stenosis in one or more coronary arteries, exercise induced ischemia, 
history of coronary revascularization or diagnosis of CAD) included in the study and 201 (20%) 
had depressive symptoms (Whooley et al., 2008).  Individuals with depressive symptoms 
compared to those without depressive symptoms reported greater symptom burden, physical 
inactivity, decreased QoL, and worse health status.  Exercise is a healthy behavior that is 
recommended for individuals with CVD to prevent worsening of their chronic illness, prevent 
secondary events, and improve mood. 
Benyamini et al. (2013) conducted a longitudinal study in Israel with post-MI patients (n 
= 540) focusing on predictors of QoL.  Participants included in the study were both men (n = 
437) and women (n = 103) with an age ≤ 65 years.  The study examined whether negative mood 
(depression and anxiety) due to an MI diagnosis were related to QoL ten years later and the 
degree to which these associations are mediated by health behaviors reported five years post-MI.  




found that negative moods were significantly related to health behaviors.  Anxiety was 
associated with greater health behaviors and depression associated with worse health behaviors 
at five years post MI.  Both anxiety and depression were related to decreased QoL ten years post-
MI. 
The effect of anxiety on healthy behaviors in individuals post-MI is not as widely studied 
as depression. Some researchers have suggested that anxiety can have positive, motivating 
effects while others have suggested that anxiety produces avoidant and restrictive behaviors 
(Herrmann, Brand-Driehorst, Buss and Ruger, 2000).  Kuhl, Fauerbach, Bush, and Ziegelstein 
(2009) conducted a study similar to their previously reported study examining depression.  Kuhl 
et al. (2009) studied the association between anxiety and adherence to healthy behaviors after 
MI.  The participants for the study were male (n = 158) and female (n = 120) patients who were 
assessed for anxiety and adherence to healthy behaviors in the hospital post-MI and four months 
after hospital discharge.  The MOS-SAS questionnaire was used to measure behavior adherence.  
Results of the study found that women had greater anxiety compared to men and that anxiety 
symptoms were significantly greater at the four-month follow-up.  Baseline anxiety was 
associated with a lower adherence to regular exercise, stress reduction, smoking cessation, and 
better adherence to carrying medical supplies.  There was no significant association between 
baseline anxiety and diet.  Anxiety measured at four months was associated with lower 
adherence to a low-sodium diet (p = 0.021), low fat diet (p = 0.013), regular exercise (p < 0.001), 
stress reduction (p = 0.001), socialization (p = 0.003), and overall adherence (p < 0.001). The 
summary scores for anxiety were associated with worse adherence to exercise (r = -0.16, p = 




smoking cessation (r = -0.26, p = 0.001), and better adherence to carrying medication (r = 0.15, p 
= 0.041). Anxiety independently predicted poor adherence to smoking cessation and increasing 
socialization.  Living alone was not associated with anxiety at baseline, but was associated with 
anxiety at four months. Overall, in post-MI patients, anxiety during the hospitalization and four 
months later was associated with decreased adherence to several healthy behaviors for CVD risk 
reduction.  There may be an optimal level of anxiety in post-MI patients where it becomes 
motivating rather than a debilitating factor. 
General Health Perceptions 
General health perceptions are a strong predictor of the use of medical and mental health 
services, as well as a strong predictor of mortality (Wilson & Cleary, 1995).  Those individuals 
who assess their health as poor are more likely to die sooner than those who perceive their health 
as good (Benyamini, Leventhal, & Leventhal, 2000). Health perceptions are purely subjective 
and are influenced by biological variables, symptom status, and functional status.  Although 
health perceptions are influenced by these other concepts, they nonetheless are different and 
require a separate measurement component (Ferrans et al., 2005).  A major component of an 
individual’s perception of their overall general health is the influence exerted by the individual’s 
perception of illness or disease (Weinman, Petrie, Moss-Morris, & Horne, 1996).  For this study, 
the variable of general health perceptions will be examined relative to illness perceptions.  
Illness Perception 
Illness perceptions are an individual’s beliefs and expectations, based on a variety of 
sources, regarding their illness.  These perceptions have been shown to relate to functional status, 




2002).  Individuals who have negative illness perceptions have more depressive symptoms, 
poorer adherence behaviors, and poorer functional status.  A review of the literature found 
studies examining whether illness perception influenced negative mood symptoms (depression 
and/or anxiety) in individuals with CAD.   
Foxwell, Morley, and Frizelle (2013) conducted a narrative review of quantitative peer-
reviewed research studies (n = 21) that measured illness perception and either QoL or mood 
(depression and/or anxiety) in individuals over the age of eighteen years with CHD.  The aim of 
the review was to examine the relationship between illness perceptions, QoL, and mood in CHD 
populations.  The studies included both male and female genders although there was a greater 
representation of males (72.72%) compared to females (27.28%). The mean age across the 
studies was 62.43 years.  The majority of the studies used the Illness Perception Questionnaire- 
Revised (IPQ-R) measurement tool that measures illness perception using six subscales:  
identity, timeline, cause, coherence, consequences, and control. The review found a consistent 
relationship between negative illness perceptions and elevated depression and anxiety across the 
CHD (MI, angina, CAD, percutaneous coronary artery angioplasty (PTCA) or coronary artery 
bypass graft (CABG) population.  Lack of illness understanding led to a perception of greater 
negative consequences, and low personal and treatment control had the strongest relationship to 
elevated depression and anxiety.  The findings from this narrative review will be broken down 
and reported according to the IPQ-R subscales. 
In terms of the IPQ-R, the identity subscale has not shown any significant relationships 
relative to depression (Foxwell et al., 2013). However, one study found a positive correlation and 




Macleod, & Sensky, 2006). Anxious individuals thought that they were at greater risk for a 
subsequent MI and had more cardiac symptoms on the identity scale (Ratcliffe et al., 2006).   
In terms of the negative consequences subscale, the majority of the studies found a 
significant correlation between increased negative consequences and elevated depression (Aalto 
et al., 2006; Cherrington et al., 2004; Grace et al., 2005).  One study found perceived 
consequences to significantly predict changes in depression using regression analysis (Stafford, 
Berk, & Jackson, 2009).  Stafford et al. (2009) examined the association of illness perceptions 
about CAD on depression symptoms and HRQoL in hospitalized CAD patients (n = 193).  The 
results concluded that negative illness perceptions were significantly associated with greater 
depressive symptoms and positive illness perceptions were significantly associated with greater 
HRQoL at three and nine months. Ratcliffe et al. (2006) found anxious individuals with CAD to 
perceive their heart problem to have more serious consequences. 
The coherence subscale represents the individual’s perceived personal understanding of 
the illness and risk factor beliefs (Moss-Morris et al., 2002).  In terms of the coherence subscale, 
studies reported that lower illness coherence was significantly correlated with elevated 
depression and anxiety (Bergman, Malm, Karlsson, & Bertero, 2008; Hermele, Olivo, Namerow, 
& Oz, 2007; Juergens, Seekatz, Moosdorf, Petrie, & Reif, 2010).  Lower illness coherence means 
there is less understanding of the illness.  However, one study found lower illness coherence did 
not correlate to elevated depression and anxiety levels using the Antonovsky’s Sense of 
Coherence measurement scale (Karlsson, Berglin, & Larsson, 2000). Karlsson et al. (2000) 
examined the relations between sense of coherence and emotional states (depression, anxiety, 




lower illness coherence correlated with increasing levels of loneliness. An increase in illness 
coherence was found in individuals with less depression, anxiety, stress, and loneliness.  Studies 
did not use regression analysis to examine causality nor did they examine other factors that may 
have affected the depression and anxiety level.  
In terms of the control subscale, the majority of the studies reported a consistent 
significant correlation between lower perceived control and elevated depression and/or anxiety 
(Grace et al., 2005; Hermele et al., 2007; Juergens et al., 2010; Stafford, Berk, & Jackson, 2009).  
In addition, Stafford et al. (2009) found that older (> 65 years) individuals perceived lower 
control over their CAD illness and that poorer personal control was associated with greater 
depressive symptoms.  One study found patients who perceived their illness to be governed by 
fate, luck, or chance showed the strongest relationship with depression and anxiety (Singh & 
Dixit, 2009).  Singh and Dixit’s (2009) study enrolled only male participants therefore the results 
of the study are not reflective of female perceived control of illness.  Ratcliffe et al. (2006) found 
significant differences between anxious and non-anxious patients for control, whereas anxious 
individuals had significantly lower perceived illness control. One study found no significant 
relationship between lower control and anxiety (Hermele et al., 2007).   
In terms of the timeline subscales, it is used to determine whether the illness is perceived 
as acute or chronic.  The timeline-cyclical subscale examines whether the illness is perceived as 
fluctuating over time.  The subscale timeline examines whether one perceives the illness as 
acute/chronic or cyclical.  The Foxwell et al. (2013) review found that increased perception of 
CAD chronicity was significantly related to elevated depression and anxiety.  The correlation 




patient was recruited in the hospital or the outpatient setting.  One study that recruited 
hospitalized patients with an initial MI reported that perceived illness chronicity was 
significantly correlated to elevated depression and anxiety (Juergens et al., 2010).  Grace et al. 
(2005) recruited male (n = 504) and female (n = 157) CAD patients from the outpatient setting 
and did not find a significant relationship between chronicity timeline and depression and 
anxiety.  There were no consistent findings that increased perception of variability (cyclical) was 
significantly correlated to elevated depression and anxiety; although women with CAD, 
compared to men with CAD, were found to perceive their illness as more chronic and cyclical.   
With the use of the causal subscale, studies can gain perspective on perceived causes of 
the illness.  The causal subscale was not analyzed in all of the studies (n = 6) due to small sample 
size (Hermele et al., 2007; Juergens et al., 2010) or unstated reason (Alsen, Brink, Persson, 
Brandstrom, & Karlson, 2010; Dickens et al., 2008; Ratcliffe et al., 2006 Stafford et al., 2009).  
Two studies found personality and stress were significantly related to depression (Dunkel, 
Kendel, Lehmkuhl, Hetzer, & Regitz-Zagrosek, 2011; Grace et al., 2005).  Grace et al. (2005) 
reported causal factors of stress, worry, mental attitude, and feeling overworked were 
significantly related to elevated depression.  Dunkel et al. (2011) found stress and mental attitude 
led to elevated depression. No studies examined the relationship between perceived causes and 
anxiety.  
The literature review of Foxwell et al. (2010) included a study by Grace et al. (2005) that 
examined differences in IPQ-R subscales between genders.  There was no significant difference 
in depressive symptoms between genders, although there was a trend that women experienced 




chronic with more cyclic episodes (p <.001).  Men perceived themselves to have more control 
over the illness. Greater depression symptoms in men were related to illness perception of a 
chronic time course, greater consequences, and lower treatment control.  Women with greater 
depression symptoms perceived the illness as a chronic time course. Grace et al. (2005) found 
illness perceptions to be related to depressive symptoms.  
In summary, illness perceptions were found to predict negative mood and QoL in CAD 
patients.  Specifically, the subscales illness coherence, perceived control, and perception of 
illness timeline are important determinants of mood and QoL.  Individuals with lower illness 
coherence, perceived lack of control, and perceived disease chronicity correlated to elevated 
depression and anxiety.  The results of this review support that illness perceptions are important 
and should be assessed by the health care provider.  Identifying illness perceptions related to 
negative mood or poorer QoL can be modified through interventions, such as cardiac 
rehabilitation, cognitive behavioral therapy, and self- management programs. 
CVD Risk Perception 
Individuals with heart disease are at a high risk for a recurrent cardiac event or worsening 
of their heart function.  Women with CVD often do not perceive themselves at risk for secondary 
cardiac events.  Moore et al. (2010) used a qualitative method to examine the perception of risk 
for CHD and perceptions of risk reducing behaviors in women (n = 7) with CHD.  CHD was 
defined as myocardial infarction, coronary artery stenting, or coronary artery bypass surgery.  
Seven women with CHD participated in the study with a sample mean age of 69.1 years.  Three 
major themes emerged from the data:  (1) the absence of symptoms was perceived as absence of 




discussion about their heart disease, and (3) a fear of the effects their heart disease may have on 
their daily lives and relationships.  In addition to the three themes, women did not perceive their 
heart disease as chronic and thought the disease was corrected by the intervention. Therefore 
they did not require risk reduction behaviors for a recurrent cardiac event.  Women expressed a 
desire to return to normal and not focus on the disease. They believed their patient-physician 
relationship lacked open dialogue and there was no discussion of heart disease and risk-reduction 
behaviors.  This lack of discussion about risk-reduction behaviors supported their belief that 
there was no need for behavior change. Women also believed their concerns were not taken 
seriously because of their sex.  All women experienced fear.  Many feared not knowing when 
something was wrong with their heart and others feared the effects of CHD on their 
relationships.  One participant reported her fear was a motivator for engaging in risk reduction 
behaviors.  
 Mosca, Hammond, Mochari-Greenberger, Towfighi and Albert (2013) conducted a cross-
sectional survey of healthy women (n = 2432) age 24-65 years to assess their awareness, 
knowledge, and perceptions of CVD risk and prevention.  The data collected in 2012 were 
compared to data collected in 1997. Awareness of heart disease as the leading cause of death was 
significantly higher in 2012 compared with 1997 (56% versus 30%, p < 0.001).  However, the 
rate of awareness was lower among younger women (24-34 years).  Awareness of atypical signs 
of a heart attack was significantly greater in 2012 versus 1997 (18% versus 10%, p < 0.001).  
Chest pain was less frequently identified as a warning sign of a heart attack in 2012 versus 1997 
(56% versus 67%, p < 0.001).  Communication from physician to patient about heart disease risk 




groups (6% for those age 25-34 years, 16% for age 35-44 years, 23% for age 45-64, 33% for age 
> 65 years). There was a high level of self-reported depression (26%) among the participants and 
more prevalent in the age groups 35-44 years and 45-64 years.  The lack of communication on 
heart disease risk and the negative emotion of depression may contribute to women’s perception 
of their risk for heart disease.  The most frequent potential barrier to preventive action was that 
only one third of women reported they lead a heart-healthy lifestyle (35%), with the greatest 
response among women ≥ 65 years (48%).  Other more common barriers preventing healthy 
heart behaviors among the women in 2012 were lack of money or insurance (16%), lack of self-
confidence to change behaviors (14%), time constraints (13%), stress (12%), lack of knowledge 
(11%), family obligations (11%), decrease perception of risk (9%), not want to change lifestyle 
(9%), depression (8%), and confusion in the media about what to do (8%).  Younger women (24-
44 years) reported different barriers to prevention of heart disease compared with older women 
and these barriers included financial burden, time constraints, depression/stress, and low 
perception of risk.  Older women (≥ 65 years) identified lack of self-confidence to change 
behaviors and lack of willingness to change lifestyle, although 10% did not perceive themselves 
at risk for heart disease.  A low perception of risk for heart disease was identified as a barrier to 
healthy heart behaviors, although more prevalent in younger women compared to older women. 
 Oliver-McNeil and Artinian (2002) used a descriptive study to describe perceptions of 
risk factors and risk-reducing behaviors among women with CHD.  The study included women 
(n = 33) age 36-85 years with a mean age of 65.64 years.  The results of the study identified that 
women had a decreased awareness of their cardiac risk.  Women with controlled hypertension on 




Overweight women did not perceive themselves as overweight.  The risk factors least identified 
were age, menopause, and physical inactivity.  There was no significant relationship between 
perceived risk and risk-reducing behaviors (r = 0.055, p = 0.82) and no significant relationship 
between knowledge of risk and risk-reducing behaviors (r = -0.011, p = 0.95). The study 
examined women’s perceived risk of cardiac risk factors and knowledge of risk factors and not 
the perceived risk of a secondary cardiac event.   Risk-perception beliefs are included in one’s 
perception of their illness.   
Quality of Life 
 HRQoL relates specifically to an individual’s health status and the way a disease 
expresses itself in an individual’s daily life, including symptoms, functional ability, 
psychological, and social and physical states (Broddadottir et al., 2009; Ferrans et al., 2005; 
Wilson and Cleary, 1995).  Individuals with CHD have worse HRQoL compared to those 
without CHD, and women with CHD consistently report worse HRQoL compared to men with 
CHD (Broddadottir et al., 2009; Ford et al., 2008).   
 Ford et al. (2008) performed a cross-sectional analysis of data from the Behavioral Risk 
Factor Surveillance System (BRFSS) conducted in 2004.  The analysis included data from ten 
states with male (n = 19,852) and female (n = 30,721) participants. The mean age of these 
individuals was 45.8 years and all had a record of MI, angina or CHD, and/or diabetes.  There 
were three aims of the study.  The first aim was to compare HRQoL between individuals with 
and without CHD.  The second aim was to examine whether HRQoL differed between 
individuals with only diabetes, only CHD, or both diabetes and CHD.  The third aim was to 




consisted of four items that measured general health, physical health, mental health, and activity 
limitation days.  Physical health included physical illness or injury, and mental health included 
stress, depression, and problems with emotions.  Activity limitation days included usual activity 
of daily life, such as self-care, work, or recreation. Individuals with CHD reported significantly 
increased physically unhealthy days, mentally unhealthy days, and activity limitation days 
compared with individuals who did not have CHD. Women with CHD compared to women 
without CHD reported ≥ fourteen physically unhealthy days (absolute difference = 9%, p < 
0.001), ≥ fourteen mentally unhealthy days (absolute difference = 4.1%, p = 0.010), and ≥ 
fourteen activity limitation days (absolute difference = 4.8%, p < 0.001) during the past thirty 
days.  Women with CHD compared to men with CHD had greater physically unhealthy days 
(absolute difference = 6.4%, p < 0.001) and greater mentally unhealthy days (absolute difference 
= 5.8%, p = 0.002), with no difference in activity limitation days (absolute difference = 2.0%, p 
= 0.090.  Impaired HRQoL was significantly greater in individuals with CHD compared to 
individuals without CHD.  Women with CHD had worse HRQoL compared to men with CHD.  
Women with CHD have higher levels of depression than men with CHD.  HRQoL can be 
significantly affected by depression. 
 Broddadottir et al. (2009) examined the effect of age and depression on HRQoL in 
women with CAD.  Participants were women (n = 437) with CAD from the Alberta Provencial 
Project for Outcome Assessment in Coronary Heart Disease (APPROACH) database from 2004-
2005.  HRQoL was measured using the Seattle Angina Questionnaire (SAQ) and the EuroQoL 5 
Dimensional Instrument (EQ-5D).  The SAQ items were physical limitations, angina stability, 




addressed mobility, self-care, usual activities, pain/discomfort, and depression/anxiety.  
Depressive symptoms were a significant predictor of HRQoL in all the categories of the SAQ 
and EQ-5D.  Younger women reported the most depressive symptoms.  Increased age was 
predictive of greater physical limitations, although not significant (p = 0.028), and of a 
significantly greater positive perception of disease (p = 0.011).   
 Stafford, Berk, Reddy and Jackson (2007) conducted a literature review (1995-2006) of 
seventeen cross-sectional and prospective studies to examine the impact of depression and its 
treatment on the HRQoL of individuals with CAD.  The literature review included a study by 
Ruo et al. (2003) who conducted a cross-sectional study of patients (n = 1204) with CAD and 
compared the effects of heart disease severity and depressive symptoms on HRQoL.  Depressive 
symptoms were strongly associated with greater symptom burden (OR 1.8, 95% CI [1.3-2.7]; p = 
.002), greater physical limitation (OR 3.1, 95% CI [2.1-4.6]; p < .001), worse QoL (OR 3.1, 95% 
CI [2.2-4.6]; p < .001), and worse overall health (OR 2.0, 95% CI [1.3-2.9]; p < .001).  Disease 
severity was not associated with symptom burden, physical limitation, diminished QoL, or worse 
overall health.  Similar results were found in cross-sectional studies of patients with acute MI 
and unstable angina.  The Sertraline Antidepressant Heart Attack Randomized Trial 
(SADHART) included patients (n = 369) with ACS and depression.  The results of the study 
concluded that depression was the strongest predictor of impaired HRQoL at baseline and that 
disease severity had little effect on HRQoL scores.  The literature review of several prospective 
studies found that depression and anxiety have a negative effect on HRQoL in CAD patients.  
The overall findings from the studies found that depression and anxiety diminish HRQoL in 




 Women with CVD report worse QoL and greater depression compared to men with CVD.  
Norris et al. (2008) examined gender and sex discrepancies in HRQoL among patients with 
CAD.  Sex refers to biology and anatomy and gender refers to the behavioral, psychological, and 
cultural traits associated with one sex.  The study included male (n = 1872) and female (n = 522) 
patients with CAD from the Alberta Provincial Project for Outcome Assessment in Coronary 
Heart Disease (APPROACH) database.  Women reported significantly more depressive 
symptoms compared to men at the time of angiography and one year later.  Men reported less 
angina at one year (men 92.3 versus women 89.8, p ≤ 0.001) and higher treatment satisfaction 
(men 91.5 versus women 88.9, p = 0.001) and a better physical limitation score (men 83.6 versus 
80.2, p ≤ 0.001). The discrepancies in the scores are only partially accounted for by sex 
differences in depression and social support.  Both at the time of angiography and one year later, 
women scored greater depressive symptoms and worse HRQoL compared to men.  Therefore, 
gender roles and perception may contribute to the differences in HRQOL in men and women 
with CAD.  
Characteristics of the Environment 
Social Support  
Prata, Ramos, Martins, Rocha-Goncalves, and Coelho (2014) conducted a systematic 
review examining the gender differences in psychosocial domains in individuals with CAD.  The 
meta-analysis included examining the relationship between social support and CAD and 
secondary events.  Social support was divided into two domains:  functional support and 
structural support.  Functional support describes the encouragement of the social network (help 




characteristics of the social network (number/frequency of contacts, marital status, group 
membership).  The literature review included a meta-analysis of thirty-two studies examining the 
role of social support in the development and outcome of CAD and MI (Barth et al., 2010).  The 
results of the analysis found low functional support was associated with increased risk of CAD 
(HR 1.53, 95% CI [1.02-2.28]) and increased risk of mortality (HR 1.59, 95% CI [1.17-2.16]) in 
patients with CAD.  Low structural support was not associated with an increased risk for CAD or 
mortality in patients with CAD (RR, 1.56, 95% CI [0.94-2.58]).   
Leifheit-Limson et al. (2010) conducted a large prospective study with MI patients (n = 
2411) examining whether baseline social support predicted patient outcomes (poorer angina, 
disease-related QoL, physical and mental functioning, and depressive symptoms) within one year 
of MI recovery.  Patients with the lowest social support had increased risk of angina (RR 1.27, 
95% CI [1.10, 1.48]), lower disease specific QoL (β -3.33, 95% CI [-5.25, -1.41]), lower mental 
functioning (β -1.72, 95% CI [-2.65, -0.79]), and greater depressive symptoms (β 0.94, 95% CI 
[0.51, 1.38]).  There was a non-significant risk toward lower physical functioning (β -.087, 95% 
CI [-1.95, 0.20]).  There was a stronger negative relationship between social support and 
outcomes in women compared to men.  Lower social support was associated with greater 
depressive symptoms and worse health status, particularly in women.   
 Compare et al. (2013) conducted a narrative review of five quantitative studies (3 
prospective cohorts, 1 case-control study, 1 randomized controlled trial) examining the 
relationship between social support, depression, and health outcomes in patients with heart 
disease.  The majority of findings suggest that low social support, being unmarried, and 




associated with an increase in sudden cardiac death while controlling for depression.  Unmarried 
individuals were less likely to receive preventive care, seek timely health care for symptoms, 
adhere to medication, or do physical activity. Therefore, being unmarried was associated with 
greater depressive levels. 
Lett et al. (2007) conducted a randomized controlled trial comparing the impact of 
network support and perceived functional support on all-cause mortality or non-fatal reinfarction 
in patients with a recent MI.  Network support included the mean number of close friends and 
relatives, married, and living with others; whereas functional support includes instrumental (help 
getting tasks done), financial (economic support), informational (providing needed information), 
appraisal (help evaluating a situation), and emotional (feelings of being loved) support. 
Participants were men (n = 1389) and women (n = 1092) with depression or low social support 
that were recruited from the Enhancing Recovery in Coronary Heart Disease (ENRICHD) trial 
and randomized to a cognitive behavioral intervention or to a usual care control group.  The 
average age of the participants was 61 years.  Higher levels of perceived social support were 
associated with improved outcome for patients without elevated depression, although this was 
not found in patients with high levels of depression. High levels of depression regardless of the 
level of support were associated with increased risk of mortality.  Perceived support and network 
support were not associated with improved health outcomes regardless of the level of depression. 
The narrative review concludes that depressive symptoms and the absence of marital or social 
support are significant risk factors for worse prognosis and may predict adverse outcomes in 
patients with heart disease. 




examining whether social support influenced progression of coronary artery disease in women 
with CAD (n = 102).  Social support included emotional support, social integration, and 
interpersonal social relations. Emotion support refers to deep emotional relationships or 
attachment that describes the availability of close family and friend support.  Social integration 
refers to one’s social network that is determined by the number and frequency of contacts.  
Interpersonal social relations include belongingness, appraisal support, and tangible support. 
Progression of disease was determined by a change in coronary luminal diameter at baseline and 
three years later that was measured by coronary artery angiogram.  At baseline, women with low 
levels of social integration and low emotional support were more likely to have a diagnosis of MI 
compared to those women with high levels of social support.  Women with higher levels of 
interpersonal support were more likely to have severe angina symptoms (77.8% vs.48.3%, p < 
.01).  There may be various causes for this finding.  Women with frequent symptoms may 
receive more attention from family and close friends or these women experiencing severe angina 
symptoms may be more proactive in seeking out help concerning the disease from others 
therefore receive more interpersonal support (Wang, Mittleman, & Orth-Gomer, 2005).  Three 
years later, women with low levels of social support had greater coronary artery luminal 
narrowing than women with high levels.  Women with low levels of emotional support showed a 
progression of 0.14 mm in coronary artery luminal narrowing compared to women with high 
levels of emotional support who showed a progression of 0.06 mm ( p = 0.02). Women with low 
levels of social integration and interpersonal social relations showed a progression of 0.16 mm 
and 0.12 mm coronary artery luminal narrowing compared to women with high levels of social 




and 0.05 mm (p < 0.03).  The results of the study found women with CAD and low social 
support, emotional support, social integration, and interpersonal social relations, were associated 
with significantly increased progression of coronary atherosclerosis. The associations were 
independent of age, BMI, menopausal status, tobacco use, educational level, marital status, 
sedentary lifestyle, alcohol intake, fibrinogen, total/high density lipoprotein cholesterol ratio, 
systolic blood pressure, left ventricular dysfunction, angina severity, diabetes, medications, or 
family history of CHD.  The study findings support that a direct pathophysiological mechanism 
involving the psycho-neuro-endocrine pathway may link social support with CHD (Wang, 
Mittleman, & Orth-Gomer, 2005).  The results of the study did not find that social support had an 
influence on healthy behaviors.  
Summary 
 In summary, this literature review provides evidence that supports the relationship 
between negative mood symptoms (depression, anxiety) to CVD and the risk for secondary 
cardiac events, functional status, illness perception, and QoL in women.  Depression has been 
identified as an independent risk factor for CVD and poor adherence to healthy behaviors.  
Anxiety has been identified as an independent risk factor for CVD, although the relationship 
between anxiety and adherence to healthy behaviors is inconsistent.  Anxiety has been found to 
promote healthy behaviors in some individuals and proved to be a debilitating factor for healthy 
behaviors in others.   
 Depressive and anxiety symptoms may influence an individual’s illness perception.  
These symptoms may negatively alter an individual’s perception of their illness, perceiving the 




significantly correlated with worse QoL.  QoL is diminished by depressive and anxiety 
symptoms, as well as poor social support. However, what has not been investigated is how 
negative emotions relate to healthy behaviors, illness perception, and QoL and whether illness 
perception has an effect on healthy behaviors.  In addition, the literature review found a lack of a 
consensus on whether age is a contributing factor to negative emotions, healthy behaviors, illness 
perception, and QoL.  Some studies report negative emotions to be more prevalent in younger 
women compared with older women and vice versa in other studies.  Overall, there are few 
studies that examine the relationship of these concepts in women with CVD.   
 Therefore, this study will make a unique contribution by examining the relationship 
between negative emotions, functional status, illness perception, and QoL in women with CVD.  
Furthermore, age will be examined as a contributing factor to this relationship.  This knowledge 
will benefit nursing practice by identifying factors that affect functional status and QoL.  This 







A cross-sectional correlational study design was used to explore the relationship between 
symptoms (depression and anxiety), functional status (health-promoting behaviors), health 
perceptions (illness perception), and QoL.  A correlational design is appropriate for the 
examination of the relationship between the key variables generated by the theoretical model at 
one point in time (Polit & Beck, 2012).  The strengths of cross-sectional studies are:  there is no 
waiting for the outcome, there is minimal if any participant attrition, they can serve as the first 
step in a cohort or experimental study, and are relatively inexpensive to conduct (Hulley, 
Cummings, Browner, Grady, & Newman, 2007). This design allowed for identifying the general 
health perceptions of women with CVD by examining each individual’s personal cardiovascular 
risk factors.  Individual characteristics (age, race/ethnicity, gender, marital status, education, 
socioeconomic status, and employment) were examined to determine the influence on health 
outcomes. In addition, environmental characteristics (social support) were examined to 
determine the influence on health outcomes.  The cross-sectional study allowed obtaining 
measurements at approximately the same time to describe and determine the relationships among 
the variables.  
Setting 




from August 2017 to March 2018.  The cardiology offices provide healthcare to women of 
various ages. Site A is a private practice which sees 232 females’ ages 43-90 years old per 
month.  Site B is a private practice which sees 218 females’ ages 54-94 years old per month.  
The two settings were chosen to allow for women of various ages and to obtain the required 
sample size. Women with known coronary artery disease receiving care from the cardiology 
outpatient offices were the participants.  The cardiology offices were located in the suburban 
community and provide care to women of various socioeconomic status and age. Permission was 
obtained from Advocate Medical Group (AMG) Cardiology to recruit participants at these sites.  
Sample 
A convenience sample of women who presented to the private outpatient cardiology 
clinics for health care was the sampling strategy.  Eighty one women completed the study.  
Women were informed of the study while at their scheduled cardiology appointment and  
participant recruitment flyers were posted in the cardiology clinics and waiting rooms.   
Inclusion criteria for participation were women age 35 – 78 years, had a personal history of CAD 
(MI, myocardial ischemia, PTCA, stent, fibrinolytic, CABG surgery), angina Canadian 
Cardiovascular Society (CCS) Class I-III, ACCF/AHA Heart Failure Stage A, B, and C New 
York Heart Association (NYHA) Class I, were able to speak, read, and write English, and were 
able to participate in the informed consent process.  The mean age for the study sample was 
65.53 ( 7.78).  The age range was based on the age women develop heart disease and the age of 
women who presented to the cardiology clinics over the past year.  Women have a longer life 
expectancy and develop heart disease at an older age resulting in a higher prevalence of heart 




was 35 to 70 years.  Initially, the upper age limit of 70 years was established on the assumption 
that women in their 70s may have cognitive impairment.  After discussing the cognitive function 
of female patients aged 70 -78 years with the cardiologists and advanced practice nurses, it was 
determined that the majority of women between the age of 70 to 78 years were cognitively intact.  
A proposal modification was made that changed the inclusion criteria age range to 35 to 78 
years.  There were a large number of women with CAD over the age of 70 years at the 
recruitment sites who met the study inclusion criteria.  Expanding the upper age to 78 years 
allowed women of older age to be represented in the study.  In addition, there continues to be 
limited inclusion of older women in CAD studies (Metha et al., 2016) and including women of 
older age is a unique contribution to the study. 
Exclusion criteria was angina CCS Class IV, ACCF/AHA Heart Failure stage C NYHA 
Class II, III, IV and stage D, stroke, and end-stage renal disease, since these individuals may 
have different perceptions of heart disease due to severity of symptoms and more frequent health 
care visits.  Interested participants were screened by the primary investigator to determine 
eligibility to participate in the study.  
Sample Size 
The sample size proposed for this study was estimated using power analysis in an effort 
to decrease the probability of making a Type I or Type II error and to increase the probability of 
finding a statistically significant effect, which in this case is the probability of finding 
associations among negative mood symptoms (depressive and/or anxiety), functional status 
(health-promoting lifestyle behaviors), health perceptions (cardiac illness perception), and QoL.  




the beta (β) 0.20 (Power 0.80) levels were used regardless of the research question.  The sample 
size calculation was based on the minimum number per variable used in multiple regression 
analysis and it was also calculated based on the relationship between depressive symptoms and 
QoL and healthy promoting behaviors. 
The first aim was to determine the relationship between negative mood symptoms, health 
promoting behaviors, illness perception, and QoL.  According to Cohen (1988) a moderate effect 
size of .30, an alpha of 0.50, a power of 0.80 is used to determine significant correlations among 
variables.  The online power analysis G*Power 3 (Faul, Erdfelder, Land, & Buchnar, 2007; 
G*Power 3, n.d.) was used to calculate a sample size of 84 using effect size .30, alpha 0.05, and 
power 0.80. 
In addition, stepwise multiple regression analyses were used to determine the variables 
that predict QoL.  Based on the recommendation of 10-15 participants per predictor variable 
(depressive symptoms, anxiety symptoms, health promoting behaviors, illness perception 
identity, illness perception coherence, illness perception emotional response, social support, 
functional comorbidities) in multiple analyses, the minimal estimated sample size was 80 and the 
maximum was 120 with eight predictor variables (Cohen, 1988).  In addition, the online power 
analysis G*Power 3 (Faul, Erdfelder, Land, & Buchnar, 2007; G*Power 3, n.d.) was used to 
calculate a sample size of 109 using a moderate effect size (.15), alpha 0.05, and power 0.80, and 
two predictors (depressive and anxiety symptoms). 
In examining the relationship between depressive symptoms and QoL and health 
promoting behaviors, a study by Savoy and Penckofer (2016) was reviewed.  In this study, 125 




the Center for Epidemiologic Studies Depression Scale (CES-D).  In addition, depressive 
symptoms explained 25% of the variance in health promoting behaviors.  G*Power 3 analysis 
(Faul et al., 2007) was used to calculate the effect size based on the squared multiple correlation 
value of .43 producing an effect size of .75.   Using the article by Rudy and Kerr (1991), this 
indicated that a large effect size can identify a significant relationship between depression and 
QoL and a moderate effect size can identify a significant relationship between depression and 
health-promoting behaviors.  With an effect size of .75 (large effect size), an alpha of 0.05, a 
power of 0.80 and 4 predictors, G*Power 3 calculated that 26 subjects would be the sample size.  
Using the variance that depressive symptoms explained health promoting behaviors, a G*Power 
analysis was used to calculate the effect size based on the squared multiple correlation value of 
.25 producing an effect size of .33, a moderate effect size.  With an effect size of .25, an alpha of 
0.05, a power of 0.80 and four predictors, G*Power 3 calculated that 42 subjects would be the 
sample size.   
The second research aim was to determine whether age is a factor contributing to 
negative mood symptoms, functional status, health perceptions, and QOL after controlling for 
social support.  An independent t-test was used to determine whether there was a difference 
between two age groups and the key variables.  In additional to the above sample size methods, 
the G*Power 3 was used to calculate the sample size of 55 for independent t-test using a 
moderate effect size (.15), an alpha 0.50, a power of 0.80.  Using these techniques for estimating 





Recruitment of Study Participants 
To begin the recruitment process, contact was established with the administrative and 
medical director of the AMG–Cardiology, Advocate Health Care cardiology offices.  The 
Institutional Review Board (IRB) forms were completed and submitted to the respective IRBs, 
first to the Advocate Health Care IRB for approval and then to the Loyola University Health 
Systems IRB for final approval.  Approval was obtained from both Advocate Health Care IRB 
and Loyola University Health Systems IRB prior to initiating the study.  The PI met with the 
cardiologists, office managers, advanced practice nurses, and medical technicians and reviewed 
the study purpose, subject inclusion/exclusion criteria, and contact information for participating 
in the study.   
The recruitment process used study informational flyers and communication about the 
study from health care providers.  The PI contacted the office manager/director(s) to identify 
ideal locations for posting flyers.  The approved study flyers were posted in the cardiology 
offices and waiting rooms.  The flyer provided an abbreviated purpose for the study, the target 
population, and instructed individuals to contact the investigator by phone number or email if 
interested in participating in the study.  To aid the recruitment process, participants would 
receive a ten-dollar gift card after completing and submitting the questionnaire at the scheduled 
office visit.  In addition, a laminated card with study name, inclusion/exclusion criteria, and PI 
contact information was provided to the cardiologists and advanced practice nurses.  
The PI was present in the cardiology offices to promote the recruitment process by 
informing the patients, physicians, advanced practice nurses, and medical technicians of the 




The PI was given a private office space at the cardiology offices to meet with women 
who were interested in the study.  The PI met with the interested participant and provided the 
purpose of the study, explained and answered questions regarding the questionnaire booklet, and 
the time required to complete the questionnaire booklet.  Women who agreed to participate in the 
study were screened for eligibility.  Approximately fifty percent of the participants were 
screened, consented, and completed the questionnaire booklet immediately after their cardiology 
appointment.  For those individuals who were not able to stay and complete the questionnaire 
booklet, the PI scheduled a meeting time with the participant either sixty minutes before their 
next cardiology office visit, or an agreed time to meet at the cardiology office, or a convenient 
designated location identified by the participant to obtain consent and completion of the 
questionnaire booklet.  The women were given a flyer with the PI’s contact information and 
encourage to call if they had any questions or needed to reschedule the appointment time.  The 
women who agreed to participate in the study and were scheduled a time to meet, received a 
telephone call confirming the scheduled time to meet at the cardiology office or designated 
location one week and one day before the scheduled appointment date.  Individuals who were not 
able to keep their appointment time, were rescheduled during that time and met at a place of 
convenience for them.   
Participants were assigned a unique identifier (number) that was be used to complete the 
questionnaire booklet.  The questionnaire booklet assessed symptoms of depression and anxiety 
in individuals with CVD disease.  The measures also included questions about their perceived 
risk for CVD events, illness perception, health promoting behaviors, quality of life, and 




informed consent was obtained and the questionnaire booklet was completed by the participant.  
The informed consent included if the patient has concerns about their mood they should talk to 
their healthcare provider and would be given Advocate information about mental health.  The PI 
reviewed the questionnaire mood surveys for any missing data.  Clarification for completing 
unanswered questions in the questionnaire booklet was provided by the investigator.  Some 
participants may not want to answer every question if it makes them uncomfortable.  Therefore, 
the PI checked whether the participant was uncomfortable answering the question before asking 
for more information to complete the questionnaire.  Missing data was completed at this time and 
the questionnaire booklet was collected.  It took 30 – 45 minutes to complete the questionnaire 
booklet.  Once completed, the participant was compensated with a $10.00 gift card to a popular 
area store prior to the leaving the office/convenient location.   
The AMG-C patients are currently screened for depression using the Patient Health 
Questionnaire-2 (PHQ-2).  Those patients that answer “yes” to either question number one or 
two on the PHQ-2 are referred to their primary care provider (PCP) for further assessment.  The 
PHQ-8 was the instrument used in the study to assess for depressive symptoms.  The PHQ-2 
questions are the first two questions on the PHQ-8.  The AMG-C patients are screened for 
depression using the PHQ-2 and there is a process in place to refer those individuals requiring 
further assessment to their PCP.  Thus, the PHQ-8 instrument was not scored at the time the 
participant completed the questionnaire.  Since the study questionnaire contained mood symptom 
assessment tools, if the patient voices concern about their mood after completion of the 
questionnaire, they were encouraged to contact their healthcare provider and would be given 




obtained from Advocate Health Services.  None of the women participants voiced concern about 
their mood.   
If needed, another strategy was identified to be used to recruit participants.  This strategy 
would consist of AMG-Cardiology (AMG-C) mailing a letter informing women about the study 
with information to contact the PI if interested in participating in the study.  The PI would 
provide a stamped envelope for the mailing and the patients address label would be applied by an 
AMG employee.  This strategy was not used for recruitment because the sample was obtained 
through recruiting in the cardiology offices. 
Measurements 
 The measurements were organized according to the revised Wilson and Cleary’s 
Model of HRQoL that was used to guide the study.  A list of the study variables and how they 
were measured are depicted in Table 1 and the measurement tools are included in Appendix A. 
Table 1. Study Variables and Measurements 
 Variable Measurement 
Characteristics of the 
Individual 
Demographics Age, race, ethnicity, marital 
status, education, income, 
employment 
Biological Function CVD Risk Factors Framingham Recurrent Risk 
Model 
Comorbidities Functional Comorbidity 
Index (FCI) 
Symptoms Depression Patient Health Questionnaire-
8 (PHQ-8) 
Anxiety Generalized Anxiety 
Disorder-7 (GAD-7) 







General Health Perceptions Illness Perception Illness Perception  
Questionnaire-Revised 
Cardiac (IPQ-R-Cardiac) 
Overall Quality of Life Satisfaction with Life QoL-Index Cardiac Version 
IV (QLI) 
Characteristics of the 
Environment 
Social Support Medical Outcomes Survey -8 
(MOS-SS) 
 
Characteristics of the Individual 
Demographics were assessed for each individual and included the measurement of age, 
gender, ethnicity/race, marital status, education, socioeconomic status, and employment.  This 
information allowed examining whether there were differences or similarities among these 
variables and identified patterns in relationships to other variables studied.  Examining 
differences among age in relation to symptoms and functional status made this information 
mandatory to obtain. 
Biological Function 
The two variables, cardiovascular risk factors and comorbid diseases, were assessed in 
order to determine the effect of biological function on symptoms, functional status, health 
perceptions, and QoL. 
Cardiovascular risk factors.  The Framingham Recurrent Risk Model was used to 
assess recurrent CVD risk.  The Framingham Recurrent Risk Model is a two-year risk prediction 
for recurrent atherosclerosis cardiovascular disease (ASCVD) in individuals with CHD 
(D’Agostino et al., 2000).  The instrument measures the risk factors age, gender, SBP, tobacco 
use, fasting total cholesterol (TC), HDL, and diabetes to determine the risk for a recurrent 




CVD event in two years.  For example, a score of 10 predicts a 2% probability of a CVD event in 
the next two years.   
 The Framingham Risk Model is preferred for use in predicting female CVD mortality 
compared to other CVD risk score models, such as the SCORE risk, HeartScore, and QRISK 
score models (Goh, Dhaliwal, Lee, Bertolatti, & Della, 2013).  The instrument is preferred over 
the other risk score models because the instrument has a female risk score and high reliability 
and validity (Coke, 2016;  D’Agostino, Pencina, Massaro, & Coady, 2013; Goh, Dhaliwal, Lee, 
Bertolatti, & Della, 2013).  The reliability and validity of the Framingham Recurrent Risk Model 
is evident by high sensitivity (67%) and specificity (98%) measures (Coke, 2016).  The 
limitation of the tool is that it does not include relevant risk factors to predict CVD mortality for 
women, such as obesity, physical activity, alcohol consumption, and use of antihypertensive 
medications (Goh et al., 2013).  Overall, the Framingham Recurrent Risk Model is a successful 
tool to identify the probability of a subsequent cardiovascular event in those who have CVD. 
 Comorbid diseases.  Several comorbidity indices have been developed to predict 
mortality or cost outcomes, such as length of hospital stay.  The Functional Comorbidity Index 
(FCI) was developed to measure comorbid conditions that have an impact on physical function.  
Physical activity (exercise) is a health promoting behavior that reduces the risk for CAD or 
worsening of one’s cardiac illness (Hammond et al., 2007;  Mosca et al., 2006).  Therefore, the 
FCI instrument was used to assess for chronic comorbid conditions in this study.  The FCI 
consists of eighteen comorbid conditions.  The eighteen comorbid conditions were derived from 
an extensive literature review, focus group studies, and two large data bases that identified 




using the Medical Outcome Study (MOS) 36-item Short Form Survey (SF-36) physical function 
subscale.   The SF-36 is a widely used reliable and valid instrument that is used to identify 
general health status and includes a reliable physical function subscale (Cronbach’s alpha 0.93).  
The SF-36 physical function subscale is made up of ten items related to walking, climbing stairs, 
lifting, vacuuming, bathing, and dressing (Ware & Sherbourne, 1992).  The FCI uses binary 
scoring (0 = disease not present and 1 = disease is present) for each comorbid condition.  The 
scores range from 0 (the lowest score) to 18 (the highest score).  The final FCI score is the sum 
of the individual’s comorbidities.  A higher FCI score indicates greater comorbidity and is 
associated with greater impairment in physical function (Groll et al., 2005).  
The reliability testing of the generic version has been previously reported for the generic 
FCI instrument.  There was a strong correlation of the FCI to the SF-36 physical function and 
role function subscale scores (-.53, p < .0001, and -.31, p < .0001) respectively.  Discriminant 
analysis was used to determine the SF-36 physical function subscale score into “low function” if 
the score was 66 or less, and “high function” for a score > 66 (Groll et al., 2005).  The FCI 
correctly classified individuals as “low function” or “high function” 76.6% of the time.  The FCI 
accounted for more variation in the physical function subscale scores compared to the Charlson 
Comorbidity Index and Kaplan-Feinstein Comorbidity Index (R2 = 0.29, 0.18, and 0.07% 
respectively (Groll et al., 2005). 
 Content validity was established by an extensive review of the literature, focus groups 
and two large data bases to identify comorbid conditions.  Independent comorbid variables 
significantly associated (Spearman’s correlation coefficient, p < 0.1) with the physical function 




used to identify the significant variables associated with physical function.  In summary, the FCI 
has demonstrated reliability and validity in measuring comorbidity using physical function as the 
outcome (Groll et al., 2005; Haines, Berney, Warrillow, & Denehy, 2014). 
Symptoms 
 The variables depression and anxiety were assessed in order to determine the effect 
of symptoms on functional status, health perceptions, and QoL.   
 Depression.  The PHQ-8 was used to measure depressive symptoms.  The PHQ-8 
originated from the Primary Care Evaluation Mental Disorders (PRIME-MD) instrument that is 
used to screen for five common mental disorders in the primary care and general population:  
depression, anxiety, and somatoform, alcohol, and eating disorders.  The PRIME-MD consists of 
a self-administered 26-item questionnaire and a clinician-structured interview.  The instrument 
was proven reliable and valid in the primary care setting, although found to be time-consuming 
for the clinician to perform the interview process.  Therefore, the PRIME-MD Patient Health 
Questionnaire (PHQ) was developed.  The PRIME-MD PHQ is a three-page, self-administered 
questionnaire that is used to identify the five common mental disorders.  The Patient Health 
Questionnaire-9 (PHQ-9) is the depression module of the PHQ.   The nine items on the PHQ-9 
were selected from the Diagnostic and Statistical Manual of Mental Disorders, fourth edition 
(DSM-4) diagnostic criteria for depression (Kroenke, Spitzer and Williams, 2001).  The DSM-4 
diagnostic criteria for depression remain current with the Diagnostic and Statistical Manual of 
Mental Disorders, fifth edition (DSM-5) (American Psychiatric Association, 2013). The PHQ-8 
instrument consists of eight of the nine items on the PHQ-9, omitting the ninth item.   The ninth 




item was the least frequently endorsed item on the PHQ-9 and fairly uncommon in the general 
population (Kroenke & Spitzer, 2002; Lee, Schulberg, Raue, & Kroenke, 2007; Razykov, 
Ziegelstein, Whooley, & Thombs, 2012).  The ninth item on self-harm was be omitted for 
sensitivity reasons.   
The PHQ-8 uses the same scoring criteria as the PHQ-9.  The PHQ-8 measures the 
severity of depressive symptoms using a 4-point Likert scale with 0 = not at all, 1 = several days, 
2 = more than half the days, and 3 = nearly every day.  Total scores range from 0-24, with higher 
scores indicating more severe depressive symptoms.  The level of depressive severity scores 
consists of five ranges:  minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), 
and severe (20-24).  The cut-off point of 10 was established by identifying that most individuals 
with a score ≥ 10 had either a depressive disorder or core depressive symptoms (sensitivity 88% 
and specificity 88%) (Kroenke et al., 2009).  A score < 5 is associated with the absence of a 
depressive disorder, whereas scores ≥ 15 usually indicate major depressive disorder.  
 The reliability of the original PHQ-9 was psychometrically tested on a sample of 6,000 
patients from eight primary care clinics and seven obstetrics-gynecology (ob-gyn) clinics.  The 
internal reliability is strong with a Cronbach’s alpha of 0.89 in the primary care setting and 0.86 
in the ob-gyn setting.  Participants completed the questionnaire and were interviewed 48 hours 
later by a mental health provider to determine the stability of the instrument.  The test-retest 
reliability was r = 0.84 with nearly identical mean scores (5.08 vs. 5.03).   
 In terms of validity, criterion validity of the PHQ-9 was established by using a structured 
psychiatric interview by a mental health professional to determine the presence of major 




between increasing PHQ-9 scores and the likelihood of major depression.  The positive 
likelihood ratios of the PHQ-9 scores of 0-4, 5-9, 10-14, 15-19, and 20-27 for major depression 
were 0.04, 0.5, 2.6, 8.4, and 36.8, respectively.  The positive likelihood ratio of these same 
scoring intervals for major or other depressive disorder was 0.12, 1.3, 4.9, 15.7, and 38.0 
respectively.  ROC analysis confirmed that the PHQ-9 discriminates well between persons with 
and without major depression by showing the area under the curve for diagnosing major 
depression was 0.95.  Construct validity was assessed by examining the correlations of the PHQ-
9 with the six subscales (physical functioning, role functioning, social functioning, mental health, 
health perceptions, and pain) of the 20-item Short Form Health Survey (SF-20) examining 
functional status.  The PHQ-9 correlated the strongest with mental health (r = 0.73), followed by 
health perceptions (r = 0.55), social functioning (r = 0.52), role functioning (r = 0.43), physical 
functioning (r = 0.37), and pain (r = 0.33).  There was a strong association between PHQ-9 
severity scores and worsening function in all six SF-20 scales.  Construct validity was also 
assessed by examining the association between the PHQ-9 severity levels and disability days, 
clinic visits, and the general amount of difficulty patients attribute to their symptoms.  The PHQ-
9 correlated the strongest with symptom-related difficulty (r = 0.55), followed by disability days 
(r = 0.39), and clinic visits (0.24).  The greater levels of depression severity were associated with 
an increase in symptom-related difficulty in activities and relationships, disability days, and 
health care utilization (Kroenke et al., 2001).  External validity was established by replicating the 
findings from the 3,000 primary care patients using a second sample of 3,000 ob-gyn patients.  
Generalizability to other populations has been established, including the cardiac population 




2013; van der Zwaan et al., 2016).  In addition, the American Heart Association recommends the 
use of the PHQ-9 instrument for depression screening in patients with coronary heart disease 
(Lichtman et al., 2008).  The scoring thresholds and the reliability and validation of the PHQ-9 
apply for the PHQ-8 (Kroenke & Spitzer, 2002).   
Anxiety.  The GAD -7 tool was used to assess for general anxiety symptoms within the 
past two weeks.  The instrument was developed because most tools measuring anxiety were 
seldom used because of their length and because they required administration by a health care 
clinician, rather than patient self-report. The GAD-7 instrument was developed by using nine 
items that reflected all the DSM-IV generalized anxiety disorder (GAD) symptoms criteria and 
four items from existing anxiety scales (Spitzer, Kroenke, Williams, & Lowe, 2006).  These nine 
items reflecting GAD in the DSM-IV remain current in the DSM-5 (2013).  The GAD-7 
measures the frequency of anxiety symptoms using a 4-point Likert scale with 0 = not at all, 1 = 
several days, 2 = more than half the days, and 3 = nearly every day.  Total scores range from 0-
21, with higher scores indicating more severe anxiety symptoms.  The level of anxiety severity 
scores fall into one of four categories:  minimal (0-4), mild (5-9), moderate (10-14) and severe 
(15-21).  The cut-off point of 10 was established by determining most individuals with GAD had 
GAD-7 scores of 10 or greater (sensitivity 89% and specificity 82%) and those without GAD had 
scores less than 10.  GAD scores greater than10 showed higher specificity, but the sensitivity 
decreased significantly with the greater score. 
The reliability testing of the original GAD 13-item tool was psychometrically tested on a 
sample of 1,654 patients from fifteen family practice and two internal medicine sites.  The 




2006).  Participants completed the questionnaire a second time to determine stability of the 
instrument. The one week test-retest stability coefficient was adequate with an interclass 
correlation (r = 0.83) using the same questionnaire.   
In terms of validity, a random sample of 965 subjects from the initial sample was 
interviewed by a mental health professional one week after completing the questionnaire to show 
procedural validity with an intra-class correlation (r = 0.83).  Factor analysis identified the seven 
items that correlated the highest on the 13-item scale (r = 0.75-0.85) (Spitzer et al., 2006).  The 
GAD-7 items were combined with the eight items of the PHQ-8 depression scale and 
confirmatory factor analysis identified two separate factors: factor 1 = depression and factor 2 = 
anxiety.  All the depression items loaded onto factor 1 (0.58-0.75) and the anxiety items loaded 
onto factor 2 (0.69-0.81).  Convergent validity was assessed by examining the correlations of the 
GAD-7 with the Beck Anxiety Inventory (BAI) (r = 0.72) and the Symptom Checklist-90 anxiety 
subscale (r = 0.74).  The data analysis resulted in identifying the seven items on the tool.   
The PHQ-8 and the GAD-7 were used to measure depressive and anxiety symptoms in 
the study which was examined in relation to functional status, health perception, and QOL.  Both 
instruments reflect the principle that the higher the score, the higher the level of symptoms.  
Functional Status 
CVD involves adopting healthy behaviors to decrease the progression of CVD or 
recurrent CVD events.  The HPLP-II tool was used to assess CVD risk-reducing behaviors.  The 
original Health-Promoting Lifestyle Profile (HPLP) tool (Walker, Sechrist, & Pender, 1987) was 
used to identify patterns and determinants of a health-promoting lifestyle and the effect that 




to better reflect the more recent health-promoting behaviors to advance health promotion science 
(Walker & Hill-Polerecky, 1996).  The tool is a 52-item questionnaire consisting of six subscales 
that measure the components of a healthy lifestyle: health responsibility, physical activity, 
nutrition, interpersonal relations, spiritual growth, and stress management.  The participant 
chooses from four Likert choices ranging among 1 (never), 2 (sometimes), 3 (often), and 4 
(routinely).  HPLP-II scores may be obtained by adding up all responses to the items and 
subscale scores may be obtained by adding up the responses to the subscales.  Higher scores 
represent greater health promotion behaviors.   
 The reliability testing of the HPLP original tool using a sample of 952 Midwestern adults 
resulted in a Cronbach’s alpha of 0.92 while the six subscales were self-actualization (r = 0.90), 
health responsibility (r = 0.81), exercise (r = 0.80), nutrition (r = 0.75), interpersonal support (r = 
0.80), and stress management (r = 0.70) (Walker et al., 1987).  Reliability testing of the revised 
HPLP II resulted in a Cronbach’s alpha of the six subscales:  health responsibility (r = 0.86), 
physical activity (r = .85), nutrition (r = 0.80), spiritual growth (r = 0.86), interpersonal relations 
(r = 0.87), and stress management (r = 0.79).  The internal reliability of the HPLP-II revised tool 
was stronger than the original HPLP tool.  The HPLP-II has been found to be reliable in research 
studying risk perception and CVD risk reduction behaviors with reported Cronbach’s alpha 0.95 
(Oliver-McNeil & Artinian, 2002; Thanavaro, Moore, Anthony, Narsavage, & Delicath, 2006).   
In terms of validity, content validity of the HPLP-II was established by a literature review 
and evaluation by content experts.  Factor analysis supported construct validity that identified six 




spiritual growth, interpersonal relations, and stress management) (Walker, Sechrist, & Pender, 
1995).  
General Health Perceptions 
A major component of an individual’s perception of their overall general health is 
influence by that individual’s perception of illness or disease (Weinman, Petrie, Moss-Morris, & 
Horne, 1996). The variable illness perception was used to measure general health perceptions to 
determine if there is a relationship to functional status.   
 Illness perception.  The IPQ-R-Cardiac version was used to measure an individual’s 
perception of illness that includes risk perception.  The IPQ-R was adapted for use in CVD by 
replacing the word “illness” with “heart disease”.  Items relevant to the identity of heart disease 
in women were identified from a literature review and inserted into the questionnaire.  The IPQ-
R originated from the Illness Perception Questionnaire (IPQ) that assessed five cognitive 
components of illness:  identity (label used to describe the illness and the symptoms), 
consequences (expected outcome of the illness), cause (ideas about cause of illness), timeline 
(how long the illness will last), and cure /control (recovery from or control of the illness) (Lau & 
Hartman, 1983; Leventhal et al., 1984).  The IPQ was used across many different populations, 
including but not limited to the following: heart disease, cancer, arthritis, diabetes, 
musculoskeletal, and including spouses/caregivers of individuals with medical illnesses.  The 
IPQ-R was developed to improve measurement reliability and expand the scope of its use by 
adding more subscales to extend the original tool: cyclic timeline, illness coherence, and 
emotional representation (Moss-Morris et al., 2002).  The instrument has shown strong internal 




eight different illness groups (asthma, diabetes, rheumatoid arthritis, chronic pain, acute pain, 
MI, multiple sclerosis, and human immunodeficiency virus (HIV)) (Moss-Morris et al., 2002).  
The IPQ-R consists of three domains and nine representations of illness perception.  The first 
domain is identity that measures perceived symptoms and their possible relationship to the 
illness.  The second domain is beliefs and includes seven representations of illness: acute/chronic 
timeline, cyclical timeline, consequences, personal control, treatment control, illness coherence, 
and emotions.  The acute/chronic and cyclical timeline represent the perceived changeability of 
the illness.  The consequences represent the perceived short- and long-term effects on physical, 
psychological, and social functioning. The personal and treatment control represent the perceived 
controllability and curability of the illness.  Illness coherence represents understanding of the 
illness.  The emotional representation identifies the emotions caused by the illness.  The third 
domain is cause, representing the individual’s perceived responsibility and curability of the 
illness.   
 The IPQ-R used a nominal scale to measure the subscale identity with 1 = yes and 2 = no.   
A 5-point Likert scale was used to measure the individual’s responses to the items on the 
subscales:  timeline acute/chronic, consequences, personal control, treatment control, illness 
coherence, timeline cyclical, emotional representations, and causes.  The Likert scale responses 
were 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, and 5 = 
strongly agree.  The subscales of the IPQ-R are scored individually.  High scores on the identity, 
timeline acute/chronic, timeline cyclical, and consequences represent stronger beliefs about the 
number of symptoms attributed to the illness, the chronicity/cyclicality of the illness, and the 




illness coherence represent positive beliefs about the personal understanding of the condition and 
controllability of the illness.   
 The IPQ-R is a common and reliable instrument use to measure illness perception.  The 
IPQ-R has strong internal reliability with a Cronbach’s alpha of each subscale:  identity (r = 
0.75), timeline acute/chronic (r = 0.89), timeline cyclical (r = 0.79), consequences (r = 0.84), 
personal control (r = 0.81), treatment control (r = 0.80), illness coherence (r = 0.87), and 
emotional representation (r = 0.88).  The cause subscale consists of four subscales with a 
Cronbach’s alpha of each subscale:  psychological attributes (r = 0.86), risk factors (r = 0.77), 
immunity (r = 0.67), and accident/chance (r = 0.23). The accident/chance subscale consisted of 
two items with low correlation and which may contribute to the low Cronbach’s alpha.  Three-
week test-retest stability coefficients of the subscales ranged from 0.46-0.89 with the personal 
control being the only scale with a correlation less than 0.50. The six-month test-retest stability 
coefficients of the subscales ranged from 0.35-0.82 with the timeline cyclical being the only 
scale with a correlation less than 0.5.  
 In terms of validity, principal component analysis (PCA) was conducted to identify the 
seven factors (acute/chronic timeline, cyclical timeline, consequences, personal control, 
treatment control, coherence, and emotion) of the second domain with item loadings greater than 
0.5. Another PCA was computed on the causal items identifying four factors (psychological 
attributions, risk factors, immunity, and accident/chance) with item loadings greater than 0.50. 
Validity of the identity subscale was established using a sample paired t-test that identified a 
significant difference between somatization and identity of illness (t(15.94), p  < .001).  In 




measure illness perception in the cardiovascular population (Alsen et al., 2010; Moss-Morris et 
al., 2002; Schoormans et al., 2014).   
Quality of Life 
The outcome variable of QoL in individuals with CVD was measured by using an 
adapted version of Ferrans and Powers Quality of Life Index (QLI).  The generic QLI was 
developed to measure satisfaction in four areas of life with the participant placing value on those 
areas.  QLI-Cardiac IV was used to measure QoL in individuals with CVD (Ferrans & Powers, 
2010).  There are four subscales assessed with this tool:  health and functioning, psychological 
and spiritual, social and economic, and family.  Part one of the questionnaire consists of thirty-
five statements measuring satisfaction where the participant chooses from six Likert choices 
ranging from 1 (very dissatisfied) to 6 (very satisfied) (Ferrans & Powers, 1992).   Part two 
consists of thirty-five statements measuring value where the participant chooses from six Likert 
choices ranging from 1 (very unimportant) to 6 (very important).  Scores range from 0 to 30 with 
higher scores indicating higher perceived overall QoL.  A score less than 19 indicates a poorer 
QoL (Personal Communication from Dr. C. Ferrans, October 16, 2018).  
 The reliability testing of the generic version using a sample of 349 hemodialysis patients 
resulted in a Cronbach’s alpha of 0.93 (Ferrans & Powers, 1992).  Factor analysis confirmed four 
distinct factors with corresponding Cronbach’s alpha as follows:  health and functioning (r = 
0.87), psychological and spiritual (r = 0.90), socioeconomic (r = 0.82), and family (r = 0.77).  
Forty-eight studies report reliability of the overall tool to be a Cronbach’s alpha 0.73-0.99.  
These studies report reliabilities for each four factor as follows:  health and functioning (r = 0.70- 




family (r = 0.63-0.92) (Ferrans & Powers, 1992).  Two-week and four-week test-retest stability 
coefficients of 0.87 and 0.81, respectively, are strong.  
Two items on the generic QLI tool were revised for the Cardiac-IV version.  The revised 
items were:  the amount of chest pain (angina) that you have, and having no chest pain (angina). 
Four items were added to the generic QLI tool to create the Cardiac-IV version.  These items are: 
the ability to breathe without shortness of breath, the changes in your life that you have had to 
make because of your heart problem, having no shortness of breath, and the changes in your life 
that you have had to make because of your heart problem.  These items are more specific to QoL 
in patients with CVD.  The cardiac version has been used in ten studies confirming Cronbach’s 
alpha ranging from 0.86-0.98 (Bliley & Ferrans, 1993; Carroll & Hamilton, 2005; Carroll, 
Hamilton, & McGovern, 1999; Delunas & Potempa, 1999; Deshotels, Planchock, Dech, & 
Prevost, 1995; Dougherty, Dewhurst, Nichol, & Spertus, 1998; Ferrans & Powers, 2010; 
Papadantonaki, Stotts, & Paul, 1994; Penckofer, Ferrans, Fink, Barrett, & Holm, 2005; Scott, 
2000; Scott, Setter-Kline, & Britton, 2004).   
Content validity was established by an extensive review of the literature and patients’ 
reports of their quality of life (Ferrans & Powers, 1995).  Convergent validity of the QLI had 
strong correlations (r = 0.61-0.93) between the overall score and measure of life satisfaction 
(Bliley & Ferrans, 1993; Campbell, Converse, & Rodgers, 1976).  The QLI-Cardiac IV is an 
important outcome variable in the study.   
The satisfaction section (Part 1) of the QLI questionnaire will only be utilized for this 
study to reduce respondent burden with permission of Dr. Carol Ferrans (Personal 




Characteristics of the Environment 
Social support was measured using the MOS-SS.  The MOS-SS is a 20-item survey that 
was originally developed for chronically ill patients in the Medical Outcomes Survey (MOS) 
(Sherbourne & Stewart, 1991).  The instrument is unique from other social support instruments 
by measuring an individual’s perceived availability of social support.  The MOS-SS contains one 
item on structural support (number of close friend and relatives) and four subscales of functional 
support:  emotional/informational (expression of positive affect, empathetic understanding, 
encouragement of feelings, and providing good advice, information, guidance or feedback); 
tangible (provision of material aid or behavioral assistance); affection (expressions of love and 
affection); and positive social interaction (availability of other people to do fun things with you).  
The structural support item obtains a numerical value of the number of close friends and relatives 
and is not included in scoring the instrument.  Each subscale consists of items ranked on a 5-
point Likert scale with 1 = none of the time, 2 = a little of the time, 3 = some of the time, 4 = 
most of the time, and 5 = all of the time, for how often each support was available.  The scores 
ranged from 0 (the lowest score) to 100 (the highest score).  The higher the score the more 
frequent the perceived social support.  The items on the instrument are short, simple, and easy to 
understand, promoting ease of use in patients of all ages with a chronic disease (McDonald, 
2006). 
In terms of reliability, this has been reported for the generic version using a sample of 
2,987 adult patients with one or more chronic disease (CAD, hypertension, diabetes, and 
depression), resulting in an overall Cronbach’s alpha of 0.97 and the subscale Cronbach’s 




positive social interaction (r = 0.94).  Test-retest reliability of the instrument one year later was 
high, with strong overall correlations (r = 0.78) and subscales correlations (r = 0.72 – 0.76).   
In terms of validity, item scale correlations confirmed convergent criterion validity of the 
subscales: emotional/informational (r = 0.72-0.87), tangible (r = 0.80-0.86), affection (r = 0.82-
0.90), and positive social interaction (r = 0.87-0.88).  Discriminant validity was established by all 
items in each subscale correlating two standards of error with their own scale than with any other 
subscale.  The single item of structural support showed low correlations with the four subscale 
scores (r = 0.18-0.24).  Factor analysis confirmed one item on structural support and four distinct 
subscales of functional support:  emotional/informational, tangible, affection, and positive social 
interaction.  
Human Subjects 
Institutional Review Board 
The research study was submitted for IRB approval through the data collection site 
(AMG–Cardiology Advocate Health Care) and to Loyola University Heath System IRB before 
beginning data collection.  The IRB reviews assured that the study design was scientifically 
secure and the protection of human subjects and ethical conduct was clearly defined.  A letter of 
organizational support for the research study (Appendix E) was obtained from AMG-Cardiology, 
Advocate Health Care giving permission to recruit study participants from the cardiology offices.  
Study Explanation to Prospective Participants 
Women who were interested in participating in the study were explained the study 
purpose, the procedure, the anticipated risks and benefits before asking them to read and sign the 




purpose of the study, the study procedures, time required to complete the questionnaire booklet, 
voluntary participation, description of the risks and benefits, compensation, and confidentiality.  
The consent includes contact information for the PI and the Advocate Health Care IRB office.   
During the consent process, prospective participants were informed they may refuse 
and/or withdraw from participating in the study at any time without penalty and there would be 
no impact on the health care they receive at Advocate Heath Care.  The participants were 
informed that all data would be collected and maintained to protect their confidentiality.  In 
addition, the participants were informed that the study questionnaire and information gathered 
from their electronic medical record would be used for purposes of the research study only.  To 
maintain confidentiality of data collected and anonymity, the subject participants were assigned a 
number rather than using their name.   A master list of the subjects’ names and their code 
numbers were secured in a locked file cabinet and electronic information was password protected 
on the investigator’s computer.   
Potential Risks 
Risks for participating in the study included 1) time required to complete the 
questionnaire and 2) discomfort in answering some questions on the PHQ-8 and GAD-7 
measurements.  As mentioned previously, the AMG-C patients are currently screened for 
depression using the PHQ-2 and there is a process in place to refer those individuals requiring 
further assessment to their PCP.  Since the study questionnaire contained depressive and anxiety 
symptom assessment tools, it was anticipated that some women may find the mood questions 
disconcerting.  Therefore, the PI asked at the completion of the questionnaire booklet if the 




about their mood.  The risks to the subjects were minimal for obtaining knowledge of the 
association of depressive and/or anxiety symptoms with health promoting behaviors, illness 
perception, and QoL in women with CAD of younger and older age groups.   
There were no known benefits for participating in the study.  However, the knowledge 
obtained through this study may support the importance to screen for depressive and anxiety 
symptoms in women with CAD, provide treatments/interventions (anti-depressants, anti-anxiety 
medication, cognitive behavioral therapy, illness perception intervention), to promote health 
promoting behaviors and improve QoL.  In addition, significant results from the study will 
support the need for future studies to test interventions for improving depressive and anxiety 
symptoms in women with CAD which can be a benefit to this population.  The overall benefit 
could be a positive impact on women’s CVD health and QoL.  This could potentially result in 
reduced future cardiovascular events which could translate to significant cost savings to the 
healthcare system.   
Data Analysis 
The data was analyzed using Pearson’s correlations, multiple regression analysis, 
independent t-test, and analysis of covariance (ANCOVA).  Specific analysis for each aim is 
identified below. 
Aim 1: To determine the relationship of symptoms (depression, anxiety) to functional status 
(health-promoting behaviors), health perceptions (illness perception) and QOL.   
 Hypothesis 1:  Negative mood symptoms (depression, anxiety) will be associated with fewer 
health-promoting behaviors, less perception of risk (illness), and poorer QOL. 




all study variables.  The data were examined for potential outliers and their impact on the 
outcomes.  Next, correlations were examined to determine the relationships among the variables 
described in the Wilson and Cleary Health-Related QoL model (as modified by Ferrans et al., 
2005).  Given the relationships among these variables, a stepwise multiple regression model was 
examined to identify the best model fit.  The variables in the model were entered into the 
regression equation in the order of which had the greatest account for the variance of the 
dependent variable.  
Aim 2:  To determine whether age is a factor contributing to negative mood symptoms, 
functional status, health perceptions, and QoL after controlling for social support.  
Hypothesis 2:  Women who are younger will have more negative symptoms, fewer 
health-promoting behaviors, less perception of risk, and lower QoL than women who are older, 
after controlling for social support. 
The groups were divided into two age groups for analysis.  One group was individuals 
age 35-64 years and the other group was women ≥ 65.  Subsequently, independent t-test was 
used to examine the difference between these age groups among key study variables.  Previous 
studies identified that social support is significant predictor of depressive symptoms, health 
promoting behaviors, illness perception, and QoL.  Therefore, analysis of covariance 
(ANCOVA) for social support (the covariate) was performed to examine differences between 






 This chapter will discuss the analysis and results of the study.  Descriptive statistics on 
the sample will be provided along with the key variables in the study.  Following will be the 
results from the analysis of the study aims.  The purpose of the study was to examine whether 
negative mood symptoms (depression, anxiety) contribute to the lack of successful change in 
healthy behaviors in women with known CVD.  The first aim of the study was to identify the 
relationship of symptoms (depression, anxiety) to functional status (health-promoting behaviors), 
health perceptions (illness perception), and QoL. The second aim of the study was to determine 
whether age is a factor contributing to negative mood symptoms, functional status, health 
perceptions, and QOL after controlling for social support. 
Enrollment 
Women (n=81) were recruited from two suburban communities located approximately 
sixteen miles from each other (Figure 2).  It was expected that the sample would closely 
resemble the racial and ethnic composition of the surrounding community.  The majority of the 
patients (n = 61, 75%) participating in the study came from within 14 miles of the study settings 
located in one county.  The racial composition for the primary county site is 68.6% White, 13.9% 
















 Data were abstracted from the completed study questionnaire booklets.  Data from the 
questionnaire booklet was stripped of all individual identifiers and entered into a statistical 
software database (SPSS Mac Version 25, SPSS, Chicago, Il.)  All data were checked manually 
for errors and data entry errors were corrected. The database was stored in a password-protected 
file and a protected backup system.  Participant codes were used to identify the raw data and the 
data was entered only using the de-identifier codes.  All participant consents were secured in a 
locked cabinet in the Advocate Medical Group Cardiology research office.  All other paper data 
was secured in a locked cabinet in the researcher’s office. 
Missing Data 
Completion of the data were verified after the women completed the questionnaire and 
before they left the study area.  Data was considered missing if there was no response to an item.  
Flyers Posted in the Clinic Verbally Informed of Study 
Discussed the Study with 
Women in the Clinic 
Enrolled Participants 
Site 1 = 73 
Site 2 = 8 





Two participants had missing data for income and reported their spouse handled their finances 
and they were unaware of their income.  The patterns of missing data on the QLI were the 
children, sex life, spouse/partner/lover, and job question.  The missing data were to be expected; 
if you do not have children, then it is realistic to not answer the item.  Scoring on these items 
does not require the replacement of missing data.  The data were manually screened for missing 
or potentially erroneous data responses.  Data entry errors were corrected and frequencies were 
run before continuing the data analysis.  Missing data were imputed for missing data on the 
income question and QLI instrument. 
Data Analysis 
Each of the key study variables were analyzed for normality, outliers, and extreme scores 
that may influence the study findings.  Histograms were used to evaluate normality.  Variables 
that appeared skewed were also analyzed for significant skewness.  The PHQ-8 and GAD-7 were 
found to be significantly positively skewed.  The QLI and MOS-SS were significantly negatively 
skewed. Although these variables were skewed, data normality is not an assumption for 
Pearson’s correlation analysis or for predictors used in multiple linear regression (Field, 2009), 
therefore no data transformations were performed to correct skewness. 
The next segments provide an analysis of the variables based on the modified Wilson and 
Cleary Health-Related Quality of Life theoretical model:  characteristics of the individual 
(demographics), biological function (Framingham Recurrent Risk Model and FCI), symptoms 
(PHQ-8, GAD-7), functional status (HPLP-II), general health perceptions (IPQ-R), overall QoL 





Characteristics of the Individual 
Individual characteristics may impact QoL, therefore demographics on the women were 
collected. 
Description of the Sample 
Eighty-one women completed the study.  The study sample can be described as suburban, 
Caucasian, married, having had high school diploma or college graduate, retired, and with 
varying income.  The socio-demographics of the study sample are summarized in Table 2. 
Table 2.  Demographics of Study Sample 
Variable N (Percent) 
Age     Mean (Standard Deviation) 
            Median (Range) 
 
Duration of CAD 
 
CAD 
             Heart Attack 
             Angioplasty 
             Stent 
             CABG 
             Chest Pain 
Ethnicity/Race 
            Caucasian 
            African American 
            Hispanic 
            Asian 
            Multiple Race/Other  
Marital Status 
            Married 
            Divorced 
            Separated 
            Single living with partner 
65.53 ( 7.78) 
67 (43 – 78) 
 






















            Single not living with partner 
            Widowed 
Education 
             High School 
             Associate degree 
             Trade, vocational, technical 
             College Degree 
             Graduate Degree 
Income 
             < $20,000 
             $20,000 - $29,000 
             $30,000 – $39,000 
             $40,000 - $54,000 
             $55,000 - $64,000 
             $65,000 - $79,000 
             $80,000 - $94,000 
              >$95,000 
Employment 
             Full time 
             Part time 
             Homemaker/student 
             Retired 
             Unemployed 
             Other (Disability) 
 
Depression/Anxiety Medication 
             Antidepressant 































Cardiovascular Risk Factors 
 The Framingham 2 Year Recurrent Risk Model for Women with CHD was used to 
identify CV risk factors and calculate the probability of a secondary cardiac event in women in 




diabetes.  Table 3 summarizes the CVD risk factors assessed in the sample according to the 
Framingham scoring system.  The women scored a 3% risk for a secondary cardiac event.  In 
order to score a 3% risk a woman would have to obtain a total of 16 points using the 
Framingham scoring system.  For this sample, the majority of points were from elevated age 
(mean = 65 years), elevated cholesterol levels, and diabetes (n = 30; 37%).  Age and diabetes are 
two scoring items that cannot be controlled.  Higher points are assigned as the individual ages, 
for example, age 55 – 59 receive 4 points, age 59 - 64 receive 5 points, age 65 – 69 receive 6 
points.  A diagnosis of diabetes is 8 points.  The controllable low risk items for a secondary event 
are non-tobacco use, normal cholesterol levels (TC < 200 mg/dl & HDL-C > 40 mg/dl) and 
blood pressure control (SBP < 140 mmHg).  The women had very low tobacco use (n = 5; 6.2%) 
and controlled SBP < 134 mmHg (n = 61; 75.30%).  Using the mean risk factor values for this 
sample, a 65 year old woman with a TC of 177 mg/dl, an HDL-C of 47 mg/dl, who does not 
smoke, does not have diabetes, and an SBP of 127 mmHg would get 6 points for age, 6 points for 
TC/HDL-C, no points for smoking, no points for diabetes, and 4 points for SBP.  Her total points 
would be 16 giving her a 3% 2-year recurrent CVD Framingham risk score.  Therefore, most of 
the points were due to age and cholesterol level.  In summary, the women on average had a 3% 
risk for a recurrent CVD event that is considered “low risk” for a secondary cardiac event.  A 
risk score less than 10% is considered low risk for having a heart attack or dying from a coronary 





Table 3.  Recurrent Risk for Cardiovascular Disease Event per Framingham Score System 
 
CVD Risk Factor N (Percent) 
Age  Mean (Standard Deviation) 
        Median (Range) 
        40-49 
        50-54 
        55-59 
        60-64 
        65-69 
        70-78 
 
TC Mean (Standard Deviation) 
      Median  
HDL-C Mean (Standard Deviation) 
             Median 
 
Smoking 
        No 
        Yes 
Diabetes 
        No 
        Yes 
 
SBP Mean  
        Median 
        < 110 
        110-114 
        115-124 
        125-134 
        135-144 
        145-154 
        155-164 
Framingham Risk Score 
         Mean  
          
             
65.53 ( 7.78) 








177 ( 33.3) 
160 (160 - 300) 
47 ( 13.2) 






















Note.  TC = total cholesterol;  HDL-C = high density lipoprotein cholesterol; SBP = systolic blood pressure. 
 
 Functional comorbidity.  Studies have shown that there is greater self-report of 




impairment in physical function is associated with poorer health related quality of life (Haines et 
al., 2013).  The FCI instrument was used to measure for diagnosed chronic illnesses, including 
calculating a BMI for obesity, to determine physical function.  The instrument uses a “yes” or 
“no” response to each chronic disease on the instrument.  The FCI total score is a sum of the 
number of “yes” chronic disease checked items with a score range of 0 – 18.  The higher the total 
score the greater impairment of physical function.  Table 4 lists the number (%) of individuals 
that reported “yes” to having the chronic disease, as well as, normative data. The normative data 
was obtained from men ( n = 84) and women (n = 17) of the approximate age group (40-84 years 
old; mean age 63 years) with recent coronary artery bypass surgery (Parry, Arthur, Brooks, 
Groll, Pavlov, 2012).  The FCI total score (mean = 4.83) indicated low functional comorbidity 
that implied greater physical function in the women.  All women reported having either angina (n 
= 18; 22.2%), heart disease (n = 45; 55.6%), or heart attack (n = 43; 53.1%).  This is an expected 
finding because heart disease was inclusion criteria for the study.  The most common diagnoses, 
in addition to the cardiac diagnoses, were obesity (n = 38; 46.9%), arthritis (n = 38; 46.9%), 
diabetes (n = 30; 37%), and upper gastrointestinal disorders (n = 30; 37%).  The women may not 
have responded “yes” to the congestive heart disease (CHF)/heart disease item because they may 
have perceived this indicated they had heart failure.  Heart failure disease was exclusion criteria 
for the study.  It is important to mention that a history of depression (n = 21; 25.9%) was 
reported by the women, although the study sample had an overall low score on the PHQ-8 
depression instrument.  This finding may be due to some women reported taking an 
antidepressant (n = 12; 14.8%) and/or anti-anxiety (n = 9; 11%) medication. The most common 




men/women of the approximate age with heart disease.  The FCI instrument had a borderline 
reliability ( = .61), therefore the data was only used as descriptive data to identify comorbidities 
with the study sample women.  The instrument is more an indication of low or high number of 
functional comorbidity diseases reported versus internal consistency of the subscale.  The FCI 
instrument was developed to predict physical function on comorbidity data and had a correlation 
coefficient of 0.53 with physical function that indicated the instrument could account for 53% of 
variance in physical function.  Although this variance is low, the instrument was comparable to 
other instruments (Comorbidity Scales for Stroke Outcomes, Chronic Disease Score, and 
General Medical Health Rating) that measured comorbidity association to mortality (Groll et al., 
2005).   
Table 4.  Functional Comorbidity Disease Frequency 
              
    Study Sample Women Normative Data 
Comorbid Disease   n (%)    n (%) 
    (n = 81)   (n = 101)     
Arthritis   38 (46.9%)   26 (26%) 
Osteoporosis   12 (14.8%)   3 (3%) 
Asthma   10 (12.3%)   9 (9%) 
COPD    13 (16%)   19 (19%) 
Angina   18 (22.2%)   73 (72%) 
CHF/Heart Disease  45 (55.6%)   101 (100%)    
Heart Attack   43 (53.1%)   55 (55%) 
Neurologic Disease  3 (3.7%)   1 (1%) 
TIA    6 (7.4%)   8 (8%) 
Peripheral Vascular Disease 9 (11.1%)   17 (17%) 




Upper GI Disease  30 (37%)   39 (39%) 
Depression   21 (25.9%)   11 (11%) 
Anxiety or Panic Disorder 19 (23.5%)   5 (5%) 
Visual Impairment  27 (33.3%)   11(11%) 
Hearing Impairment  4 (4.9%)   4 (4%) 
Degenerative Disc Disease 25 (30.9%)   9 (9%) 
Obesity   38 (46.9%)   34 (34%) 
              
Note. Normative data were obtained from men and women aged 40-84 years (mean = 63) post coronary artery 




Depression severity was measured using the self-report PHQ-8 instrument.  The PHQ-8 
scoring is the simple sum of the item scores and can range from 0-24.  The level of depressive 
scores consists of five ranges: minimum (0-4), mild (5-9), moderate (10-14), moderately severe 
(15-19), and severe (20-24).  Higher scores reflect greater depressive symptoms.  A score less 
than 5 is associated with the absence of a depressive disorder, a score 5-9 is associated with mild 
depressive symptoms, a score 10 is associated with a depressive disorder or moderately severe 
depressive symptoms, and a score greater than 15 usually indicates major depressive disorder.  
The score of 10 is the cut-off for determining the presence of a depressive disorder.  Table 5 lists 
the mean score for the total instrument, frequency response for each of the five ranges, and the 
normative mean score. The normative mean score was obtained by women (n = 814) of the 
approximate age group (18-94 years; mean age 60) with a history of a myocardial infarction 
(Mallik et al., 2006).  Using the PHQ-8 guidelines 64% of the women (n = 52) have no to 




depressive symptoms.  Even though the women in the study had a lower PHQ-8 score compared 
to the normative mean score, depressive symptoms were present in the sample. In summary, 
while it is true that 64% of the women are healthy, there is another 36% who are with depressive 
symptoms. The PHQ-8 had an alpha coefficient of .82 indicating high reliability with the study 
sample. 






















3.87 ( 3.82) 52 (64%) 22 (27%) 5 (6%) 2 (3%) 0 (0%) 6.8 ( 5.8) 
Note. Normative mean scores were obtained from women aged 18-94 years (mean = 60 years) with Myocardial 
Infarction (Mallik et al., 2006). 
 
Anxiety Symptoms 
The GAD-7 is a self-report instrument that was used to measure anxiety symptoms using 
a 4-point Likert scale of 0 (not at all) to 3 (nearly every day).  The GAD-7 scoring is the sum of 
the item scores and ranges from 0-21.  Higher scores reflect greater anxiety symptoms.  The level 
of anxiety scores consists of four ranges: minimum (0-4), mild (5-9), moderate (10-14), and 
severe (15-21).  The score >10 is associated with generalized anxiety disorder.  Table 6 lists the 
mean scores for the total and each of the four ranges, as well as the normative mean score.  
Using the GAD-7 guidelines, 73% (n = 59) of the women have no to minimal anxiety, 25% (n = 
20) have mild anxiety, and 3% (n = 2) have severe anxiety symptoms.  The normative mean 
score (6.1) was obtained by women (n = 1780) of approximate age group (18-95; mean age 47.5) 




validity of the GAD-7 instrument and found anxiety scores similar in women aged < 47 years 
and those aged > 47 years.  Lowe et al. (2008) conducted a study to establish normative data of 
the GAD-7 in the general population and found women (n = 2678) with a mean age of 48 years 
had a normative mean score of 3.20 (SD= 3.52).  Even though the women in this study had a 
lower GAD-7 total mean score compared to the normative total mean score identified in the 
primary care and/or general population, anxiety symptoms were present in the study sample.  In 
summary, although 73% of the women are healthy, there are 28% who are with anxiety 
symptoms.  The GAD-7 had an alpha coefficient of .89 indicating high reliability of the 
instrument.   
The data from the GAD-7 showed the mean score was 2.74 (SD = 3.38) with a median of 
1.00.  It is important to note that the standard deviation (SD) was greater than the mean score.  
Knowing that the SD is only affected by how much each data point is away from the average 
value, it is very likely that data dispersion accounted for the high SD.  The data from the GAD-7 
was widely dispersed which likely accounts for the high SD value.  The GAD-7 instrument 
scores range from 0 to 21, and the frequency of scores from the study ranged from 0 to 18.  The 
GAD-7 frequency scores can be found in Table 7.  Figure 3 displays the dispersion of scores 
using a histogram for easier visualization.  Although the majority of the women reported 
minimal (score 0-4) symptoms, there were others that scored mild (score 5-9), or severe anxiety 
symptoms (score 15-21).  The SD greater than average (mean) identifies that the data points are 
widely dispersed with several extreme values.  Although the extreme scores are unusual values, 











Range Frequency Normative 










2.74 ( 3.38) 59 (73%) 20 (25%) 0 (0%)  2 (3%) 6.1 
Note. Normative mean score was obtained from women aged 18-95 years (mean = 47  15.5 years) from primary 
care settings (Spitzer et al., 2006). 
 
Table 7.  GAD-7 Item Frequency Scores 






























 Health promoting behaviors were measured by the HPLP-II. Table 8 lists the frequency 
response for the HPLP-II total and subscale scores.  Table 9 lists the alpha coefficients and the 
mean scores for the total and subscales, as well as the normative mean scores. The mean score 
for the total and for each six subscales are based on a Likert scale of 1 (“never”), 2 
(“sometimes”), 3 (“often”), and 4 (“routinely”).  Higher scores reflect greater health promoting 
behaviors.  The HPLP-II total mean score of 3.23 indicates that on average the sample performed 
health promoting behaviors in the often-to-routinely range.  The highest scoring subscales were 
interpersonal relations (mean = 3.64) and spiritual growth (mean = 3.46). These scores indicate 




behaviors.  The nutrition (mean = 3.20), health responsibility (mean = 3.09), and stress 
management (mean = 3.09) subscales indicate that on average the women were “often” 
performing healthy nutrition, health responsibility, and stress reducing activities.  The women 
scored the lowest on the physical activity subscale (mean = 2.74) indicating that on average they 
“sometimes” to “often” performed physical activity behaviors.  The alpha coefficients (.74 - .88) 
for the HPLP subscales confirmed reliability of the subscales.  The normative mean scores were 
obtained from women (n = 125) of a similar age group (48-67 years old; mean age = 57.7) 
without CAD (Savoy & Penckofer, 2015). Oliver-McNeil & Artinian (2002) examined women 
(n = 33) with heart disease and obtained similar HPLP-II mean scores (total mean score 2.44; SD 
.50) compared to the normative scores provided from women without CAD.  In summary, the 
women in the study were above average in performing heath promoting behaviors compared to 
other women of the same age that are with or without heart disease (Oliver-McNeil & Artinian, 
2002; Savoy & Penckofer, 2015; Thanavaro et al., 2006).   
Table 8.  Health-Promoting Lifestyle Profile II (HPLP-II) – Frequency Results 
Scale    Never (1) Sometimes (2)  Often (3) Routinely (4) 
      N (%)   N (%)    N (%)   N (%)  
Total Score       0  6 (7.4%)  50 (61.7%) 25 (30.9%) 
Subscales: 
Health Responsibility      0  14 (17.3%)  46 (56.8%) 21 (25.9%) 
Physical Activity  3 (3.7%) 33 (40.7%)  27 (33.3%) 18 (22.2%) 
Nutrition       0  5 (6.2%)  54 (66.7%) 22 (27.2%) 
Spiritual Growth      0  4 (4.9%)  36 (44.4%) 41 (50.6%) 
Interpersonal Relations     0  1 (1.2%)  27 (33.3%) 53 (65.4%) 




Table 9.  Health-Promoting Lifestyle Profile II (HPLP-II) and Subscale Scores 
    # of Alpha  Mean Score  Median Normative   
    Items Coefficient   (SD)  (Range)        Mean Score(SD) 
HPLP-II Total Score  52 .94  3.23 ( .576) 3.00 (2 – 4) 2.63 (.38) 
Subscales            
  
Health Responsibility  9 .80  3.09 ( .655) 3.00 (2 – 4) 2.6 (.52) 
Physical Activity  8 .88  2.74 ( .848) 3.00 (1 – 4) 2.1 (.68) 
Nutrition   9 .74  3.20 ( .541) 3.00 (2 – 4) 2.7 (.60) 
Spiritual Growth  9 .85  3.46 ( .592) 4.00 (2 – 4) 3.0 (.55) 
Interpersonal Relations 9 .80  3.64 ( .507) 4.00 (2 – 4) 3.1 (.50) 
Stress Management  8 .76  3.09 ( .636) 3.00 (1 – 4) 2.4 (.53) 
Note. Normative mean scores were obtained from women aged 48-67 years (mean = 57.7 years) without CAD 
(Savoy & Penckofer, 2015). 
 
General Health Perceptions 
Illness Perception 
 Illness perception was measured by the IPQ-R-Cardiac Version instrument that includes 
eight subscales (identity, timeline acute/chronic, timeline cyclical, consequences, personal 
control, treatment control, illness coherence, and emotional representation).  The IPQ-R scores 
are obtained from the individual subscales.  The scores on the subscales provide knowledge on 
whether the individual has a negative perception or a positive perception of the illness.  It is 
believed that individuals with negative illness perception may not manage their illness 
effectively (Weinman, Petrie, Sharpe & Walker, 2000).  High scores on the identity, timeline, 
consequences, cyclical, and emotional representation subscales indicates the belief that there are 
more symptoms related to the illness, the illness is chronic, the illness is permanent, the illness 
has negative consequences, and the illness causes distress.  More symptoms related to illness, 
illness has negative consequences, and illness causes distress are all negative perceptions of 




the belief the illness can be personally controlled, the illness can be treated, and there is a greater 
understanding of the illness.  These are all positive perceptions of illness.  Individuals with a 
positive illness perception would be expected to manage their illness more effectively (Weinman 
et al., 2000).  The causal subscale identifies the perceived cause of the illness.  
The IPQ-R identify subscale assessed the experience of 20 symptoms: pain, sore throat, 
nausea, breathlessness, weight loss, fatigue, stiff joints, sore eyes, wheeziness, headaches, upset 
stomach, sleep difficulties, dizziness, loss of strength, chest pain, shortness of breath, loss of 
appetite, weakness, unusually scared, and indigestion.  For each symptom the subject indicates 
“yes” or “no” if she believes the symptom is related to her CVD illness.  “Yes” responses are 
counted and averaged to yield a mean number of symptoms believe to be related to the CVD 
illness.  A higher mean score indicates a greater number of symptoms are believed to be attributed 
to CVD illness.  The IPQ-R subscales (timeline acute/chronic, consequences, personal control, 
treatment control, illness coherence, timeline cyclical, and emotional representation, causal) use a 
5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree).  Higher scores indicate a 
strong belief that the illness will be chronic, illness symptoms will occur often, consequences of 
the illness will be negative, the illness can be personally controlled, the illness can be treated, a 
greater understanding of the illness, and the illness causes distress.  The IPQ-R causal subscales 
(psychological attributes, risk factors, immunity, and accident/chance) use a 5-point Likert scale 
from 1 (strongly disagree) to 5 (strongly agree).  High score on the subscale indicates belief the 
specific causal factor caused the illness.  Lower score on the subscale indicates there is no belief 
the specific causal factor caused the illness.  For example, high score on the psychological 




Thirteen items, IP1, IP4, IP8, IP15, IP17, IP18, IP19, IP23, IP24, IP25, IP26, IP27, and 
IP36, are reversed-coded before tabulating the score. Eight aspects of illness perception were 
assessed.  Table 10 lists the alpha coefficient and mean subscale scores. Table 11 lists subscale 
mean scores compared to normative mean scores obtained from women of the same age group 
with CAD or diabetes (Alsen et al., 2010; Calvin et al., 2009 ; Fennessy, Devon, Ryan, Lopez & 
Zerwic, 2011).  Alsen et al. (2010) examined illness perception in women with a mean age of 64 
years (n = 58) four months post MI.  Fennessy at al. (2011) examined illness perception in men 
and women with a mean age of 67 years (n = 51) with CAD either 30 days post PTCA or optimal 
medical therapy.  Calvin et al. (2009) studied illness perception in women with a mean age of 53 
(n = 143) with chronic type 2 diabetes for approximately 2 years.  These comparisons were made 
to obtain a rough estimation on how the women in the study with CVD perceived their illness in 
relation to other women with CAD or chronic illness.  The women reported higher scores than 
other women with CAD, MI or diabetes on timeline dimension (acute/chronic) and illness 
coherence indicating they perceived their illness to be more chronic and had a greater 
understanding of their illness compared with these groups.  These findings may be due to the 
women in the sample had a longer duration of CVD compared to the women in the comparison 
studies.  Otherwise, the reported subscale scores were similar to women of the same age group. 
The IPQ-R instrument had acceptable reliability among this population, with the 
exception of the treatment control subscale and causal subscales.  Borderline reliability was 
found with the treatment control subscale ( = 0.65).  Low reliability in the treatment subscale 
( = .60, .56, .50) has been found in other comparable studies (Byrne et al., 2005; Calvin et al., 




lead to the possibility that additional items or improvement in measurements may be needed for 
the IPQ-R questionnaire.  In addition, borderline reliability was found with the IPQ-R causal 
subscales risk factors ( = .57), immunity ( = .60), and accident/chance ( = .59).  The causal 
subscale psychological attributes was the only causal subscale with acceptable reliability ( = 
.85).  The low reliability findings in the causal subscales may be due to the low number of items 
in each subscale.  The number of items on each subscale ranged from 2 - 7 items (psychological 
attributes (6 items), risk factors (7 items), immunity (3 items), and accident/chance (2 items).   
The women attributed a low number of symptoms to CVD (identity) (mean = 3.78, SD 
3.79).  Table 12 identifies the most frequently reported symptoms experienced and symptoms 
believed to be related to CVD.   There was a wide distribution of reported symptoms.  Some 
reported no symptoms and others reported sixteen symptoms.  The most common symptoms 
reported were fatigue, pain, sleep difficulties, stiff joints, and shortness of breath.  It was an 
expected finding that the women associated fatigue, pain, and shortness of breath symptoms with 
CVD, as well as, the symptoms stiff joints were not related to CVD.  Although, a concern is that 
they did not perceive sleep difficulties were related to CVD.  Sleep difficulties may indicate 
heart disease, including cardiac arrhythmias, myocardial ischemia, and sleep apnea. 
The women’s illness perception subscale mean scores indicate they believed CVD would 
be more chronic (timeline acute/chronic) (mean = 24.26, SD 4.79), CVD symptoms would occur 
often (timeline cyclical) (mean = 10.25, SD 3.28), CVD would have negative consequences 
(consequences) (mean = 19.55, SD 4.77), and CVD caused emotional distress (emotional 
representation) (mean = 15.79, SD 5.30).  Despite negative illness perceptions of the duration 




and emotional distress (emotional representation), the sample women believed they could control 
CVD (personal control) (mean = 24.86, SD 3.45), CVD could be treated (treatment control) 
(mean = 18.52, SD 2.98), and understood CVD (illness coherence) (mean = 20.04, SD 3.92). 
The women identified CVD risk factors and psychological attributes (causal subscale) as 
the top causes for their CVD.   Table 13 displays the most frequent reported causes for CVD.  
The CVD risk factors the women most frequently reported were hereditary (mean = 4.07, SD 
1.22), diet or eating habits (mean = 3.77, SD 1.06), my own behavior (mean = 3.56, SD 1.08), 
and ageing (3.38, SD 1.13).  The psychological attributes most frequently reported were stress or 
worry (mean = 3.56, SD 1.27) and family problems or worries (mean = 3.02, SD 1.24).  In 
summary, the women had a strong perception that hereditary, ageing, health related behaviors, 
and psychological attributes caused their CVD.  In their review of the literature, Al-Samadi et al. 
(2016) found that most women report hereditary and psychological attributes, not health related 
behaviors, as causes for their CVD.  Whereas, men most frequently report health related 
behaviors as the cause for CVD. 
Table 10.  Illness Perception Questionnaire-Revised Subscale Mean Scores 
             
    # of  Alpha Range of  Mean Score  
    Items    Coeff.   Scores (SD)     
Subscales 
Identity   20 .85 0 – 20  3.78 (3.79)   
Timeline (Acute/Chronic) 6 .87 6 – 30  24.26 (4.79)   
Timeline Cyclical  4 .80 4 – 20  10.25 (3.28)   
Consequences   6 .73 6 – 30  19.55 (4.77)   
Personal Control  6 .79 6 – 30  24.86 (3.45)   
Treatment Control  5 .65 5 – 25  18.52 (2.98)   
Illness Coherence  5 .85 5 – 25  20.04 (3.92)   
Emotional Representation 6 .89 6 – 30  15.79 (5.30)   




Table 11. IPQR Subscale Mean Scores (SD) Compared With Reference Women Populations 
IPQR Subscales Study Sample        Stable CADa   MIb        Type 2 Diabetesc 
   (N = 81)          (N = 51)         (N = 58)        (N = 143)  
Timeline   24.26 (4.79)         18.2 (3.2)       19.30 (4.66) 17.03 (5.21) 
(acute/chronic) 
Timeline Cyclical 10.25 (3.28)          6.9 (3.2)        11.93 (2.78) 11.7 (2.97) 
Consequences  19.55 (4.77)         12.7 (2.1)       18.38 (4.60) 20.36 (3.57) 
Personal Control 24.86 (3.45)         18.1 (3.6)       20.53 (4.00) 25.42 (2.35) 
Treatment Control      18.52 (2.98)         21.9 (.83)       17.88 (2.84) 20.36 (1.70) 
Illness Coherence 20.04 (3.92)         17.4 (5.2)       17.42 (3.74) 15.96 (4.15) 
Emotional   
Representation 15.79 (5.30)         10.6 (1.8)       16.73 (4.40) 16.88 (3.93)  
Note. CAD = coronary artery disease; MI = myocardial infarction.  a Published means by Fennessy et al. (2011); b 
Published means by Alsen et al. (2010); c Published means by Calvin et al. (2009). 
 
Table 12.  IPQR Identity Subscale Frequency Scores 
______________________________________________________________________________ 
   Symptom Experienced Symptom Related to CVD 
    (n = 81)         
Fatigue   71.6%    63.8% 
Pain    64.2%    44.2% 
Sleep Difficulties  59.3%    29.2% 
Stiff Joints   58%    10.6% 
Shortness of Breath  53.1%    79.1%      
 
Table 13.  IPQR Causal Subscale Mean Scores 
 
Causes for CVD 
 n = 81    Mean (SD)        
Hereditary    4.07 (1.22) 
Diet or Eating Habits   3.77 (1.06) 
My Own Behavior   3.56 (1.08) 
Stress or Worry   3.56 (1.27) 
Ageing    3.38 (1.13) 
Family Problems or Worries  3.02 (1.24)        
 
Quality of Life 
QoL was measured using the QLI Cardiac-IV instrument that includes a total score and 
four subscales (health and functioning, social and economic, psychological/spiritual, and family).  




The higher the score the greater perceived QoL.  The mean score for the QLI total and for each 
four subscales were based on the possible range of scores from 0-30.  A review of the mean 
scores for the women gives a sense of the overall status of QoL with a score less than 19 
indicating poorer QoL (Personal Communication from Dr. C. Ferrans on October 16, 2018). 
Table 14 lists the mean scores and number scoring less than 19 for the total and subscales, as 
well as normative mean scores.  The normative mean scores were obtained from women without 
CAD of the same age group (30-75 years; mean age 57.7) (Savoy & Penckofer, 2015).  The QLI 
total mean score of 23.74 indicates that on average the sample perceived above average 
satisfaction with QoL. On the Likert scale the sample scored in the “slightly to moderately 
satisfied” range.  An overall greater satisfaction with QoL is reflected by the low number of 
women with a total score of less than 19 (n = 12).  The highest scoring subscale was social and 
economic (mean = 24.58) with 12.3% scoring less than 19.  This score indicates that on average, 
the women were “moderately to very satisfied” with their social and economic status.  The 
psychological/spiritual growth subscale (mean = 24.19) had 17.3% women scoring less than 19.  
This score indicates that on average, the women were “moderately satisfied” with their personal 
self and spirituality.  The family subscale (mean = 24.13) was not the highest mean score, 
although had the least women (9.9%) scoring less than 19. This score indicates that on average, 
the women were “moderately satisfied” with their family life.  The women scored the lowest on 
the health and functioning subscale (mean = 23.01), with 21% of the women scored less than 19. 
This score indicates that on average the women were “slightly to moderately satisfied” with their 
health and functional status. Some of the items in the function domain included ability to 




Other studies with women with or without heart disease of the same age group found similar 
scores for the overall QLI and health functioning, social economic, psychological/spiritual and 
family subscales (Carroll & Hamilton, 2005; Savoy & Penckofer, 2015).  The QLI Cardiac IV 
instrument alpha coefficient was .90 confirming strong reliability of the instrument with the 
study sample.  Overall, the women scored favorable satisfaction with the various aspects of 
quality of life. 
Table 14.  Quality Life Index Cardiac-IV (QLI) and Subscale Scores and Normative Mean Score 
______________________________________________________________________________ 
Mean Score     Median Number Scoring Normative 
          (SD)    (Range) Less Than 19 (%)   Mean Score (SD) 
QLI Cardiac IV Total Score 23.74 (4.64) 24.75 (5-30)    12 (14.8%)  22.4 (4) 
 
Subscales   
  
Health and Functioning 23.01 (4.98)  23.60 (3-30)    17 (21%)  21.5 (4.6)  
Social and Economic  24.58 (4.94)  25.71 (7-30)    10 (12.3%)  22.7 (4.5) 
Psychological/Spiritual 24.19 (5.25)  25.72 (8-30)    14 (17.3%)  23.2 (4.9)  
Family    24.13 (5.55)  25.20 (4-30)      8 (9.9%)  23.0 (5.3)  
Note. Normative mean scores were obtained from women aged between 30-75 years (mean 57.7 years) (Savoy & 
Penckofer, 2015). 
Characteristics of the Environment 
 Social support was examined because it is an environment factor that may impact the 
QoL in women with heart disease. 
Social Support 
 The MOS-SS was used to measure perceived social support. The MOS-SS uses a 5-point 
Likert scale of 1 (none of the time), 2 (little of the time), 3 (some of the time), 4 (most of the 
time), and 5 (all of the time). The higher the score the greater perceived social support.  Social 
support was evaluated because the literature identifies this variable as a potential covariate 




with heart disease and found an association between low social support and the development of 
depression or worsening depression.  Whereas, high levels of social support predicted low 
depressive symptoms (Frasure-Smith et al., 2000). The MOS-SS item #1 (number of close 
friends/relatives) measures structural support and is omitted when scoring the instrument.  Table 
15 lists the mean scores for the total and subscales, as well as, the normative mean scores.  The 
normative mean scores were obtained from patients with chronic disease (HTN, CHD, diabetes, 
depression) with a mean age of 55 years (Sherbourne & Stewart, 1991).  It is important to note 
that the study sample from where the normative scores were obtained included men (39%) and 
women with a lower mean age (mean age = 55 years) than the women (mean age = 65 years) in 
this study.  This same study results found that men and older age (> 45 years) perceived greater 
social support compared to women and younger age (Sherbourne & Stewart, 1991).  The mean 
score for the total, each four subscales, and one additional item were determined using a formula 
that transforms the scale scores to a 0 – 100 scale (Social Support Survey Instrument Scoring 
Instructions, Rand.org).  The MOS-SS total mean score of 83.98 indicated that 87% of the study 
sample perceived above average social support.  On the Likert scale the study sample scored in 
the “most of the time” range for having social support.  The highest scoring subscale was 
affectionate (mean = 90.02).  This score indicates on average the women felt expression of love 
and affection, scoring between “most of the time” and “all of the time” range for affectionate 
support.  The women scored above average in all of the subscales, emotional/informational 
(mean = 82.90), tangible (mean = 81.10), positive social interaction (mean = 85.80), and the one 
additional item (mean = 80.50).  The one additional item was “having someone to do things 




of the time” using the Likert scale. The women in the study perceived greater social support 
compared to normative scores from other individuals with heart disease. Overall, the women 
perceived having a strong social support network that may bias their self-report perceived 
depression score indicating lower depressive symptoms.  The MOS-SS had an alpha coefficient 
of .96 confirming strong reliability of the instrument.   
Table 15.  Medical Outcomes Survey-Social Support (MOS-SS) and Subscale Scores 
______________________________________________________________________________ 
# of Range of  Mean Score (SD) Normative 
    Items  Scores            Mean Score (SD) 
  
MOS-SS Total Score  19 19 - 95   83.98 (17.8)  70.1 (24.2) 
Subscales 
  
Emotional/Informational  8 8 - 40  82.90 (19.5)  69.6 (25.5)  
Tangible     4 4 - 20  81.10 (24.0)  69.8 (28.5) 
Affectionate     3 3 – 15  90.02 (17.4)  73.7 (28.3) 
Positive Social Interaction  3 3 – 15  85.80 (18.9)  69.8 (26)   
Note.  Range of Scores is possible lowest and highest score. Normative mean scores were obtained from patients 
with a chronic disease (HTN, CHD, diabetes, depression) (Sherbourne & Stewart, 1991). 
 
Data Analysis of Study Aims 
 Aim 1: To determine the relationship of symptoms (depression, anxiety) to functional 
status (health promoting behaviors), health perceptions (illness perception), and QoL. 
Hypothesis: Negative mood symptoms (depression or anxiety) will be associated with 
fewer health-promoting behaviors, less perception of risk (illness), and poorer QOL. 
The primary study aim was to examine whether there was a relationship between 
depression/anxiety symptoms, health promoting behaviors, illness perception and QoL.  
Pearson’s correlations were performed to assess the correlation between the variables.  Table 16 




behaviors, QoL, social support and functional comorbidities.  There were statistically significant 
correlations between depressive symptoms, anxiety symptoms, health promoting behaviors, 
QoL, social support and functional comorbidities. More depressive symptoms were associated 
with greater anxiety symptoms (r = .689, p < .01), less health promoting behaviors (r = -.366, p < 
.01), poorer QoL (r = -.673, p < .01), less social support (r = -.380, p < .01), and greater 
functional comorbidities (r = .431, p < .01).  Anxiety symptoms demonstrated similar results. 
More anxiety symptoms were associated with less health promoting behaviors (r = -.328, p < 
.01), poorer QoL (r = -.687, p < .01), less social support (r = -.431, p < .01), and greater 
functional comorbidities (r = .345, p <. 01).  Better QoL was significantly associated with more 
health promoting behaviors (r = .535, p < .01), greater social support (r = .490, p < .01) and less 
functional comorbidities (r = -.471, p < .01).  In summary, women with more depressive and/or 
anxiety symptoms performed less health promoting behaviors, and had poorer QoL, less social 
support, and greater functional comorbidities. 
Table 16.  Depression/Anxiety Correlations to Key Study Variables  
             
             PHQ-8  GAD-7 HPLP-II QoL MOS-SS FCI     
PHQ-8  --- 
GAD-7 .698**  --- 
HPLP-II -.366** -.328** --- 
QoL  -.673** -.687** .535**  --- 
MOS-SS -.380** -.431** .366**  .490**      ---   
FCI  .431**  .345**  -.172  -.471**    -.179 ---  
Note. PHQ-8 = depressive symptoms, GAD-7 = anxiety symptoms, HPLP = health promoting lifestyle profile, QoL 
= quality of life, MOS-SS = social support, FCI = functional comorbidities, ** statistically significant at p < .01. 
 
Examining the relationship between illness perception subscales and depressive 
symptoms, anxiety symptoms, health promoting behaviors and QoL provided knowledge on 




specific illness perception domain(s) that attributed to the negative/positive perception.  There 
were statistically significant correlations between certain domains of illness perception and 
depressive symptoms, anxiety symptoms, health promoting behaviors and QoL.  Table 17 lists 
illness perception subscale correlations to depression, anxiety, health promoting behaviors, and 
QoL.  More depressive symptoms were significantly associated with the belief that CVD 
attributed to a greater number of symptoms (r = .274, p < .05), difficulty understanding CVD (r = 
-.340, p < .01), and CVD caused more distress (r = .431, p < .01).  Similar to depressive 
symptoms, more anxiety symptoms were significantly associated with CVD attributing a greater 
number of symptoms (r = .246, p < .05), difficulty understanding CVD (r = -.332, p < .01), and 
CVD caused more distress (r = .522, p < .01).  These results indicate that women with more 
depressive and/or anxiety symptoms were associated with a negative perception of their CVD.  
Better QoL was significantly associated with lower number of symptoms attributed to CVD (r = 
-.318, p < .01), CVD had less negative consequences (r = -.266, p < .05), better understanding of 
CVD (r = .424, p < .01), and CVD did not cause distress (r = -.497, p < .01).  Individuals with a 
more positive perception of their illness were associated with better QoL.  Better health 
promoting behaviors were significantly associated with beliefs that CVD could be personally 
controlled (r = .296, p < .01) and better understanding of CVD (r = .283, p < .05).  In summary, 
women who perceived CVD attributed to less symptoms, CVD had few negative consequences, 
CVD could be personally controlled, and had a better understanding of CVD performed more 
health promoting behaviors and had greater QoL. Unfortunately, women with greater depressive 
and/or anxiety symptoms believed their heart disease attributed to more symptoms, had difficulty 




promoting behaviors and had poorer QoL. 
Table 17.  Illness Perception Correlations to Depression, Anxiety, HPLP-II, and QoL 
            
Illness Perception   Depression Anxiety HPLP-II QoL   
Subscales            
Identity   .274*  .246*  -.019  -.318** 
Timeline Acute-Chronic .013  -.061  .052  -.012 
Timeline Cyclical  .067  .156  -.052  -.175 
Consequences   .178  .104  -.092  -.266* 
Personal Control  -.111  -.176  .296**  .192  
Treatment Control  -.022  -.050  .195  .115 
Illness Coherence  -.340** -.322** .283*  .424** 
Emotional Representation .431**  .522**  -.171  -.497**  
Note. * statistically significant at p < .05, ** statistically significant at p < .01. 
 
Stepwise multiple regression method was used to determine the variables that predict 
QoL.  This method was used to identify the best model fit and because there were several 
variables with a sample size of 81.  Regression coefficients and standard errors can be found in 
Table 18.   Anxiety symptoms explained 46.5% of the variance in QoL, F(1, 79) = 70.468, p < 
.001.  Anxiety symptoms, health promoting behaviors, functional comorbidity, IPQR emotional 
representation, and social support R2 for the overall model was 68.1% with an adjusted R2 of 
66.0%, a large size effect according to Cohen (1988).  Anxiety symptoms ( = -.324 (SE = .120, 
t = -3.69, p < .001), health promoting behaviors ( = .292 (SE = .014, t = 4.08, p < .001), 
functional comorbidities ( = -.257 (SE = .119, t = -3.68, p < .001), illness perception CVD 
caused distress ( = -.215 (SE = .067, t = -2.80, p < .01) and social support ( = .152 (SE = .026, 
t = 2.03, p < .05) were significant predictors of QoL.  Greater anxiety symptoms, greater 
functional comorbidities, and the belief that CVD caused distress predicted poorer QoL.  Greater 
health promoting behaviors and greater social support predicted greater QoL.  Although 




1.85, p = .069) toward poorer QoL.  An important finding is that anxiety symptoms ( = -.324) 
were a greater predictor of poorer QoL than depressive symptoms ( = -.178) in this sample of 
women.  The assumptions of regression were met. There was no evidence of multicollinearity, as 
assessed by the variance inflation factor (VIF) less than 5, tolerance values greater than 0.1, and 
no variables had high variance proportions for the eigenvalue.  
Table 18.  Multiple Regression with QoL as the Outcome 
Variable   b  SEB    t  p  
Intercept   17.263  2.93      
Depression       -.178  -1.85  .069 
Anxiety   -.444  .120  -.324*** -.369  .000 
Health Promoting Behaviors  .058  .014  .292*** 4.078  .000 
Social Support   .052  .026  .152*  2.03  .046 
Functional Comorbidities -.440  .119  -.257*** -3.68  .000 
Illness Perception CVD 
Symptoms       -.129  -1.86  .067 
Illness Perception  
Understanding CVD      .076  1.03  .306 
Illness Perception Distress -.188  .067  -.215** -2.80  .006  
Note. aAnxiety, Health Promoting Behaviors, Functional Comorbidities, Illness Perception Distress, Social Support; 
R2 = .681; adjusted R2 = .660; F(5,75) = 32.077; p < .001. b = unstandardized regression coefficient; SEB = Standard 
error of the coefficient;   = standard coefficient. * p < .05; ** p < .01; *** p < .001. 
 
 In summary, anxiety symptoms were a stronger predictor of poorer QoL than depressive 
symptoms.  Depressive symptoms were trending toward predicting poorer QoL.  Greater health 
promoting behaviors and social support predict greater QoL.  Greater functional comorbidities 
and the belief CVD caused more distress predicted poorer QoL.  Other studies found a prediction 
between depressive/anxiety symptoms and health promoting behaviors (Huffman et al., 2013; 
Bauer et al., 2012) and negative illness perception (Hermele et al., 2007; Le Grande et al., 2012). 
Aim 2: To determine whether age is a factor contributing to negative mood symptoms, 




Hypothesis:  Women who are younger will have more negative symptoms, fewer health-
promoting behaviors, less perception of risk (illness), and lower QoL than women who are older 
(≥ 65 years) after controlling for social support. 
The second study aim was to determine whether age is a factor contributing to negative 
mood symptoms, functional status, health perceptions, and QoL after controlling for social 
support.  There is evidence to support that social support is associated with negative mood 
symptoms, healthy behaviors, illness perception, and QoL.  Poor social support is associated with 
greater depressive and anxiety symptoms, poorer healthy behaviors, greater perception of being 
ill, and poorer QoL.  Age was categorized into two separate groups with group one being younger 
women (< 65 years) and group two being older women (≥ 65 years).  There were thirty-six 
individuals in the younger age group and forty-four individuals in the older age group.   
The independent t-test was run to determine whether there was a difference between the 
age groups among age, CVD duration, CVD related symptoms, social support, and functional 
comorbidities (Table 19). The two-tailed statistical test was selected because there was no strong 
theoretical basis for a directional hypothesis. The level of significance was set at an  of .05. The 
assumptions for the independent t-test were met by the use of continuous dependent variables, 
the variances in the populations being roughly equal and the scores are independent coming from 
different people.  The standard error means were low for all five dependent variables indicating 
the group means value was an accurate estimate of the group mean (Table 19). 
The t-test group statistics concluded there were slightly less number of individuals in the 
younger group (n = 36) compared to the older group (n = 45). The mean age for the younger group 




weeks was less in the younger group (M = 332.67, SE = 70.56) compared to the older women 
group (M = 501.64, SE = 69.03) which was an expected finding.  Less social support was found in 
younger women (M = 79.19, SE = 2.45) than older women (M = 85.73, SE = 1.78), a statistically 
significant difference, M = -6.54, 95% CI -12.58, -.497, t = (79) = -2.16, p < .05. The younger 
group of women reported more symptoms were related to CVD (M = 4.52, SE = .675) than the 
older group of women (M = 3.17, SE = .521). Although, this difference was not significant t(79) = 
1.58, p > .05.  Younger women had slightly less functional comorbidities (M = 4.63, SE = .480) 
than the older women (M = 4.97, SE = .386). This difference was not significant t(79) = -.550, p > 
.05. In summary, younger women had significantly less social support than older women. Although 
younger women believe more symptoms were related to CVD, there was no significant difference 
found between the younger and older women.  An unexpected finding was the absence of a 
significant difference between functional comorbidities between the younger and older women.  
This may be due to the low number of functional comorbidities reported among the women.   
Table 19.  Independent t test Comparison of Variables Among Age Groups 
______________________________________________________________________________ 
Variable      Age < 65      Age  65       t-statistic p value 95% CI 
       Mean (SE)      Mean (SE)         
Age       58.14 (.785)    71.44 (.517         14.16 .000**  -15.11, -11.50 
CAD duration 
(weeks)      332.67(70.56)  501.64 (69.03)   -1.71 .091  -365.5, -27.58 
CVD related 
Symptoms      4.52 (.676)      3.17 (.521)            1.58 .118  -.352, 3.05 
Social Support   79.19 (2.45)      85.73 (1.78)          -2.16 .034*  -12.58, -.497 
Functional 
Comorbidities      4.63 (.480)        4.97 (.386)           -.550 .584  -1.57, .889   
*p < .05, **p < .01 
 




the age groups and specific health promoting behavior subscales (health responsibilities, physical 
activity, nutrition, spiritual growth, interpersonal relations, and stress management).  Younger 
women had poorer nutrition, less interpersonal relations, less spiritual growth, and greater stress 
compared to the older women (Table 20), although the differences were not statistically significant. 
Table 20.  Summary of Age Group Differences of HPLP-II Subscales 
Variable Age < 65 
N = 36 
Age  65 
N = 45 











































ANCOVA was used to examine the statistical significance of among age groups and the 
key variables while controlling for social support (Table 21).  Previous studies identified that 
social support influences mood, health promoting behaviors, and quality of life (Lett et al., 2005; 




While controlling for social support, QoL was found to be significantly greater in older 
women compared to younger women, F (1,78) = 5.82, p < .05.  Anxiety symptoms (F(1,78) = 
3.41, p = .068) and the belief that CVD causes distress (F(1,78) = 3.86, p = .053) are trending 
toward a significant difference between younger and older women.  The findings indicate that 
younger women have greater anxiety symptoms and the belief that CVD causes distress 
compared to older women.  Younger women as compared to older women reported more 
depressive symptoms, fewer health promoting behaviors, and related more symptoms to CVD; 
however, the difference was not statistically significant between groups. 
Table 21.  ANCOVA for Social Support 
Variable  Instrument Age < 65  Age  65  F p value 
     Mean (SE)  Mean (SE)     
Depression  PHQ-8  4.04 (.606)  3.75 (.541)  .112 .728 
 
Anxiety  GAD-7 3.46 (.513)  2.17 (.457)  3.41 .068 
 
Health Promoting 
Behaviors  HPLP-II 142.60 (3.69)  146.99 (3.28)  .765 .384 
 
CVD Related  IPQR 
Symptoms  Identity 4.45 (.639)  3.24 (.569)  1.93 .169 
 
Understanding  IPQR 
CVD   Coherence 19.62 (.645)  20.37 (.575)  .745 .391 
 
CVD Causes  IPQR  
Distress  ER  17.08 (.868)  14.76 (.773)  3.86 .053 
 
QoL   QLI  22.52 (.669)  24.71 (.596)  5.82 .018* 
 
Functional 
Comorbidities  FCI  4.49 (.455)  5.10 (.406)  .968 .328  





In conclusion, the hypothesis that women who are younger will have more negative 
symptoms, fewer health promoting behaviors, less perception of (risk) illness, and lower QoL 
than older women was partially supported.  Overall, younger women with CVD reported worse 
outcomes than older women.  The QoL in younger women was somewhat lower than older 
women (p = .018) which has been reported in the literature (Beckie et al., 2015; Leung et al., 
2014).  However, overall the women reported good QoL.  There was a trend for younger women 
to have greater anxiety symptoms and the belief that CVD caused more distress.  These findings 
were supported by other researchers examining women with CVD (Beckie et al., 2015; 
LeGrande et al., 2014).  Although depressive symptoms and health promoting behaviors were 
not significantly different among age groups, women who were younger reported more 
symptoms and engaged in fewer health promoting behaviors.    
 Studies have found that negative mood is more prevalent in younger women (< 55 years) 
with CVD compared to younger men or older women and the use of antidepressants or anti-
anxiety medications improved their mood and QoL (Mazza et at. 2010; Wang, Hoffman & 
Blumenthal, 2011).  Other studies have found the use of antidepressants in younger women with 
chronic disease improved their depression, as well as, engaging in self-care behaviors (Lustman, 
Williams, Sayak, Nix & Clouse, 2007).  Younger women with CVD are more likely to have 
negative mood, altered illness perception, less healthy behaviors, and poorer QoL compared to 
older women.  These findings support the importance to target the younger women to treatments, 








 This chapter provides a discussion of the study findings, implications for nursing, and 
recommendations for future research.  This study was important to conduct to gather more 
information on women with CVD to improve their overall QoL.  CVD is a widespread chronic 
illness that is the leading cause of death for women (Xu, Murphy, Kochanek, & Bastian, 2016).  
Overall, there is an underrepresentation of women with CVD in studies that examined negative 
mood, healthy behaviors, illness perception, and QoL.  There are even fewer studies that 
explored whether the association between these variables are different among younger and older 
age groups.  Depressive and anxiety symptoms are common in women with CVD and associated 
with an increased risk for cardiac events leading to greater morbidity and mortality rates 
(Lichtman et al., 2014; Gan et al., 2014; Roest, Martin, de Jonge, & Denollet, 2010).  Studies 
found that increased cardiac events were associated with less health promoting behaviors 
(Kronish et al., 2006; Lichtman et al., 2014).  Also, there is limited knowledge on whether 
depressive/anxiety symptoms influence illness perception, that may influence healthy behaviors 
and QoL.  In addition, women with CVD report poorer QoL compared to men with CVD or 
women without CVD (Broddadottir et al., 2009; Ford et al., 2008).  This study was important to 
conduct because it contributed data that provided a better understanding of the effect of 




in women with CVD.  In addition, this study provided significant data that identified there was a 
difference in the relationship of these variables between younger and older women.   
This cross-sectional study explored the relationships between mood symptoms, functional 
status, health perceptions, and QoL in women with CVD.  The modified Wilson and Cleary 
Health-Related Quality of Life Model guided the exploration of the study variables. For this, the 
characteristics of the individual were measured by age, race/ethnicity, marital status, education, 
socioeconomic status, and employment.  Biological function was measured by the Framingham 
Recurrent Risk Model and the FCI tools.  The PHQ-8 and GAD-7 measured mood symptoms.  
The functional status of the women was measured using the HPLP-II.  General health 
perceptions were measured by the IPQ-R-Cardiac instrument.  The QLI was used to measure 
overall QoL.  The characteristics of the environment was measured using the MOS-SS 
instrument. 
Overall findings identified that in a group of women with CVD, that depressive and/or 
anxiety symptoms were associated with less health promoting behaviors, poorer QoL, less social 
support, and more comorbid condition.  The relationship between depressive and/or anxiety 
symptoms and the illness perception subscales was examined to determine whether there were 
specific illness perception domains that were influenced by negative mood. The study findings 
identified that depressive and/or anxiety symptoms were associated with greater illness 
symptoms, less understanding of the illness, and the illness caused distress.  The significant 
predictors of QoL were less anxiety (-.324, p <.001), better HPB (.292, p <.001), fewer 
comorbidities (-.257, p <.001), less distress in risk perception (-.215, p <.05) and more social 




depression as a predictor (-.178, p = .069).  ANCOVA indicated that QoL was higher in older 
women (p = .018) and there was a trend for younger women to have more anxiety (p = .068) and 
emotional distress for risk perception (p = .053). 
Overall, findings support the need to target assessment of anxiety in all women 
presenting with CVD to enhance health behavior, reduce distress and improve QoL.  Women 
who are less than 65 years of age need to be strongly targeted to reduce anxiety which may 
include education, psychological therapy and/or possible medications since they will be at 
greater risk for future CVD events.  
Characteristics of the Individual 
 The sample consisted of 81 women with a diagnosis of CVD for a duration from one 
week to 40 years, with a mean duration of 8.19 years. Over half (52%) had a prior history of MI, 
65% had a percutaneous coronary intervention (angioplasty/stent), a quarter (24%) previously 
underwent CABG, and over a third (35%) reported prior history of chest pain.  The women were 
between 35 to 78 years old with a mean age was 65.5 ( 7.78), with forty-four individuals age  
65 years and thirty-six individuals age < 65 years. The age range was similar to other samples 
studying depressive and/or anxiety symptoms in women with CVD (Broddadottir et al., 2009; 
Mallik et al., 2006; Rutledge et al., 2012; Shah et al., 2014; Spitzer et al., 2006).  The women 
were predominately white (81.5%), married (51.9%), college degree (38.3%), retired (51.9%), 
and yearly income > $55,000 (59.3%).  The racial composition of the sample corresponds to the 
surrounding area around the recruitment sites.  There is an under-representation of Hispanic and 
Asian women compared to the county’s ethnic composition.  There were a handful of Hispanic 




speak the English language.  Inclusion criteria for the study required the ability to read and speak 
the English language.   
 Women have a longer life expectancy and develop heart disease at an older age resulting 
in a higher prevalence of heart disease over sixty-five years of age (Mozaffarian, 2015).  The 
original age range for the study was 35 to 70 years.  The upper age limit of 70 years was based 
on the assumption that women in their 70s may have cognitive impairment.  Although, after 
spending three weeks at the recruitment sites and discussing with the cardiologists and advance 
practice nurses the cognitive function of the female patients aged 70 -78 years, it was found that 
the majority of women between the age of 70 to 78 years were cognitively intact.  The upper age 
limit of 78 years was determined to exclude those women who may have cognitive impairment 
due to older age.  A proposal modification was made that changed the inclusion criteria age 
range to 35 to 78 years.  There were a large number of women with coronary heart disease over 
the age of 70 years at the recruitment sites who met the study inclusion criteria.  Expanding the 
upper age to 78 years allowed women of older age to be represented in the study which also 
aided in the testing of hypothesis 2.    
Biological Function 
 Overall, women had low functional comorbidity.  The Functional Comorbidity Index 
identifies chronic comorbidities that decrease one’s level of physical function.  The study sample 
mean score of 4.83 indicated low functional comorbidity, indicating the women would be able to 
engage in physical activities.  Being physically active, such as walking, swimming, dancing, or 
stretching, decreases one’s risk for CV events.  The most frequent chronic illness identified, with 




gastrointestinal disorders (37%).  From a physical functioning standpoint, the study sample 
women reported similar physical function compared to individuals with a history of CABG that 
were of approximate age (Parry et al., 2012).  Obesity and arthritis are known factors that can 
reduce the ability to engage in physical activities due to pain or increased fatigue. Depression is a 
known comorbid condition in individuals with diabetes (Penckofer, Doyle, Byrn & Lustman, 
2014).  Diabetes was found to be present in 37% of the women therefore increasing the risk for 
depressive symptoms.  Heart disease is another chronic illness that is associated with depressive 
and/or anxiety symptoms and was present in 100% of the women.  This study sample 
contradicted the norm because there were less depressive and/or anxiety symptoms in the women 
compared to related studies (Mallik at al., 2006; Spitzer et al., 2006).  Although, with this sample 
having low chronic illnesses it is expected to find a lower level of depressive symptoms. 
 In terms of their risk for a secondary cardiac event, women in this study had a low 
probability, less than 4%, for a secondary cardiac event in the next two years.  This probability 
was determined by the Framingham 2-year Recurrent Risk Model for Women with CHD.  The 
Framingham Risk tool measures the risk factors age, total cholesterol, HDL, diabetes, tobacco 
use, and systolic blood pressure to determine the risk for a CVD event.  The instrument uses the 
cutoffs of  10% is low risk, 10-20% is intermediate risk, and  20% is high risk.  The majority 
of points for this sample of women was age, elevated cholesterol level, and diabetes.  SBP and 
no tobacco use were not risk factors in the sample.  The majority of the women 75.3% (n = 61) 
had a SBP  134 mmHg.  The goal SBP is < 140 mmHg. There was a significant number of 
former smokers 51% (n = 41) that may have contributed to their initial cardiac event, although 




lack of taking in consideration the race or ethnic diversity, diastolic blood pressure, stroke, LDL-
C level, and age limit of 74 years (Nayor & Ramachandran, 2016). These risk factors are 
substantial to include to determine the overall risk for a CV event and are included in some 
modified Cardiac Risk instruments. 
Symptoms 
 The symptoms explored in this study were depression as well as anxiety.  The moods 
reported by the women were inconsistent with previous studies identifying depression and 
anxiety as prevalent findings in women with heart disease (Lichtman et al., 2014; Batelaan et al., 
2016).  A cut-off score of 10 on the PHQ-8 was used to indicate the presence of depressive 
symptoms or depressive disorder.  In this study sample 36% of the women were with depressive 
symptoms, with 9% scoring  10, indicating a depressive disorder.   Even though the women in 
this study had a lower PHQ-8 score compared to other studies of women with heart disease, 
depressive symptoms were present in the sample.   
The findings for the presence of anxiety symptoms were similar to depressive symptoms.  
A cut-off score of 10 on the GAD-7 was used to indicate the presence of a generalized anxiety 
disorder.  Anxiety symptoms were present in 28% of the women, with 3% scoring  10.  
Although the women in this study had a lower GAD-7 score compared to other women in the 
primary care or general population, anxiety symptoms were present.  The lower level of negative 
mood found in the current study may be due to the small sample size (n = 81), the greater 
number of women   65 years old (n = 45; 56%), married or living with a partner (n = 43; 53%), 
retired (n = 42; 52%), had an average yearly income that was > $55,000 (N = 48; 59%), evidence 




have found that negative mood is greater in women < 65 years old, living alone, unemployed, of 
lower socioeconomic status, lack of social support, and with heart failure (Alhurani et al., 2015; 
Broddadottir et al., 2009; Gan et al., 2014).  Heart failure was an exclusion criterion for this 
study.  Several of the women were living alone and commented how grateful they were to have 
close friends to confide in and attend social events.  The demographic characteristics of the 
women may have contributed to the overall findings of lower depression and anxiety levels.  
Despite the small sample size and composition, differences were noted between younger women 
(< 65 years) and older women ( 65 years) with younger women having greater anxiety 
symptoms, but this difference was not statistically significant for depressive symptoms. 
Functional Status 
 Health Promoting Lifestyle Behaviors were used to assess the dimensions of functional 
status.  The findings from this study indicated that women were above average in performing 
health promotion behaviors.  The highest areas of health promotion were interpersonal 
relationships (81%) and spiritual growth (78%), followed by nutrition (69%), stress management 
(66%), and health responsibility (64%).  The lowest area of health promotion was physical 
activity (56%).  This means a large number of the women reported they did not exercise.  The 
highest areas of health promotion in this sample of women is similar to other studies examining 
women with and without heart disease (Oliver-McNeil et al., 2002; Savoy & Penckofer, 2016; 
Thanavaro, Thanavaro & Delicath, 2010).  The lowest area of health promotion (physical 
exercise) was also a consistent finding with other research studies.  Lack of physical exercise has 
been found to be a common barrier to health promotion in several other research studies on 




increased risk for secondary CVD events.  The unhealthy behaviors include high fat diet, 
sedentary lifestyle, and stress.  In this study, older women (> 65) compared to the younger 
women, reported better health behaviors in nutrition, spiritual growth, interpersonal 
relationships, and stress management.  There was no difference between the age groups in terms 
of physical activity and health responsibility.   
 The current sample had fewer negative moods that may contribute to the overall above 
average performance of health promoting behaviors.  Negative mood has been found to 
contribute to the lack of health promoting behaviors in women (McKenzie & Skelly, 2010; 
Mommersteeg et al., 2013).  In addition, studies have found that low education, low income, and 
poor social support were significant predictors for poor healthy behaviors (Mochari-Greenberger 
et al., 2010).  The women in this study had above high school education (67%), income > 
$55,000 (59%), and strong social support (87%) that provides additional support for the greater 
engagement in health promoting behaviors. 
General Health Perceptions 
 Illness perception was measured to examine the women’s health perception and included 
the following:  the view of their cardiac disease as an illness and whether illness perception was 
related to mood and/or health promoting behaviors.  The IPQ-R consists of several subscales to 
explore illness perception.  The subscales include illness identity, control, chronicity, coherence, 
consequences and cause.  The study women reported a low number of symptoms related to their 
heart disease.  The most common symptoms reported and believed to be related to their heart 
disease were fatigue, pain, and shortness of breath.  Although sleep difficulty was a common 




heart disease.  The study women perceived their illness to be controllable, chronic, 
asymptomatic, understandable, and have negative consequences. The perceived cause for their 
heart disease were risk factors, that included genetic/hereditary, unhealthy diet, own behavior, 
and aging, as well as, psychological attributes (stress, worry).  Illness control consists of both 
personal control and treatment control.  The higher scores on personal control and treatment 
control indicated the women had more positive beliefs about being able to control their cardiac 
illness.  Studies have found a significant correlation between depressive and/or anxiety 
symptoms and lower perceived illness control (Grace et al., 2005; Hermele et al., 2007; Juergens 
et al., 2010; Stafford, Berk, & Jackson, 2009).  This sample of women had low scores for 
depressive and/or anxiety symptoms that may reflect their more positive beliefs of illness 
control.  Heart disease is a chronic illness therefore it would be expected for individuals with 
heart disease to identify the illness as chronic.  Also, identifying an illness as chronic may 
influence women to engage in health promoting behaviors to stay healthy and prevent worsening 
of their heart disease.   
There was a high perception of illness coherence found in this study.  Illness coherence is 
understanding of heart disease.  The women acknowledged that they understood their heart 
disease.  Although, it was found that women with greater depressive and anxiety symptoms had 
less understanding of CVD.  Other studies found a significant correlation between greater 
depressive/anxiety symptoms and low illness coherence (Fennessy et al., 2011; Alsen et al., 
2010; Calvin et al., 2009).  This study sample had lower depressive/anxiety symptoms that may 
have contributed to greater understanding of their heart disease, therefore, greater health 




The participants in this study believed their illness had negative consequences on their 
life, that included seriousness of the disease, financial consequences, major consequences on 
their life, and caused difficulties for others close to them.  Several studies found a significant 
correlation between negative mood and negative consequences of the illness (Aalto et al., 2006; 
Cherrington et al., 2004; Grace et al., 2005).  It may be possible that perceiving heart disease has 
negative consequences may contribute to depressive or anxiety symptoms.  Dickens et al (2008) 
found negative perception of heart disease in MI patients was associated with new onset of 
depressive symptoms.  This may be a significant factor in women’s perception of chronic illness 
and engagement in health promoting behaviors.  In addition, individuals who perceive their 
illness has negative consequences may view their illness as a life threat and take action to change 
behaviors.  Viewing one’s illness as a life threat may influence greater health promoting 
behaviors to reduce the threat.   
 Overall, the participants viewed their heart disease as asymptomatic.  This may be 
because most women did not have structural damage to the heart muscle that would result in 
greater symptoms, such as heart failure.  As mentioned earlier, heart failure was an exclusion 
criterion for the sample.  In addition, although the women had a history of coronary artery 
disease, there usually are no symptoms unless there is significant coronary artery blockage or 
spasm.  The lack of symptoms may be another factor for greater engagement in health promoting 
behaviors.  Many studies on heart disease patients with symptoms (fatigue, shortness of breath, 
chest pain), such as heart failure patients, found symptoms were associated with less engagement 
in healthy behaviors due to heart impairment, as well as, lack of motivation and time (Klompstra, 




 The sample of women identified risk factors for heart disease to be the greatest cause of 
their illness.  Health promoting behaviors are known to reduce risk factors for heart disease.  
Therefore, it is an expected finding that the participants had strong health promoting behaviors to 
reduce their risk for a secondary event.  The participants identified that tobacco was a cause for 
their heart disease and stopped tobacco use after their first cardiac event.  The fact that these 
women identified that risk factors caused their heart disease and adopted healthy behaviors was a 
significant finding for the prevention of chronic disease complications and greater QoL.   
Quality of Life 
 The study participants had overall above average satisfaction with QoL.  The high QoL 
rating was similar to other studies obtained from women with or without heart disease of the 
approximate same age (Savoy & Penckofer, 2015; Carroll & Hamilton, 2005).  Although, it has 
been identified in other studies that women with heart disease had lower QoL compared to 
women without heart disease (Broddadottir et al., 2009;  Ford et al., 2008).  This study sample 
women had overall strong social support, economic stability, low negative mood, positive 
outlook, few comorbidities, and stable cardiac condition.  These study sample characteristics 
correspond to a perceived higher QoL.   
Characteristics of the Environment 
 The sample of women had overall a very strong perception of social support with above 
average levels for all four domains:  emotional, tangible, affection, and positive social 
interaction.  This means that the women felt love and affection, had positive social interactions, 
had someone to care for them, and someone to do things with.  The strong perception of social 




perception, and improve overall QoL (Broddadottir et al., 2007; Greco et al., 2014; Frasure-
Smith et al., 2000; Leifheit-Limson et al., 2010; Lett et al., 2005; Pragodpol & Ryan, 2013; Ruo 
et al., 2003).  Therefore, the strong social support reported by the women in the current study 
may have contributed to their lower negative mood, increased healthy behaviors, less illness 
perception (less perception of being ill), and greater QoL.  It is important to note that social 
support was significantly stronger in older women (> 65) compared to younger women.  The 
older women also had less negative mood, greater health promoting behaviors, less negative 
illness perceptions, and greater QoL.  This will be discussed in more detail in the study Aim 2 
discussion section.  
Discussion of Study Aims 
 There were two study aims and two study hypotheses for this research study.   
 Aim 1:  The relationship of mood symptoms to functional status (healthy promoting 
behaviors), health perceptions (illness perception), and QoL. 
Hypothesis: Negative mood symptoms (depression or anxiety) will be associated with 
fewer health-promoting behaviors, less perception of risk (illness), and poorer QoL. 
 The first study aim was to determine the relationship between negative mood symptoms 
(depression/anxiety), health promoting behaviors, illness perception, and QoL in women with 
heart disease.  The hypothesis was that negative mood symptoms would be associated with fewer 
health promoting behaviors, less perception of illness, and poorer QoL.  The hypothesis was 
partially supported.  The findings revealed significant inverse relationships between depressive 
symptoms and health promoting behaviors (r = -.366, p < .001), QoL (r = -.673, p < .001), and 




associated with less health promoting behaviors, poorer QoL, and less social support.  There was 
a positive relationship between depressive symptoms and functional comorbidities (r = .431, p < 
.001).  This finding indicates that greater depressive symptoms were associated with more 
functional comorbidities.  The same findings were found with anxiety symptoms.  There was a 
significant relationship between anxiety and health promoting behaviors (r = -.328, p < .001), 
QoL (r = -.687, p < .001), and social support (r = -.431, p < .001).  Anxiety had a positive 
relationship to functional comorbidities (r = .345, p < .001).  Therefore, women with more 
anxiety symptoms performed less health promoting behaviors, had poorer QoL, less social 
support, and greater functional comorbidities.  Women who performed more health promoting 
behaviors reported better QoL.  The study findings that women with CVD with greater negative 
mood performed less health promoting behaviors and had poorer QoL is supported by other 
researchers (Savoy & Penckofer, 2015; Reigel et al., 2017; Pragodpol & Ryan, 2013).  Huffman 
et al. (2013) conducted a literature review on the associations between depression and health 
promoting behaviors in CVD patients.  The summary of findings concluded that individuals with 
greater depressive symptoms were less likely to engage in health promoting behaviors (Bauer et 
al., 2012; Casey, Hughes, Waechter, Josephson, & Rosneck, 2008; May et al., 2010; McGrady, 
McGinnis, Badenhop, Bentle, & Rajput, 2009; Whooley et al., 2008; Ziegelstein et al., 2000).  
Although, some researchers (Bauer et al., 2012; Kuhl et al., 2009) found that greater anxiety 
symptoms were associated with less health promoting behaviors, others (Herrmann et al., 2000) 
have found anxiety symptoms increased health promoting behaviors.   These findings may 




 The illness perception subscales were examined to determine whether depressive/anxiety 
symptoms, health promoting behaviors, and QoL were related to an individual’s positive or 
negative perception of their illness, as well as, identify the specific illness perception domain(s) 
that attribute to the negative/positive perception.  The study findings revealed women with more 
depressive and/or anxiety symptoms perceived more symptoms were related to their heart 
disease, had difficulty understanding CVD, and believed that CVD caused greater distress 
(worry, fear, anger).  In this study, depressive and/or anxiety symptoms were not related to the 
perception that CVD was chronic, CVD caused negative consequences, or CVD was 
uncontrollable.  These results of depressive/anxiety symptoms and illness perception were 
partially supported in the literature.  Researchers examining depressive and/or anxiety symptoms 
and illness perception in CVD individuals found that greater negative illness perception (more 
symptoms are related to the illness, the illness is chronic, symptoms are unpredictable, the illness 
causes negative consequences, and the illness causes distress) was associated with greater 
depressive and/or anxiety symptoms (Broadbent et al., 2009; Hermele et al., 2007; Le Grande et 
al., 2012; Savoy & Penckofer, 2015; Stafford et al., 2009).   
Other researchers have found that depression was predicted by the perception that CVD 
caused negative consequences (Stafford, Berk & Jackson, 2009), CVD was difficult to 
understand (Hermele, Olivo, Namerow & Oz, 2007), and CVD could not be controlled (Dickens 
et al., 2008).  In addition, a greater negative perception of illness predicted negative mood and 
increased complications in MI patients (Cherrington, 2014).  Le Grande et al (2012) examined 
illness perception in heart disease patients and found greater depressive symptoms was 




In addition, they reported that younger individuals believed their illness to be chronic, treatment 
to be in-effective, CVD caused distress, with resulting greater depressive symptoms and lower 
QoL (Le Grande et al., 2012; Grace et al., 2005).  The results from this study examining the 
relationship between illness perception domains and depressive and/or anxiety symptoms may 
differ from other research findings because only women were enrolled in this study, whereas 
other researchers enrolled both men and women with most of participants being men.  In 
addition, the study women reported low depressive and anxiety symptoms that may impact the 
relationship to other variables.  
Illness perceptions have been found to differ between men and women with CVD.  A 
meta-analysis conducted by Al-Smadi et al (2016) examined illness perception in individuals 
with CVD and included gender differences in illness perception.  The analysis found that women 
had higher perception of illness (belief that they were ill), as well as, a greater negative 
perception of CVD compared to men.  Women perceived CVD contributed to more symptoms, 
CVD was chronic, and CVD caused more distress.  On the other hand, men perceived CVD can 
be controlled, CVD caused more negative consequences, and CVD was understandable.  The 
findings from the meta-analysis supports that gender may contribute to this study results 
differing from other studies in the literature that included both genders.  Illness perceptions in 
individuals with CVD have been found to change based on the individual’s duration of the 
disease, as well as, the severity of the disease (Alsen et al., 2010; Broadbent et al., 2008).  In this 
study, the majority of the women had CVD for eight years without heart failure.  Heart failure is 




Research studies on heart disease patients have found that one’s perception or beliefs 
about their CVD can predict negative mood, health promoting behaviors, and QoL (Alsen et at., 
2010; Cherrington, 2014; Kunschitz et al., 2016).  In addition, women with depressive and/or 
anxiety symptoms had a greater negative illness perception compared to women without 
depressive and/or anxiety symptoms (Broadbent et al., 2009; Hermele et al., 2007; Le Grande et 
al., 2012; Stafford et al., 2009).  Review of the literature has identified that illness perception 
varies among women with CVD and has an impact on the occurrence of negative mood, health 
promoting behaviors, and QoL (Alsen et al., 2010).  In addition, younger age contributes to 
greater negative illness perceptions (Beckie et al., 2015; Le Grande et al., 2012).  Therefore, the 
current study findings support that illness perception is an important area for further 
investigation among younger women with CVD to improve overall QoL. 
 Stepwise linear regression examined whether depressive/anxiety symptoms, health 
promoting behaviors, illness perception, social support and functional comorbidities predict 
QoL.  The significant predictors of QoL were less anxiety, better HPB, fewer comorbidities, less 
distress in risk perception, and more social support which explained 66% of the variance in the 
model.  In addition, there was a trend for greater depressive symptoms to be a predictor for 
worse QoL.  Other studies have found that less depressive and/or anxiety symptoms were 
significant predictors of better QoL (Savoy & Penckofer, 2015; Alsen et al., 2010; Broddadottir 
et al., 2009; Stafford et al., 2007).   
Aim 2. To Determine Whether Age is a Factor Contributing to Negative Mood 
Symptoms, Functional Status, Health Perceptions, and QoL After Controlling for Social Support.




promoting behaviors, less perception of (risk) illness, and lower QoL than women who are older 
( 65 years), after controlling for social support. 
  The second study aim was to determine whether age is a factor contributing to negative 
mood symptoms, functional status, health perceptions, and QoL while controlling for social 
support.  The hypothesis was women who are younger will have more negative symptoms, fewer 
health promoting behaviors, less perception of illness, and lower QoL than women who are older 
( 65 years).  The younger and older age groups were almost evenly distributed with thirty-six 
individuals in the younger age group and forty-four individuals in the older age group.   
ANCOVA was used to compared the two groups while controlling for social support and the 
findings indicated that QoL was higher in older women and there was a trend for younger 
women to have more anxiety, and perceive that CVD caused emotional distress. 
 To support these findings, researchers have found that negative mood (depressive and/or 
anxiety symptoms) is more prevalent in younger women (< 55 years) with or without CVD 
compared to men or older women (Beckie, Fletcher, Groer, Kip & Ji, 2015; Broddadottir et al., 
2009;  Fang et al., 2018; Huffman et al., 2013; Mazza et al., 2010; Mallik et al., 2006; Wang, 
Hoffman & Blumenthal, 2011; Shah et al., 2014).  Few studies were identified that reported the 
age difference in women with CVD and anxiety symptoms.  Beckie et al (2015) examined 
women with CVD (n = 252) who were enrolled in cardiac rehabilitation, after acute coronary 
syndrome or MI, and found anxiety and depressive symptoms to be greater in younger women (< 
55 years) compared to older women.  Young women reported significantly greater anxiety 
symptoms (41.7, SD  14.1 vs. 33.3; SD  11.0) and depressive symptoms (24.5, SD 13.4 vs. 




anxiety symptoms in men and women with CVD and found anxiety symptoms greater in women 
(58.8%) compared to men (25.5%), although age was not reported.  Fang et al (2018) studied 
anxiety symptoms in men and women with a MI and found anxiety symptoms were greater in 
younger women and men, although there was no difference between genders.  
The current study found greater depressive symptoms were reported by women < 65 
years, although the finding was not statistically significant.  Research studies have found 
significantly greater depressive symptoms in younger women compared to older women with 
CVD (Beckie et al., 2015; Shah et al., 2014).  Shah et al (2014) studied whether depression was 
associated with higher incident and greater adverse outcomes in men (n = 2136) and women (n = 
1100) undergoing coronary angiogram for the evaluation of CVD.  The study results found that 
younger women age < 55 years had more depressive symptoms (27%), than women age 56-64 
(18% depressive symptoms), or women  65 years (12% depressive symptoms) (Shah et al., 
2014). The small sample size of the current study may contribute to the lack of significant 
findings in predicting greater depressive symptoms in younger women.   
 The sample of younger women perceived more symptoms related to their CVD, less 
understanding of CVD, and CVD caused more distress.  Although the difference between 
younger and older women were not statistically significant, other researchers have found results 
indicating issues with younger women.  A review of the literature found two studies that reported 
illness perception differences between younger and older individuals with heart disease.   These 
researchers identified that younger individuals with CVD reported greater negative illness 
perceptions compared to older individuals (Beckie et al., 2015; Le Grande et al., 2012).  Beckie 




perceptions (perceived themselves to be more ill) compared to older women.  Le Grande et al 
(2012) found that younger individuals (mean age = 63) believed that CVD severely impacted 
their life, would last their lifetime, treatment would be ineffective, caused severe distress, had 
greater depressive symptoms, and poorer QoL.  The older individuals (mean age = 69) believed 
their disease to be chronic and treatment was ineffective, although they had fewer depressive 
symptoms and greater QoL.  Further investigation on examining the differences in illness 
perception among younger and older age groups is needed to identify and implement illness 
perception interventions that are specific to the individuals’ health needs.  Individuals with 
greater negative illness perceptions have been found to have greater depressive symptoms, 
engage in less healthy behaviors, and have poorer QoL.  The results of the current study support 
the need to target the younger women with CVD and provide interventions to decrease their 
negative illness perceptions.  In addition, decreasing one’s negative perception of being ill may 
minimize depressive and/or anxiety symptoms and promote greater QoL. 
 Younger women had somewhat lower QoL compared to older women in the current 
study.  There are several studies in the literature that support QoL is poorer in women with CVD 
compared to women without CVD (Ford et al., 2008; Norris et al., 2010).  In the literature, there 
is limited research examining differences in QoL among age groups in women with CVD.  The 
few studies that did examine QoL in men and women with CVD found that younger patients (< 
65 years) had poorer QoL compared to older patients ( 65 years), and women reported poorer 
QoL compared to men (Beckie, Fletcher, Groer, Kip & Ji, 2015; Xiu, Wu, Zheng, Sullivan, Zhan 




differences with negative mood, health promoting behaviors, illness perception, and QoL may be 
due to the limited inclusion of older women in CVD studies (Mehta et al., 2016). 
The current sample of younger women reporting poorer QoL compared to older women 
may have been influenced by their perception of more symptoms related to CVD, less 
understanding of CVD, CVD caused more distress, and greater negative mood symptoms, 
although these differences were not statistically significant.  In addition, poorer QoL in younger 
women may be explained by the fact that CVD may have a stronger impact on patients in their 
productive years than those who are retired.  CVD may restrict younger individuals from 
performing or pursuing their professional goals and social roles as opposed to older retired 
individuals.  This restriction may contribute to poorer QoL. 
In the current study, health promoting behaviors were found to be less in younger women 
(142.6, SE 3.68 vs. 146.9, SE 3.28) compared to older women, although the difference was not 
found to be statistically significant.  The findings that younger women perform less health 
promoting behaviors is supported in the literature.  There is evidence in the literature that 
younger women perceived specific barriers to health promoting behaviors that included time 
constraints, stress, depression, family obligations, and ambivalence to behavior change (Mosca et 
al., 2013; Galbraith, Mehta, Veledar, Vaccarino & Wenger, 2011).  In the current study, younger 
women reported equal physical activity and health responsibilities (i.e. knowledge of heart 
disease) compared to older women.  Although, unhealthy diet, lower social support, less spiritual 
growth, and greater stress was found in the younger women versus the older women.  The study 
findings, although not significant, were similar to findings in the literature examining healthy 




2013).  Mehta et al (2016) conducted a comprehensive review of the literature on 
biopsychosocial mechanisms in women with a history of MI.  In this review, findings support 
that younger women performed less healthy behaviors that included poorer stress management, 
less physical function, and less social support compared to men.  Beckie et al (2015) found 
greater stress, lower social support, greater anxiety symptoms, and lower enrollment or 
sustainability in cardiac rehabilitation in younger women compared to older women.    
Summary of Major Findings 
 The correlational analyses demonstrated that greater depressive and anxiety symptoms 
were associated with fewer healthy behaviors, poorer QoL, less social support and more 
functional comorbidities.  Illness perception was also associated with healthy behaviors and 
QoL.  Women who perceived CVD attributed to less symptoms, CVD had few negative 
consequences, CVD could be personally controlled, and CVD was understandable were 
associated with more health promoting behaviors and greater QoL. In addition, the perception 
that more symptoms are related CVD, CVD caused distress, and CVD was difficult to 
understand were associated with greater depressive and/or anxiety symptoms. 
 In terms of regression analyses, the significant predictors of QoL were less anxiety, better 
HPB, fewer comorbidities, less distress in risk perception, and more social support.  Although 
anxiety was a stronger predictor of poorer QoL than depressive symptoms, there was a trend for 
depressive symptoms as a predictor.  Greater health promoting behaviors and social support 
predict greater QoL.  Greater functional comorbidities and the belief CVD caused more distress 




Younger women with CVD reported worse outcomes than older women.  Younger 
women had poorer QoL than older women and there was a trend for younger women to have 
more anxiety and the belief that CVD caused more emotional distress.  Although depressive 
symptoms and health promoting behaviors were not significantly different among age groups, 
women who were younger had greater depressive symptoms, fewer health promoting behaviors, 
and less social support.    
Limitations 
The non-experimental design of the study affects the internal validity of the findings and 
was perhaps the greatest limitation of this study.  As a cross-sectional correlational design study, 
no causal relationships can be established.  However, the study did identify the relationship of 
depressive and/or anxiety symptoms, health promoting behaviors, and illness perceptions to 
overall quality of life, therefore, added knowledge to the health status of women with CVD.  
Participation selection bias also occurred because a convenient nonrandom sample of women 
was used.  The sampling technique did not allow for an equal number of participants for the 
younger and older age groups.  Although the groups were almost equal, there were more older 
women than younger women and the difference in age groups may have contributed to the 
findings.  Another threat to internal validity was instrumentation.  The use of self-report 
questionnaires relies on honest reporting and accurate self-assessment.  It is impossible to know 
if the study participants over or under-estimated negative mood, health promoting behaviors, 
illness perception, social support, or QoL.  In addition, testing was a concern due to the length of 
time it took to complete the questionnaires.  Response burden may have occurred because the 




Questionnaires that are long and time consuming may negatively impact the motivation and 
effort to answer the items accurately.  To address this potential limitation, the participants were 
informed of the time required to complete the questionnaire prior to consenting to participate in 
the study.  There was minimal amount of missing data from the self-report questionnaires.  In 
order to reduce missing data, the questionnaires were reviewed after they were completed by the 
participant to reduce this error.  There was one item, annual income, on the demographic 
questionnaire that was missing data from two participants, otherwise there was no other missing 
data.  Participants were recruited from two separate sites that may have also been a potential 
threat to internal validity.  However, the two site locations had similar demographics and 
received treatment from the same cardiology group practitioners.  They also had the same 
practice standards and education material at both site locations, thus minimizing this threat.   
 Using a convenience sample, there is selection bias which is a threat to external validity 
by reducing the generalizability to the general population.  The majority of the participants 
(75%) came from within 14 miles of the recruitment sites in the same county.  The racial 
composition of the county was 68.6% White, 13.9% Hispanic, 10.8% Asian, and 4.6% Black 
(Census Bureau:  America Community Survey, 2015).  The racial composition of the study 
participants were largely White (81.5%) and there was less minority representation (3.7% 
Hispanic, 1.2% Asian, and 8.6% Black).  Lack of enrollment of more Hispanic women may be 
due to the study inclusion criteria to be able to read and speak the English language.  Increase in 
ethnic participation is a challenge in clinical research, however, this should be a consideration for 
future researchers conducting this type of work.  Overall, the study sample was not racially 




support, and experienced few depressive/anxiety symptoms.  Finally, study exclusion criteria 
may have been a threat to external validity.  The results of this study may not apply to women 
with heart failure, previous cerebral vascular accident, end-stage renal disease, and non-English 
speaking or reading women because these were identified exclusion criteria.  This study’s 
limitations should be noted when interpreting the study findings. 
Nursing Implications 
 This study was conducted to gain more knowledge on the impact that depressive and/or 
anxiety symptoms have on health promoting behaviors, illness perception, and QoL in women 
with CVD.  The findings from the study found that there was a trend for anxiety symptoms and a 
negative perception of CVD illness to be greater in younger women.  In addition, younger 
women reported less social support compared to older women.  This is an important finding 
because social support is associated with greater QoL.  A key finding from this study was that 
negative mood was a barrier to illness perception by its relationship to perceiving more 
symptoms were related to CVD, less understanding of CVD, and CVD caused more distress 
(worry, fear, anger).  Other researchers found that negative mood altered illness perception by its 
association to perceiving CVD was chronic, CVD caused more negative consequences, and CVD 
could not be controlled (Dickens et al., 2008; Le Grande et al., 2012; Stafford et al., 2009). The 
findings from this study support the importance to initiate anxiety screening and continue 
depression screening for early detective of negative mood.   As well as, examine illness 
perceptions of women with CVD.  Once early detection of negative mood is established, the 
appropriate strategies can be discussed with the patient and implemented by a nurse driven team 




include medication, cognitive therapy, illness perception interventions, education on CVD, 
healthy behavior interventions, and social support.  Overall, these strategic interventions will be 
to treat negative mood symptoms, promote healthy behaviors, address illness perceptions of 
CVD, and promote social support in women with CVD, with the ultimate goal of greater QoL. 
Most nurse practitioners focus on behavioral changes to health (e.g. medication 
adherence, diet, physical activity), however, these may not be effective if there is not detection 
and resolution of the emotional responses to the disease.  Nurse practitioners have the 
opportunity to establish evidence-based guidelines that address a more holistic approach to 
address the biopsychosocial needs of women with negative mood using a collaborative care 
model.  Evidence-based collaborative care models have been developed for effective 
improvement in the treatment of both depression and health care in patients with depression and 
chronic disease, including CVD (Ludman et al., 2013;  Katon et al., 2010; Rosenberg, Lin, 
Peterson, Ludman, VonKorff, & Katon, 2013).  The advanced practice nurse is the manager of 
the collaborate care program who works jointly with the patient and primary care physician and 
specialist physician(s) (cardiologists, psychiatrist, and psychologist) to improve depression, 
medical disease control, and patient self-management.  Since the development of a team care 
approach to address depression and chronic disease, other research has shown the effectiveness 
of the collaborative care model with other negative moods, including anxiety (Bickett & Tapp, 
2016; Celano et al., 2016; Huffman et al., 2014).  Researchers have found that collaborative care 
programs for the delivery of care to individuals with negative mood and CVD are more effective 
in improving negative mood, healthy behaviors, and QoL, as well as, cost effective and 




developing, implementing, and managing collaborative care models, the advanced practice nurse 
must work with other health care professionals to develop methods for evaluating the 
effectiveness of the program.  This would include evaluating changes in negative mood, illness 
perceptions, healthy behaviors, and QoL, as well as, the cost effectiveness of the program. 
Overall, findings from this study support the need to identify early detection of negative 
mood and implement interventions to promote engagement in healthy behaviors and improve 
QoL.  Collaborative care models, managed by advanced practice nurses, have been shown to be 
more effective in improving negative mood, healthy behaviors, and QoL in patients with CVD.  
Ultimately, advanced practice nurses have the opportunity to develop evidence-based practice 
guidelines to develop and implement a collaborative care approach to improve women’s CVD 
health and QoL.  The overall benefit could potentially reduce CVD secondary events that 
translate to cost savings to the health care system. 
Also important for nurses to address when caring for women with CVD is that younger 
women had trended toward greater anxiety symptoms and negative perceptions of their CVD 
illness, but experienced a lower QoL compared to older women that was statistically significant.  
Whether this has clinical significance may be of question.  They also had more depressive 
symptoms and poorer healthy behaviors than older women, but these findings were not 
statistically significant.  Of key importance, however, is that younger women with CVD have an 
increased risk for poorer health outcomes or a secondary cardiac event (i.e. MI).  Studies have 
found that greater depressive and/or anxiety symptoms are found in younger women and the use 
of anti-depressants or anti-anxiety medications have improved their mood, engagement in 




2007; Mavrides & Nemeroff, 2015; Mazza et al., 2010; Wang, Hoffman & Blumenthal, 2011).  
In addition, cognitive behavior therapy and stress management have been found to improve 
depressive and/or anxiety symptoms in CVD patients (Berkman et al., 2003; Dau et al., 2011; 
Freedland et al., 2009; Mavrides & Nemeroff, 2015).  In the literature, there has been discussion 
on the safety and efficacy of selective serotonin uptake inhibitors (SSRI’s) to treat depression in 
CVD patients.  Mayrides & Nemeroff (2015) literature review on the treatment of depression in 
CVD found fourteen clinical trials demonstrating the efficacy and safety of anti-depressant 
medication and psychotherapy (cognitive behavioral therapy and interpersonal therapy) in heart 
disease patients.  Cognitive behavioral therapy focus on altering cognitions and behavioral 
activations, whereas, interpersonal therapy focus on resolving interpersonal issues that are 
characteristic of depression (Scherrer et al., 2011). These are important research findings to 
support that health care providers need to target the younger women to treatments (anti-
depressants, anti-anxiety medication, illness perception interventions, healthy behavior 
education, stress management, and cognitive behavioral therapy) because it appears the older 
women have less risk for poorer health outcomes. Additional research examining whether there 
are age group differences with negative mood, health promoting behaviors, illness perception, 
and QoL in women with CVD may provide more knowledge on age groups to target for 
treatment.  As well as, research examining the effectiveness of the treatments/interventions for 
health care outcomes, including QoL, in women with CVD. 
Future Research 
In 2008, the American Heart Association (AHA) advisory recommended screening for 




AHA advisory has not recommended routine screening of anxiety in CVD patients, although 
anxiety symptoms are present in CVD patients and associated with increased mortality and CV 
adverse events, as well as, reduced healthy behaviors, altered perception of being ill, and poorer 
QoL (Frasure-Smith et al., 2008; Foxwell et al., 2013; Kuhl et al., 2009; Martens et al., 2010; 
Roest et al., 2012).  There are currently not enough randomized clinical trials demonstrating that 
anxiety screening is safe, cost effective and is associated with clinical benefits, that include the 
reduction of anxiety symptoms and improved clinical outcomes (Bunevicius et al., 2013).  
Current research being conducted is the Understanding the Benefits of Exercise and 
Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) randomized clinical 
trial that is examining the efficacy of treating anxiety in CVD patients for reducing symptoms 
and improving clinical outcomes (Blumenthal et al., 2016).  Although, over the past few years 
there has been an increase number of research studies identifying an association between anxiety, 
CVD, healthy behaviors and QoL, additional clinical trials are warranted to determine whether 
routine anxiety screening and treatment will improve anxiety symptoms and QoL.  In addition, 
further research is needed examining both depressive and anxiety symptoms and the association 
between healthy behaviors, illness perceptions, and QoL in women of younger and older age 
groups with CVD.  The current study identified differences among younger and older women, 
with younger women trending toward more anxiety symptoms, greater negative perceptions of 
being ill, and statistically significant poorer QoL.  The results from this study identified that 
health care providers need to target the younger women to strategic interventions to improve 




The American Heart Association (AHA) Council on Cardiovascular and Stroke Nursing 
(CVSN) is charged to promote the AHA 2020 strategic goal of improving CV health and 
reducing mortality (AHA, 2017).  In 2018, the AHA Council on CVSN identified CV nursing 
science priorities for future CVD research.  Based on the results of the current study and the 
AHA Council on CVSN recommendations for future research, it would be realistic to design a 
longitudinal interventional study that evaluated the effectiveness of using collaborative care 
models to implement evidence-based interventions (antidepressants, anti-anxiety medications, 
cognitive behavioral therapy, illness perception interventions, healthy behavior education, stress 
management) to address the biopsychosocial needs of women with CVD for improved QoL.  The 
evaluation would need to include consistent measurement of the current study key variables, 
depressive and/or anxiety symptoms, healthy behaviors, illness perception, and QoL.  Further 
research is needed examining illness perception and whether it predicts healthy behaviors or 
negative mood.  It would be interesting to identify whether increased knowledge on CVD would 
alter the individual’s illness perception and whether the change in illness perception would 
reduce depressive and/or anxiety symptoms and increase healthy behaviors. Further research is 
needed examining the effect that treatment/interventions have on the key variables and whether 
this treatment predicts a change in the associations between these variables.   
Another area for future research is to assess and validate existing instruments or develop 
instruments that can be used to evaluate these key variables.  Participant response burden from 
lengthy questionnaires can be avoided by using short form instruments.  This is important to 
consider especially with longitudinal studies obtaining repeated measurements of the variables.  




items) to measure anxiety symptoms, and the IPQR-cardiac (76 items) to measure illness 
perceptions.  Shorter versions of each of these instruments, PHQ-2 (2 items), GAD-2 (2 items), 
and Brief IPQ (11 items), have been found to be reliable and valid tools and could be used to 
prevent response burden.  Ongoing assessment and validation of instruments may lead to the 
development of new instruments that are shorter in length, reliable, and valid tools. 
The findings of this study are important in considering future research that will determine 
ways to minimize negative mood and improve QoL in women with CVD, especially younger 
women.  This study found that younger women trended toward greater anxiety symptoms and a 
negative perception of CVD illness which may have contributed to their poorer QoL, although it 
is not clear whether this is clinically significant.  Future nursing research should focus on 
discovering early detection of negative mood and treatments/interventions that will improve 
mental health, healthy behaviors, illness perceptions and QoL in women with CVD.  In addition, 
it would be important to identify whether a positive alteration of these key variables is associated 
with a reduction of secondary cardiac events. 
Finally, while designing future research studies on women with CVD, there needs to be 
an increased effort to obtain representation of vulnerable populations.  Although there are limited 
studies on women with CVD, there are even less studies that include non-white female 
participants.  Strategies to recruit more women of ethnicity/race needs to be a priority for future 
studies.  This is particularly important as there is evidence that women of Hispanic, Asian, 
American Indian, Alaska Native ethnicity and African American women are underserved, 
understudied and at greatest risk for CVD.  Heart disease is the leading cause of death in African 




and Alaska Native women (Benjamin et al., 2018).  Cultural beliefs may vary among women of 
different ethnicity/race.  These cultural beliefs may have a strong influence on heathy behaviors 
and illness perceptions that may increase the risk for CVD.  Future research including women 
from vulnerable populations will help identify the most effective interventions for decreasing 









Demographic and Health History Information 
 
Date:____________________ ID#:  _____________ MRN#:_________________ 
 
Zip code: _________________ 
 
Please fill out the information below: 
 
1. Age: _____________ 
  
2.  History of Heart Disease (please circle all that you have) 
o Heart attack 
o Angioplasty 
o Stent 
o Coronary artery bypass surgery 
o Chest pain symptoms from blocked arteries in your heart 
 
3.  How long have you had heart disease?__________________________________ 
 
4.  Ethnicity/Race:  (please circle one) 




o Pacific Islander 
o American Indian 
o Alaska Native:______________ 
o Other:__________________________ 
  




o Single, and living with partner 
o Single, and not living with partner 
o Widowed 
  
6.  Education Status: (please circle the highest level of education) 
o High school 
o Associate degree 
o Trade, vocational, technical 
o College degree 





7.  Household income: (please circle one) 
o < $20,000 
o $20,000 - $29,999 
o $30,000 - $39,999 
o $40,000 – $54,999 
o $55,000 – $64,999 
o $65,000 - $79,999 
o $80,000 - $94,999 
o > $95,000 
8.  Employment Status:  (please circle one ) 
o Full time 






9.  Please list any prescribed medications you are currently taking: 
 
_____________________ ______________________ ________________________ 
_____________________ ______________________ ________________________ 
_____________________ ______________________ ________________________ 
_____________________ ______________________ ________________________ 
_____________________ ______________________ ________________________ 
10.  Over the counter medications (including vitamins and supplements): 
_____________________ ______________________ _________________________ 
_____________________ ______________________ _________________________ 






















THE FUNCTIONAL COMORBIDITY INDEX 
 
Have you ever been told by a doctor that you have any of the following?  If yes, Circle YES. If no, Circle NO. 
 
             YES    NO 
1 Arthritis (rheumatoid and osteoarthritis) YES NO 
2 Osteoporosis  YES NO 
3 Asthma YES NO 
4 Chronic Obstructive Pulmonary Disease (COPD),  respiratory distress syndrome, or 
emphysema 
YES NO 
5 Angina  YES NO 
6 Congestive Heart Failure (or heart disease) YES NO 
7 Heart Attack (Myocardial Infarct) YES NO 
8 Neurological Disease (such as Multiple Sclerosis or Parkinson’s) YES NO 
9 Stroke or TIA YES NO 
10 Peripheral Vascular Disease  YES NO 
11 Diabetes Types I and II YES NO 
12 Upper Gastrointestinal Disease (ulcer, hernia, reflux). YES NO 
13 Depression YES NO 
14 Anxiety or Panic Disorders  YES NO 
15 Visual Impairment (such as cataracts, glaucoma, macular degeneration) YES NO 
16 Hearing Impairment (very hard of hearing, even with hearing aids) YES NO 
17 Degenerative disc disease (back disease, spinal stenosis, or severe chronic back 
pain) 
YES NO 
18 Obesity and/or Body Mass Index >30 (weight in kg /( height in meters)2 ) 
height_____________________(cm or inches?) 




If the FCI is self-administered question 18 can be modified to read: 
What is your current height___________  weight________________ 
And then BMI is calculated by the researchers.  If BMI is greater then 30, 1 point is added for obesity. 
Groll, D. L., To, T., Bombardier, C. & Wright, J. G. (2005).  The development of a comorbidity index with physical function as 




Functional Comorbidity Index (FCI) 
Scoring Guidelines 
The eighteen items are scored as a no or yes: No  = 0 
       Yes  = 1 
The scale score ranges from 0 – 18. 
The score for FCI is obtained by calculating and adding each item to obtain a total score. 
The higher the FCI score indicated greater comorbidity and is associated with greater impairment 




































Patient Health Questionnaire-8 (PHQ-8) 
 
Over the past few weeks, how often have you been bothered by any of the following?  Place an “X” in the box to 
indicate your answer.     
   
 
 
Kroenke, K., Spitzer, R. L. & Williams, J. B. W. (2001).  The PHQ-9:  Validity of a Brief Depression Severity Measure.  Journal 





Patient Health Questionnaire-8 (PHQ-8) 
Scoring Guidelines 
The items are scored as: Not at all   = 0 
    Several days   = 1 
    More than half the days = 2 
    Nearly every day  = 3  
 
The scale score ranges from 0 – 24 
 
The score for depressive symptoms is obtained by calculating by adding each item score to 
obtain a total score.  A score of ≥ 10 is the cutoff score for the possible diagnosis of depressive 
disorder and confirm by further evaluation. 
 
Interpreting the Score: 
 
Total Score  Level of Depression Severity 
0-4   Minimal 
5-9   Mild 
10-14   Moderate 
15-19   moderately severe 




Kroenke, K., Spitzer, R. L. & Williams, J. B. W. (2001).  The PHQ-9:  Validity of a Brief Depression Severity Measure.  Journal 
of General Internal Medicine, 16, 606-613. 
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T. & Mokdad, A. H. (2009).  The PHQ-8 as a measure of 









Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Lowe, B. (2006).  A brief measure for assessing generalized 










The items are scored as: Not at all   = 0 
    Several days   = 1 
    More than half the days = 2 
    Nearly every day  = 3 
 
The scale score ranges from 0 - 21 
The score for GAD is obtained by calculating the adding each item score to obtain a total score.  
A score ≥ 10 is the cutoff score for the possible diagnosis of GAD and confirm by further 
evaluation. 
 
Interpreting the Score:  
 
Total Score   Level of Anxiety Severity 
0-4   Minimal 
5-9    Mild  
10-14   Moderate  
15-21   Severe  
 
Spitzer, R. L., Kroenke, K., Williams, J. B. W. & Lowe, B. (2006).  A brief measure for assessing generalized 






















Items are scored as: Never (N)   =  1 
Sometimes (S)  =  2 
Often (O)  =  3 
Routinely (R)   =  4 
 
A score for overall health-promoting lifestyle is obtained by calculating a mean of the 
individual's responses to all 52 items; six subscale scores are obtained similarly by calculating a 
mean of the responses to subscale items. The use of means rather than sums of scale items is 
recommended to retain the 1 to 4 metric of item responses and to allow meaningful 
comparisons of scores across subscales.  
 
The items included on each scale are as follows: 
 
Health-Promoting Lifestyle 1 to 52 
 
Health Responsibility 3, 9, 15, 21, 27, 33, 39, 45, 51 
 
Physical Activity 4, 10, 16, 22, 28, 34, 40, 46 
 
Nutrition 2, 8, 14, 20, 26, 32, 38, 44, 50 
 
Spiritual Growth 6, 12, 18, 24, 30, 36, 42, 48, 52 
 
Interpersonal Relations 1, 7, 13, 19, 25, 31, 37, 43, 49 
 


















Illness Perception Questionnaire – Revised (IPQ-R) Cardiac Version 
Perceived Heart Risk (4 items) 
YOUR VIEWS ABOUT YOUR HEART DISEASE 
 
Listed below are a number of symptoms that you may or may not have experienced since your heart 
disease.  Please indicate by circling Yes or No, whether you have experienced any of these symptoms 
since your heart disease, and whether you believe that these symptoms are related to your heart disease. 
 
   I have experienced this    This symptom is related to my 
   symptom since my heart disease    heart disease 
 
Pain    Yes  No _____________ Yes  No 
Sore Throat   Yes  No _____________ Yes  No 
Nausea    Yes  No _____________ Yes  No 
Breathlessness   Yes  No _____________ Yes  No 
Weight Loss   Yes  No _____________ Yes  No 
Fatigue    Yes  No _____________ Yes  No 
Stiff Joints   Yes  No _____________ Yes  No 
Sore Eyes   Yes  No _____________ Yes  No 
Wheeziness   Yes  No _____________ Yes  No 
Headaches   Yes  No _____________ Yes  No 
Upset Stomach   Yes  No _____________ Yes  No 
Sleep Difficulties  Yes  No _____________ Yes  No 
Dizziness   Yes  No _____________ Yes  No 
Loss of Strength  Yes  No _____________ Yes  No 
Chest Pain   Yes  No _____________ Yes  No 
Shortness of Breath  Yes  No _____________ Yes  No 
Loss of Appetite  Yes  No _____________ Yes  No 
Weakness   Yes  No _____________ Yes  No 
Unusually Scared  Yes  No _____________ Yes  No 






We are interested in your own personal views of how you now see your current heart disease. 
 
Please indicate how much you agree or disagree with the following statements about your heart 
disease by ticking the appropriate box. 
 









IP1 My heart disease will last a short 
time 
     
IP2 My heart disease is likely to be 
permanent rather than temporary 
     
IP3 My heart disease will last for a 
long time 
     
 










IP4* This heart disease will pass 
quickly 
     
IP5* I expect to have this heart disease 
for the rest of my life 
     
IP6 My heart disease is a serious 
condition 
     
IP7 My heart disease has major 
consequences on my life 
     
IP8* My heart disease does not have 
much effect on my life 
     
IP9 My heart disease strongly affects 
the way others see me 
     
IP10 My heart disease has serious 
financial consequences 
     
IP11 My heart disease causes 
difficulties for those who are 
close to me 
     
IP12 There is a lot which I can do to 
control my symptoms 
     
IP13 What I do can determine whether 
my heart disease gets better or 
worse 
     
IP14 The course of my heart disease 
depends on me 






Nothing I do will affect my heart 
disease 
     
IP16 I have the power to influence my 
heart disease 
     
IP17
* 
My actions will have no affect on 
the outcome of my heart disease 
     
IP18
* 
My heart disease will improve in 
time 
     
IP19
* 
There is little that can be done to 
improve my heart disease 
     
IP20 My treatment will be effective in 
curing my heart disease 
     
IP21 The negative effects of my heart 
disease can be prevented 
(avoided) by my treatment 
     
IP22 My treatment can control my 
heart disease 
     
IP23
* 
There is nothing which can help 
my condition 
 
     
IP24 The symptoms of my condition 
are puzzling to me 
     
IP25 My heart disease is a mystery to 
me 
     
IP26 I don’t understand my heart 
disease 
     
IP27 My heart disease doesn’t make 
any sense to me 
     
IP28
* 
I have a clear picture or 
understanding of my condition 
     
IP29 The symptoms of my heart 
disease change a great deal 
     
IP30 My symptoms come and go in 
cycles 
     
IP31 My heart disease is very 
unpredictable 
     
IP32 I go through cycles in which my 
heart disease gets better and 
worse 
     
IP33 I get depressed when I think 
about my heart disease 
     
IP34 When I think about my heart 
disease I get upset 




IP35 My heart disease makes me feel 
angry 
     
IP36
* 
My heart disease does not worry 
me 
     
IP37 Having this heart disease makes 
me feel anxious 
     
IP38 My heart disease makes me feel 
afraid 
     
 
Causes of My Heart Disease 
 
We are interested in what you consider may have been the cause of your heart disease.  As 
people are very different, there is no correct answer for this question.  We are most interested in 
your own views about the factors that caused your heart disease rather than what others including 
doctors or family may have suggested to you.  Below is a list of possible causes for your heart 
disease.  Please indicate how much you agree or disagree that they were causes for you by 
ticking the appropriate box. 
 







C1 Stress or worry      
C2 Hereditary – it runs in my family      
C3 A Germ or virus      
C4 Diet or eating habits      
C5 Chance or bad luck      
C6 Poor medical care in my past      
C7 Pollution in the environment      
C8 My own behavior      
C9 My mental attitude e.g. thinking 
about life negatively 
     
C10 Family problems or worries      
C11* Overwork      
C12* My emotional state e.g. feeling 
down, lonely, anxious, empty 
     
C13* Ageing       
C14* Alcohol      
C15* Smoking      
C16* Accident or injury      
C17* My personality      





In the table below, please list in rank-order the three most important factors that you now believe 
caused YOUR heart disease.  You may use any of the items from the box above, or you may 
have additional ideas of your own. 
 




3.  ______________________________________________________ 
Reference 
Moss-Morris, R., Weinman, J., Petrie, K.J., Horne, R., Cameron, L.D. & Buick, D. (2002). The 
Revised Illness Perception Questionnaire(IPQ-R). Psychology and Health, 17(1), 1-16 
 
Using and Scoring the IPQ-R Subscales 
 
It is advisable to have a good read of the IPQ-R paper before you use the questionnaire.  The 
paper can be downloaded from this website. As outlined in the paper, the questionnaire can be 
adapted for particular groups.  Items relevant to the identity and causes of the illness can readily 
be inserted into the questionnaire.   
 
The pdf English version of the IPQ-R on this website asks the questions in relation to illness.  
Wherever possible, the word illness should be replaced with the name of the particular illness or 
condition under study e.g. diabetes, chronic fatigue syndrome. 
 
SCORING THE IPQ-R 
Please note: 
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly 
held beliefs about the number of symptoms attributed to the illness, the chronicity of the 
condition, the negative consequences of the illness, and the cyclical nature of the condition. 
High scores on the personal control, treatment control and coherence dimensions, represent 
positive beliefs about the controllability of the illness and a personal understanding of the 
condition.  
Coding: for identity scale yes = 1; no = 0 
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 
Reverse score: IP1, IP4, IP8, IP15, IP17, IP18, IP19, IP23, IP24, IP25, IP26, IP27, IP36 
 
1.  Identity: sum yes-rated symptoms in column 2 (this symptom is related to my illness) on p. 1 
 





3.  Consequences:  sum items IP6 - IP11 
 
4.  Personal control: sum items IP12 - 1P17 
 
5.  Treatment control items: sum items IP19 – IP23 
 
6.  Illness coherence items: sum items IP24 – IP28 
 
7.  Timeline cyclical: sum items IP29 – IP32 
 
8.  Emotional representations: sum items IP33 – IP38 
 
9.  Causes:  items C1 - C18   
Do not use these as a scale. Start analysis with separate items - used as grouping variables 
(ie those who do/do not believe in a specific causal factor). With a sufficient sample size 
(n=85 or more), factor analysis can be used to identify groups of causal beliefs (eg lifestyle; 
stress etc) which can then be used as sub-scales (see the following papers for examples). 
References 
Moss-Morris, R., Weinman, J., Petrie, K.J., Horne, R., Cameron, L.D. & Buick, D. (2002). The 
Revised Illness Perception Questionnaire (IPQ-R). Psychology and Health, 17(1), 1-16. 
Weinman, J., Petrie, K., Sharpe, N. & Walker, S. (2000). Causal attributions in patients and 
spouses following a heart attack and subsequent lifestyle changes. British Journal of 






































The Satisfaction Section (Part 1) will only be used to measure QOL. 
 
STEPS FOR CALCULATING QLI SCORES FOR THE SATISFACTION SECTION 
ONLY: 
 
When using the Satisfaction Section only, insert a “6” score for all the important responses in 
Section 2 of the Quality of Life Index Cardiac Version-IV.  Conceptually this will make all items 




1.  Subtract the number 1 from the response for each satisfaction item. 
2.  Multiply each item by the number 6. 
3.  Sum the appropriate items for the scale (these are listed on the QLI under Questionnaires and 
Scoring  Subscale Items).  This is on the QLI website at www.uic.edu/orgs/qli. 
4.    Divide the sum obtained in step 3 by the number of items answered by that person.  This can be 
accomplished by calculating a mean for EACH individual person (NOTE: this is different from a 






MOS SOCIAL SUPPORT SURVEY 
 
Next are some questions about the support that is available to you. 
 
1.  About how many close friends and close relatives do you have (people you feel at ease with 
and can talk to about what is on your mind)? 
  
Write in number of close friends                        number of close relatives 
 
People sometimes look to others for companionship, assistance, or other types of support. 
How often is each of these following types of support available to you if you need it? 
 
Circle one number on each line 
 
        None A little Some Most All 
        Of the of the of the of the of the 
        Time Time Time Time Time 
 
2.   Someone to help you if you were confined to bed 1 2 3 4 5 
 
3.   Someone you can count on to listen to you when 
      you need to talk      1 2 3 4 5 
 
4.   Someone to give you good advice about a crisis  1 2 3 4 5 
 
5.   Someone to take you to the doctor if you needed it 1 2 3 4 5 
 
6.   Someone who shows you love and affection  1 2 3 4 5 
 
7.   Someone to have a good time with   1 2 3 4 5 
 
8.   Someone to give you information to help you  
       understand a situation     1 2 3 4 5 
9.    Someone to confide in or talk to about yourself or 
       your problems      1 2 3 4 5 
 
10.  Someone who hugs you     1 2 3 4 5 
 











People sometimes look to others for companionship, assistance, or other types of support. 




Circle one number on each line 
 
        None A little Some Most All 
        Of the of the of the of the of the 
        Time Time Time Time Time 
 
12.  Someone to prepare your meals if you were unable 
       to do it by yourself     1 2 3 4 5 
 
13.  Someone whose advice you really want   1 2 3 4 5 
 
14.  Someone to do things with to help you get your 
       mind off things      1 2 3 4 5 
 
15.  Someone to help with daily chores if you were sick 1 2 3 4 5 
 
16.  Someone to share your most private worries and  
       fears with       1 2 3 4 5 
 
17.  Someone to turn to for suggestions about how to  
       deal with a personal problem    1 2 3 4 5 
 
18.  Someone to do something enjoyable with  1 2 3 4 5 
 
19.  Someone who understands your problems  1 2 3 4 5 
 
20.  Someone to love and make you feel wanted  1 2 3 4 5 
 
Reference 
Sherbourne, C. D. & Stewart, A. L. (1991).  The MOS social support survey.  Social Science 



































Call or Email Today!!! 
Jacqueline Tulley 





• Women with heart 
disease 
• Age 35 to 78 
Reimbursed for 
time and effort $10 
Target gift card 
Questionnaire ~ 45 
minutes 
Does Mood Affect 
Healthy Behaviors 





LETTER OF INTENT 




April 3, 2017 
 
Jacqueline Tulley, MSN, ACNP-BC, RN 
Loyola University of Chicago 
Nursing PhD Student 
Dear Ms Tulley: 
Thank you for choosing Advocate Medical Group Cardiology (Downers Grove, Naperville, and 
Elmhurst locations) as the site for your nursing research project. We would like to extend this 
letter of support to participate in your study “The Impact of Mood on Health Behaviors and 
Quality of Life in Women with Cardiovascular Disease”. Our participation would be contingent 
upon the approval of the Advocate Medical Group Cardiology Protocol Review Committee and 
the Institutional Review Board at Advocate Health Care. 
I will be your contact person at AMG and can be reached at 630-785-2661 or 
lea.elder@advocathealth.com. If you have questions or we can provide you with additional 
information, please do not hesitate to call. Again, thank you for choosing Advocate Medical 
Group. 
Sincerely, 
Lea Elder, RN, MSN, MBA, CCRC 
Director of Research 
Advocate Medical Group, Cardiology 
 
cc.  Lawrence Barr, MD 

























Consent to Take Part in a Human Research Study 
 
Title of Research Study:  The Impact of Mood on Health Behaviors and Quality of Life in 
Women with Cardiovascular Disease 
Principal Investigator: Jacqueline Tulley, MSN, ACNP, RN 
Address:   Loyola University Chicago, Marcella Niehoff School of Nursing 
2160 S. 1st Avenue / Maywood, Illinois  60153 
Phone:     815-735-9824 
 
Why am I being invited to take part in a research study? 
You are being invited to take part in a research study because you are a woman with heart disease.  
There is evidence that shows mood may contribute to the lack of successful change in healthy 
behaviors in women with heart disease.  In addition, mood may have an effect on one’s illness 
perception and overall quality of life.  There are few studies examining the effect of mood on 
these factors in women with known heart disease, and thus the reason this study is being 
conducted. 
 
What should I know about a research study? 
• Someone will explain this research study to you. 
• Whether or not you take part is up to you. 
• You can choose not to take part. 
• You can agree to take part and later change your mind. 
• Your decision will not be held against you. 
• You can ask all the questions you want before you decide. 
 
Who can I talk to? 
If you have questions, concerns, or complaints, or think the research has hurt you, talk to the 
research team at Advocate Health Care IRB. 
This research has been reviewed, approved and will be monitored by the Institutional Review 
Board (“IRB”) of Advocate Health Care and Loyola University Chicago.  An IRB is a committee, 
independent of the Loyola University Chicago investigators, that reviews and oversees research 
studies to protect the rights and safety of participants.  You may talk to them at 630-929-6148 or 
email IRBMail@advocatehealth.com  if: 
• Your questions, concerns, or complaints are not being answered by the research team. 
• You cannot reach the research team. 
• You want to talk to someone besides the research team. 
• You have questions about your rights as a research subject. 









Why is this research being done? 
The purpose of this study is to see if mood impacts the perceptions of your health and whether 
 this may affect your ability to engage in healthy behaviors such as taking your medication, 
exercise and diet. We know that being depressed can often affect how well you take care of 
yourself.  However, we don’t know if it affects how you perceive your health.   Therefore, in 
order to better understand these relationships, we are asking questions about your mood, health 
perceptions, health behaviors, and quality of life.   
 
How long will the research last? 
You will only be in the study for the time it takes to complete the questionnaires which may be up 
to one hour.  
 
How many people will be studied? 
We expect up to 128 people for the study. 
 
What happens if I say yes, I want to be in this research? 
• If you agree to participate in this study you will be required to fill out a packet of 
questionnaires that describes your mood, illness perception, healthy behaviors, quality of 
life and demographic information.   
• Jacqueline Tulley, the principal investigator who is also a doctoral student at Loyola 
University, will contact you to schedule a date and time to meet at your cardiology 
outpatient office or designated location for you to complete the questionnaire.  
• The questionnaire will take approximately 45 minutes to complete.  You will only be 
asked to complete the questionnaires one time.  
• In order to meet the goals of the research study, Jacqueline Tulley will collect information 
on you from your Advocate Medical Group medical record (including, but not limited to, 
history and physical exam notes, progress notes, consultation reports, laboratory test 
results, and/or operative reports). 
What are my responsibilities if I take part in this research? 
If you take part in this research, you will be responsible for completing questionnaires and 
allowing me to access your medical record to record your age, height, weight, blood pressure, 
total cholesterol, HDL, smoking status, major diseases. 
What happens if I do not want to be in this research? 
You can leave the research at any time and it will not be held against you.  Your decision whether 
or not to participate will not affect your current or future relationship with Advocate Health Care.   
 
What happens if I say yes, but I change my mind later? 
You can leave the research at any time it will not be held against you.  You can stop the survey at 
 
  




any time without it affecting your medical care.  The partially completed surveys will be kept to 
determine reasons for partial completion and compare to those who completed the entire survey. 
 
Is there any way being in this study could be bad for me? 
Enrollment in this study may cause you to feel uncomfortable when answering some of the survey 
questions.  After completing the surveys if there are concerns about your mood, you should talk to 
your healthcare provider and you will be provided Advocate information about mental health. 
Will there be any costs to me if I participate? 
There will not be any costs to you if you participate. 
You will receive a $10 Target gift card as a thank you for your time participating in this study 
when you complete the questionnaires. 
 
Will being in this study help me in any way? 
You will not benefit from participating in this study. 
What happens to the information collected for the research? 
Efforts will be made to limit the use and disclosure of your personal information, including 
research study and medical records, to people who have a need to review this information. We 
cannot promise complete confidentiality. Organizations that may inspect and copy your 
information include the Advocate Health Care IRB and other representatives of this organization 
involved in the monitoring and oversight of research. 
 
Federal law provides additional protections of your medical records and related health infor-
mation. That law is the Health Insurance Portability and Accountability Act (HIPAA). This study’s 
HIPAA statement is provided below. You are providing your authorization if you sign this form. 
HIPAA Authorization 
 
How will my information be kept confidential? 
Your identity will be protected as required by law and according to any policies described in the 
Confidentiality section above.  You should be aware that your study records (which include your 
medical records, your signed consent form, and other identifiable information) will be shared as 
needed for the purposes of the study.  If this is a sponsored study, researchers may share your 
information with representatives of the sponsor for the purposes of managing and overseeing the 
study.  Usually the health information sent to sponsors does not directly identify participants (for 
example, by name or address).  Instead initials and a code number are used.  Some personal 
information, such as date of birth, will usually be included but will not be used to identify you.  
 
Additionally, governmental oversight authorities [e.g. the U.S. Food and Drug Administration 
(FDA) or the Department of Health and Human Services Office for Human Research Protections 
(OHRP)] may have access to your information.  Representatives of the Institutional Review 
Board overseeing this study may have access to your data. 
 
Please note that the study doctor or study staff may also share personal information about you if 
required by law (for example, if the study doctor or study staff suspects that you are going to 
harm someone or yourself).  If you have questions about this, please ask the study doctor. 
 




How will my information be used and shared for this study? 
This section explains who will use and share your health information if you agree to be in this 
study.  You must authorize this use and sharing of your information by signing this form or you 
cannot be in the study.  
 
The study principal investigator and study staff will collect, use, and share identifiable health 
information about you, including any information needed to conduct the study.  Information used 
and shared may include: 
• information from your medical records related to the research; 
• information collected about you during the research and any follow-up concerning study 
visits, tests, procedures, outcomes, etc. 
 
Your information may be used and shared for some or all of the following purposes:  
• to conduct this research; 
• to review the study, and to check the safety and results of the study; 
• to seek government approval of an investigational study drug, vaccine, device or product 
if such was involved in the trial; 
• to facilitate a public health authority that is authorized by law to collect or receive such 
information for the purpose of preventing or controlling disease, injury, or disability, and 
conducting public health surveillance, investigations, or interventions. 
 
After your information is shared with the organizations listed above, the law may not require 
them to protect the privacy of your information.  To maintain the integrity of this research, you 
might not have access to any health information developed as part of this study until it is 
completed.  At that point, you generally would have access to your health information.  
 
You can cancel your authorization to use and share your information at any time by writing a 
letter to the study doctor.  If you cancel your authorization, you will not be able to continue in the 
study.  If some aspects of the study were optional, you may cancel your authorization for the 
optional part(s) of the study and still remain in the main study. 
 
If you cancel your authorization, the study doctor and study staff will still be able to use and share 
your information that has already been collected to maintain the integrity of the study.  No new 
information will be collected without your permission.  This authorization to use and share your 
information has no expiration date.  If study information is used for scientific publications or 
educational purposes, all identifying information will be removed. 
 
Signature Block for Capable Adult 
 
Your signature documents your permission to take part in this research. 
   
Signature of subject  Date 
 
 
Printed name of subject 
                                                                                                          
Signature of person obtaining consent  Date 
                                                                                  
Printed name of person obtaining consent   
 









Behavioral Health Service 
Locations   
Naperville Counseling & 
Psychotherapy Center 
Naperville 
1555 Naperville Wheaton Road 
Suite 212 
Naperville, Illinois 60563 
1-866-296-5262 
 
Oak Brook Counseling & 
Psychotherapy Center 
Oak Brook 
2625 Butterfield Rd 
Suite 101N 
Oak Brook, IL 60523 
1-866-296-5262 
 
Christian Counseling Center 
Lombard 
2020 Meyers Road 




Associates in Professional Counseling 
Naperville 
1804 N. Naper Blvd #370 
Naperville, Il 60563 
1-888-545-5707 
 
Heritage Professional Associates 
Hinsdale 
120 East Ogden Ave 
Suite 220 




1737 S. Naperville Rd. 
Suite 206 






Linden Oaks Behavioral Health 
Naperville 
825 South West Street 
Naperville, Il 60540 
1-630-305-5027 
 
New Prairie Counseling Services 
Elmhurst 
360 W. Butterfield Rd 
Suite 120 







Depression and Coronary Artery Disease 
There is a link between depression and coronary artery disease.  People with heart disease are 
more likely to get depression.  And if a person has both depression and heart disease, they may 
not stay as healthy as possible.  They are less likely to take their medicines and get regular 
exercise.  And this may raise their risk of having a heart attack. 
Watch for symptoms of depression 
Depression causes you to feel sad and hopeless much of the time.  It’s different from normal 
feelings of sadness, grief, or low energy.  Depression is a medical problem that needs treatment.  
If you think you may be depressed, see your doctor for diagnosis and treatment right away.  
Untreated depression may get worse.  And your heart disease may get worse too. 
Your doctor can help 
If you have heart disease, your doctor will probably ask you some simple questions to check for 
any symptoms of depression.  But if you think you have symptoms of depression, do not wait to 
ask for help.  Your doctor can help find out if you are depressed and talk to you about your 
options for treatment. 
On your regular doctor visits, he or she might ask how often you have been bothered by any of 
the following problems in the past 2 weeks: 
• You don’t have interest or pleasure in doing things 
• You feel down, depressed, or hopeless 
If your doctor thinks you might have depression symptoms, he or she will ask you more about 
your symptoms.  Your doctor may refer you to another doctor who diagnoses and treats 
depression. 
Ask for help 
If you think you might be depressed, talk to your doctor.  The sooner you know if you are 
depressed, the sooner you can get treatment.  Treating depression is good for your health. 
Many people have concerns about seeking treatment for a mental health problem.   You might 
feel too embarrassed to ask for help.  Or maybe you think that you’ll get over depression on your 
own.  You may think it’s a sign of weakness, or you don’t want people to know about it.  It’s 
important to overcome these reasons for not seeking treatment. 
Take care of yourself 
If you have depression and heart disease, try hard to stay healthy.  Having both of these 
conditions can make it hard to take your medicines or do healthy things like exercise and eat 
right. 
For friends and family 
If you think that someone you know is depressed, the best thing you can do is to get the person to 
see a doctor.  The sooner someone with depression gets treatment, the sooner he or she will feel 
better. 
©2006-2017 Healthwise, Incorporated.  Care instructions adapted under license by your 
healthcare professional.  If you have questions about a medical condition or this instruction, 
always ask your healthcare professional.  Healthwise, Incorporated disclaims any warranty or 











Variables and Measurements of Study 
 
Following the revised version of Wilson & Cleary’s (1995) conceptual model of Health-Related 





Study Variable  
 
Measurement Tool Data collection method 
Biological Function Cardiovascular risk 
factors 
Co-morbidities 
Age, height, weight 
HDL, total cholesterol 
Diabetes 
Tobacco use 
Systolic blood pressure 












Cardiac Health Factors 
medications 
Demographic form 
(created by researcher) 
Self-report 
Symptom Status Depression Patient Health 
Questionnaire-8 (PHQ-8) 
Self-report 
Anxiety Generalized Anxiety 
Disorder-7 (GAD-7) 
Self-report 













Overall Quality of Life Satisfaction with life Quality of Life-Index 
Cardiac version (QLI- 
Cardiac IV) 
Self-report 
Characteristics of the 
Individual 
Age Demographic form 
(created by researcher) 
Self-report 
Race/Ethnicity Demographic form 
(created by researcher) 
Self-report 
Marital status Demographic form 
(created by researcher) 
Self-report 
Education status Demographic form 
(created by researcher) 
Self-report 
Employment Demographic form 
(created by researcher) 
Self-report 
Social economic status Demographic form 
(created by researcher) 
Self-report 




Medical Outcomes Study 
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